<html lang="en" class="js"><head><link rel="preload" href="/static/fonts/HardingText-Regular-Web-cecd90984f.woff2" as="font" type="font/woff2" crossorigin=""><script async="" src="//cdn.jsdelivr.net/npm/mathjax@2.7.5/MathJax.js?config=TeX-AMS-MML_SVG.js"></script><script async="" src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2"></script><script type="text/javascript" async="" src="https://pagead2.googlesyndication.com/tag/js/gpt.js"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-MRVXSHQ"></script><script type="text/javascript" src="https://www.nature.com/RI3Dp4oxwREth4kfD4BLEnpdZVtIoUz0xS2XLNxnR5XG0owOMfuSyd7A_l6qDMgUTLW8kaVPhXcG1nnxdID6sQ=="></script><script src="https://cmp.nature.com/production_live/en/consent-bundle-8-85.js" onload="initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')"></script>
    <title>Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy | Nature Medicine</title>
    
        
<link rel="alternate" type="application/rss+xml" href="https://www.nature.com/nm.rss">


    
        

        <script id="save-data-connection-testing">
            function hasConnection() {
                return navigator.connection || navigator.mozConnection || navigator.webkitConnection || navigator.msConnection;
            }

            function createLink(src) {
                var preloadLink = document.createElement("link");
                preloadLink.rel = "preload";
                preloadLink.href = src;
                preloadLink.as = "font";
                preloadLink.type = "font/woff2";
                preloadLink.crossOrigin = "";
                document.head.insertBefore(preloadLink, document.head.firstChild);
            }

            var connectionDetail = {
                saveDataEnabled: false,
                slowConnection: false
            };

            var connection = hasConnection();
            if (connection) {
                connectionDetail.saveDataEnabled = connection.saveData;
                if (/\slow-2g|2g/.test(connection.effectiveType)) {
                    connectionDetail.slowConnection = true;
                }
            }

            if (!(connectionDetail.saveDataEnabled || connectionDetail.slowConnection)) {
                createLink("/static/fonts/HardingText-Regular-Web-cecd90984f.woff2");
            } else {
                document.documentElement.classList.add('save-data');
            }
        </script>
    

<link rel="preconnect" href="https://cmp.nature.com" crossorigin="">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<meta name="360-site-verification" content="5a2dc4ab3fcb9b0393241ffbbb490480">

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"letter","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"epidemiology","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Medicine","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Letter","status":null}},"article":{"doi":"10.1038/s41591-021-01334-5"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/4.0/"}}},"contentInfo":{"authors":["Giulia Giordano","Marta Colaneri","Alessandro Di Filippo","Franco Blanchini","Paolo Bolzern","Giuseppe De Nicolao","Paolo Sacchi","Patrizio Colaneri","Raffaele Bruno"],"publishedAt":1618531200,"publishedAtString":"2021-04-16","title":"Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy","legacy":null,"publishedAtTime":null,"documentType":"aplusplus","subjects":"Epidemiology"},"journal":{"pcode":"nm","title":"nature medicine","volume":"27","issue":"6","id":41591,"publishingModel":"Hybrid Access"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"BR","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"],"baiduId":"d38bce82bcb44717ccc29a90c4b781ea","japan":false}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        baiduId: 'd38bce82bcb44717ccc29a90c4b781ea',
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>

<script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>
 



     
    
    
        
    
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card--major .c-card__title,.c-card__title,.u-h2,.u-h3,h2,h3{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.u-h3,h3{font-size:1.25rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}html{line-height:1.15;text-size-adjust:100%;box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;line-height:1.76;margin:0;min-height:100%}details,main{display:block}h1{font-size:2em;margin:.67em 0}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input,select{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=checkbox]{box-sizing:border-box;padding:0}summary{display:list-item}[hidden]{display:none}button{border-radius:0;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;font-size:2rem;letter-spacing:-.0390625rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,.u-h3,h2{font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-card--major .c-card__title,.u-h2,h2{font-weight:700;-webkit-font-smoothing:antialiased;font-size:1.5rem;line-height:1.6rem}.u-h3{font-size:1.25rem}.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h4,h5,h6{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,h3{font-family:Harding,Palatino,serif;font-size:1.25rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,h3{font-weight:700;-webkit-font-smoothing:antialiased;letter-spacing:-.0117156rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;letter-spacing:-.0117156rem}input+label{padding-left:.5em}nav ol,nav ul{list-style:none none}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Harding,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-body p{margin-bottom:24px;margin-top:0}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-code-block{border:1px solid #eee;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-cod,.c-reading-companion__panel--active{display:block}.c-cod{font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-basis:75%;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#069;border:1px solid #069;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#069}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-context-bar--sticky .c-pdf-download{display:block;margin-bottom:0;white-space:nowrap}@media only screen and (max-width:539px){.c-pdf-download .u-sticky-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:16px}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.c-article-extras .c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:0}@media only screen and (min-width:540px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:none}@media only screen and (max-width:1023px){.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:block}}.c-recommendations-column-switch .c-meta{margin-top:auto}.c-article-recommendations-card__meta-type,.c-meta .c-meta__item:first-child{font-weight:700}.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.app-author-list{color:#6f6f6f;font-family:inherit;font-size:1rem;line-height:inherit;list-style:none;margin:0;padding:0}.app-author-list>li,.c-breadcrumbs>li,.c-footer__links>li,.js .app-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.app-author-list>li:not(:first-child):not(:last-child):before{content:", "}.app-author-list>li:not(:only-child):last-child:before{content:" & "}.app-author-list--compact{font-size:.875rem;line-height:1.4}.app-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .app-author-list__hide{display:none;visibility:hidden}.js .app-author-list__hide:first-child+*{margin-block-start:0}.c-meta{color:inherit;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;list-style:none;margin:0;padding:0}.c-meta--large{font-size:1rem}.c-meta--large .c-meta__item{margin-bottom:8px}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;margin-right:4px;padding-right:4px}@media only screen and (max-width:539px){.c-meta__item--block-sm-max{display:block}.c-meta__item--block-sm-max:not(:last-child){border-right:none;margin-right:0;padding-right:0}}@media only screen and (min-width:1024px){.c-meta__item--block-at-lg{display:block}.c-meta__item--block-at-lg:not(:last-child){border-right:none;margin-right:0;padding-right:0}}.c-meta__type{font-weight:700;text-transform:none}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}svg.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888;height:10px;width:10px}@media only screen and (max-width:539px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-card{background-color:transparent;border:0;box-shadow:none;display:flex;flex-direction:column;font-size:14px;min-width:0;overflow:hidden;padding:0;position:relative}.c-card--no-shape{background:0 0;border:0;box-shadow:none}.c-card__image{display:flex;justify-content:center;overflow:hidden;padding-bottom:56.25%;position:relative}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0}}.c-card__image img{left:0;min-height:100%;min-width:100%;position:absolute}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{height:100%;object-fit:cover;width:100%}}.c-card__body{flex:1 1 auto;padding:16px}.c-card--no-shape .c-card__body{padding:0}.c-card--no-shape .c-card__body:not(:first-child){padding-top:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}[lang=de] .c-card__title{hyphens:auto}.c-card__summary{line-height:1.4}.c-card__summary>p{margin-bottom:5px}.c-card__summary a{text-decoration:underline}.c-card__link:not(.c-card__link--no-block-link):before{bottom:0;content:"";left:0;position:absolute;right:0;top:0}.c-card--flush .c-card__body{padding:0}.c-card--major{font-size:1rem}.c-card--dark{background-color:#29303c;border-width:0;color:#e3e4e5}.c-card--dark .c-card__title{color:#fff}.c-card--dark .c-card__link,.c-card--dark .c-card__summary a{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin:8px 24px 8px 0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;gap:8px 8px;line-height:1.4;list-style:none;margin:0 -8px;padding:0}@media print{.c-header__menu{display:none}}@media only screen and (max-width:1023px){.c-header__menu--hide-lg-max{display:none;visibility:hidden}}.c-header__menu--global{font-weight:400;justify-content:flex-end}.c-header__menu--global svg{display:none;visibility:hidden}.c-header__menu--global svg:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__menu--global svg{display:block;visibility:visible}}.c-header__menu--journal{font-size:.875rem;margin:8px 0 8px -8px}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}.c-header__item{padding-bottom:0;padding-top:0;position:static}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}.c-header__item--padding{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}@media only screen and (min-width:1024px){.c-header__item--hide-lg{display:none;visibility:hidden}}@media only screen and (max-width:767px){.c-header__item--hide-md-max{display:none;visibility:hidden}.c-header__item--hide-md-max:first-child+*{margin-block-start:0}}.c-header__link{align-items:center;color:inherit;display:inline-flex;gap:4px 4px;padding:8px;white-space:nowrap}.c-header__link svg{transition-duration:.2s}.c-header__show-text{display:none;visibility:hidden}.has-tethered .c-header__heading--js-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__show-text{display:inline;visibility:visible}}.c-header__dropdown{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}@media print{.c-header__dropdown{display:none}}.c-header__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4;margin-bottom:8px}.c-header__heading--keyline{border-top:1px solid;border-color:#2f2f2f;margin-top:16px;padding-top:16px;width:100%}.c-header__list{display:flex;flex-wrap:wrap;gap:0 16px;list-style:none;margin:0 -8px}.c-header__flush{margin:0 -8px}.c-header__visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.c-header__search-form{margin-bottom:8px}.c-header__search-layout{display:flex;flex-wrap:wrap;gap:16px 16px}.c-header__search-layout>:first-child{flex:999 1 auto}.c-header__search-layout>*{flex:1 1 auto}.c-header__search-layout--max-width{max-width:720px}.c-header__search-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #fff;border-radius:2px;color:#fff;cursor:pointer;display:flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.15;margin:0;padding:8px 16px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:100%}.u-button svg,.u-button--primary svg{fill:currentcolor}.c-header__input,.c-header__select{border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:8px 16px;width:100%}.c-header__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}@media only screen and (min-width:540px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:0;right:auto}}.c-header__dropdown.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header__dropdown.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header__dropdown.has-tethered{min-width:225px}}.c-header__dropdown--full-width.has-tethered{padding:32px 0 24px;transform:none;width:100%}.has-tethered .c-header__heading--js-hide{display:none;visibility:hidden}.has-tethered .c-header__list--js-stack{flex-direction:column}.has-tethered .c-header__item--keyline,.has-tethered .c-header__list~.c-header__list .c-header__item:first-child{border-top:1px solid #d5d5d5;margin-top:8px;padding-top:8px}.c-header__item--snid-account-widget{display:flex}.c-header__container{padding:0 4px}.c-header__list{padding:0 12px}.c-header__menu .c-header__link{font-size:14px}.c-header__item--snid-account-widget .c-header__link{padding:8px}.c-header__menu--journal{margin-left:0}@media only screen and (min-width:540px){.c-header__container{padding:0 16px}.c-header__menu--journal{margin-left:-8px}.c-header__menu .c-header__link{font-size:16px}.c-header__link--search{gap:13px 13px}}.u-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}.u-hide-at-lg:first-child+*{margin-block-start:0}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.c-nature-box svg+.c-article__button-text,.u-ml-8{margin-left:8px}.u-pa-16{padding:16px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-article__button{background-color:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;margin-bottom:16px;padding:13px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-article__button,.c-article__button:hover{text-decoration:none}.c-article__button--inverted,.c-article__button:hover{background-color:#fff;color:#069}.c-article__button--inverted:hover{background-color:#069;color:#fff}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.c-nature-box{background-color:#fff;border:1px solid #d5d5d5;border-radius:2px;box-shadow:0 0 5px 0 rgba(51,51,51,.1);line-height:1.3;margin-bottom:24px;padding:16px 16px 3px}.c-nature-box__text{font-size:1rem;margin-bottom:16px}.c-nature-box--access-to-pdf{display:none}@media only screen and (min-width:1024px){.c-nature-box--mobile{display:none}}.c-nature-box .c-pdf-download{margin-bottom:16px!important}.c-nature-box--version{background-color:#eee}.c-nature-box__wrapper{transform:translateZ(0)}.c-nature-box__wrapper--placeholder{min-height:165px}.c-pdf-download__link{padding:13px 24px} } </style>




    
        <link data-test="critical-css-handler" data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    
    <noscript>
        <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
    </noscript>

<link rel="stylesheet" type="text/css" href="/static/css/article-print-c9121fecab.css" media="print">
    



<link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicons/nature/apple-touch-icon-f39cb19454.png">
<link rel="icon" type="image/png" sizes="48x48" href="/static/images/favicons/nature/favicon-48x48-b52890008c.png">
<link rel="icon" type="image/png" sizes="32x32" href="/static/images/favicons/nature/favicon-32x32-3fe59ece92.png">
<link rel="icon" type="image/png" sizes="16x16" href="/static/images/favicons/nature/favicon-16x16-951651ab72.png">
<link rel="manifest" href="/static/manifest.json" crossorigin="use-credentials">
<link rel="mask-icon" href="/static/images/favicons/nature/safari-pinned-tab-69bff48fe6.svg" color="#000000">
<link rel="shortcut icon" href="/static/images/favicons/nature/favicon.ico">
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content="/static/browserconfig.xml">
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                if (h.indexOf('test-www.nature.com') > -1) {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                } else {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                }
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


<script id="js-position0">
    (function(w, d) {
        w.idpVerifyPrefix = 'https://verify.nature.com';
        w.ra21Host = 'https://wayf.springernature.com';
        var moduleSupport = (function() {
            return 'noModule' in d.createElement('script');
        })();

        if (w.config.mustardcut === true) {
            w.loader = {
                index: 0,
                registered: [],
                scripts: [
                    
                        {src: '/static/js/global-article-es6-bundle-c8a573ca90.js', test: 'global-article-js', module: true},
                        {src: '/static/js/global-article-es5-bundle-d17603b9e9.js', test: 'global-article-js', nomodule: true},
                        {src: '/static/js/shared-es6-bundle-e9d2061c95.js', test: 'shared-js', module: true},
                        {src: '/static/js/shared-es5-bundle-1cbf3a8b56.js', test: 'shared-js', nomodule: true},
                        {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                        {src: '/static/js/header-150-es5-bundle-994fde5b1d.js', test: 'header-150-js', nomodule: true}
                    
                ].filter(function (s) {
                    if (s.src === null) return false;
                    if (moduleSupport && s.nomodule) return false;
                    return !(!moduleSupport && s.module);
                }),

                register: function (value) {
                    this.registered.push(value);
                },

                ready: function () {
                    if (this.registered.length === this.scripts.length) {
                        this.registered.forEach(function (fn) {
                            if (typeof fn === 'function') {
                                setTimeout(fn, 0); 
                            }
                        });
                        this.ready = function () {};
                    }
                },

                insert: function (s) {
                    var t = d.getElementById('js-position' + this.index);
                    if (t && t.insertAdjacentElement) {
                        t.insertAdjacentElement('afterend', s);
                    } else {
                        d.head.appendChild(s);
                    }
                    ++this.index;
                },

                createScript: function (script, beforeLoad) {
                    var s = d.createElement('script');
                    s.id = 'js-position' + (this.index + 1);
                    s.setAttribute('data-test', script.test);
                    if (beforeLoad) {
                        s.defer = 'defer';
                        s.onload = function () {
                            if (script.noinit) {
                                loader.register(true);
                            }
                            if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                loader.ready();
                            }
                        };
                    } else {
                        s.async = 'async';
                    }
                    s.src = script.src;
                    return s;
                },

                init: function () {
                    this.scripts.forEach(function (s) {
                        loader.insert(loader.createScript(s, true));
                    });

                    d.addEventListener('DOMContentLoaded', function () {
                        loader.ready();
                        var conditionalScripts;
                        
                            conditionalScripts = [
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-464a2af269.js', test: 'pan-zoom-js',  module: true },
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-98fb9b653b.js', test: 'pan-zoom-js',  nomodule: true },
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es6-bundle-23597ae350.js', test: 'math-js', module: true},
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es5-bundle-6532c6f78b.js', test: 'math-js', nomodule: true}
                            ];
                        

                        if (conditionalScripts) {
                            conditionalScripts.filter(function (script) {
                                return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                            }).forEach(function (script) {
                                loader.insert(loader.createScript(script));
                            });
                        }
                    }, false);
                }
            };
            loader.init();
        }
    })(window, document);
</script><script id="js-position1" data-test="global-article-js" defer="" src="/static/js/global-article-es6-bundle-c8a573ca90.js"></script><script id="js-position2" data-test="shared-js" defer="" src="/static/js/shared-es6-bundle-e9d2061c95.js"></script><script id="js-position3" data-test="header-150-js" defer="" src="/static/js/header-150-es6-bundle-5bb959eaa1.js"></script><script id="js-position4" data-test="math-js" async="" src="/static/js/math-es6-bundle-23597ae350.js"></script>










<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="https://www.nature.com/search">
<link rel="search" href="https://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">





    
    <script type="application/ld+json">{"mainEntity":{"headline":"Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy","description":"Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)1, population-wide interventions are still crucial to manage the pandemic, which has been aggravated by the emergence of new, highly transmissible variants. In this study, we combined the SIDARTHE model2, which predicts the spread of SARS-CoV-2 infections, with a new data-based model that projects new cases onto casualties and healthcare system costs. Based on the Italian case study, we outline several scenarios: mass vaccination campaigns with different paces, different transmission rates due to new variants and different enforced countermeasures, including the alternation of opening and closure phases. Our results demonstrate that non-pharmaceutical interventions (NPIs) have a higher effect on the epidemic evolution than vaccination alone, advocating for the need to keep NPIs in place during the first phase of the vaccination campaign. Our model predicts that, from April 2021 to January 2022, in a scenario with no vaccine rollout and weak NPIs (\n                \n                  \n                \n                $${\\cal{R}}_0$$\n                \n               = 1.27), as many as 298,000 deaths associated with COVID-19 could occur. However, fast vaccination rollouts could reduce mortality to as few as 51,000 deaths. Implementation of restrictive NPIs (\n                \n                  \n                \n                $${\\cal{R}}_0$$\n                \n               = 0.9) could reduce COVID-19 deaths to 30,000 without vaccinating the population and to 18,000 with a fast rollout of vaccines. We also show that, if intermittent open–close strategies are adopted, implementing a closing phase first could reduce deaths (from 47,000 to 27,000 with slow vaccine rollout) and healthcare system costs, without substantive aggravation of socioeconomic losses. Integration of variables to account for different speeds of vaccination rollouts and transmission dynamics of new SARS-CoV-2 strains into the SIDARTHE-V model suggests that maintaining non-pharmaceutical interventions during the COVID-19 vaccination campaign in Italy is essential for minimizing mortality in Italy into 2022.","datePublished":"2021-04-16T00:00:00Z","dateModified":"2021-04-16T00:00:00Z","pageStart":"993","pageEnd":"998","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41591-021-01334-5","keywords":["Epidemiology","Biomedicine","general","Cancer Research","Metabolic Diseases","Infectious Diseases","Molecular Medicine","Neurosciences"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig2_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig3_HTML.png"],"isPartOf":{"name":"Nature Medicine","issn":["1546-170X","1078-8956"],"volumeNumber":"27","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group US","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Giulia Giordano","url":"http://orcid.org/0000-0002-8600-1738","affiliation":[{"name":"University of Trento","address":{"name":"Department of Industrial Engineering, University of Trento, Trento, Italy","@type":"PostalAddress"},"@type":"Organization"}],"email":"giulia.giordano@unitn.it","@type":"Person"},{"name":"Marta Colaneri","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo","address":{"name":"Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Alessandro Di Filippo","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo","address":{"name":"Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Franco Blanchini","affiliation":[{"name":"University of Udine","address":{"name":"Dipartimento di Scienze Matematiche, Informatiche e Fisiche, University of Udine, Udine, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Paolo Bolzern","affiliation":[{"name":"Politecnico di Milano","address":{"name":"Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Giuseppe De Nicolao","affiliation":[{"name":"University of Pavia","address":{"name":"Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Paolo Sacchi","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo","address":{"name":"Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Patrizio Colaneri","affiliation":[{"name":"Politecnico di Milano","address":{"name":"Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy","@type":"PostalAddress"},"@type":"Organization"},{"name":"IEIIT-CNR","address":{"name":"IEIIT-CNR, Milan, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Raffaele Bruno","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo","address":{"name":"Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Pavia","address":{"name":"Department of Clinical, Surgical, Diagnostic, and Paediatric Sciences, University of Pavia, Pavia, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>




    
    
    


    
    <link rel="canonical" href="https://www.nature.com/articles/s41591-021-01334-5">
    
    
    <meta name="journal_id" content="41591">
    <meta name="dc.title" content="Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy">
    <meta name="dc.source" content="Nature Medicine 2021 27:6">
    <meta name="dc.format" content="text/html">
    <meta name="dc.publisher" content="Nature Publishing Group">
    <meta name="dc.date" content="2021-04-16">
    <meta name="dc.type" content="OriginalPaper">
    <meta name="dc.language" content="En">
    <meta name="dc.copyright" content="2021 The Author(s)">
    <meta name="dc.rights" content="2021 The Author(s)">
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="dc.description" content="Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)1, population-wide interventions are still crucial to manage the pandemic, which has been aggravated by the emergence of new, highly transmissible variants. In this study, we combined the SIDARTHE model2, which predicts the spread of SARS-CoV-2 infections, with a new data-based model that projects new cases onto casualties and healthcare system costs. Based on the Italian case study, we outline several scenarios: mass vaccination campaigns with different paces, different transmission rates due to new variants and different enforced countermeasures, including the alternation of opening and closure phases. Our results demonstrate that non-pharmaceutical interventions (NPIs) have a higher effect on the epidemic evolution than vaccination alone, advocating for the need to keep NPIs in place during the first phase of the vaccination campaign. Our model predicts that, from April 2021 to January 2022, in a scenario with no vaccine rollout and weak NPIs ( $${\cal{R}}_0$$ = 1.27), as many as 298,000 deaths associated with COVID-19 could occur. However, fast vaccination rollouts could reduce mortality to as few as 51,000 deaths. Implementation of restrictive NPIs ( $${\cal{R}}_0$$ = 0.9) could reduce COVID-19 deaths to 30,000 without vaccinating the population and to 18,000 with a fast rollout of vaccines. We also show that, if intermittent open–close strategies are adopted, implementing a closing phase first could reduce deaths (from 47,000 to 27,000 with slow vaccine rollout) and healthcare system costs, without substantive aggravation of socioeconomic losses. Integration of variables to account for different speeds of vaccination rollouts and transmission dynamics of new SARS-CoV-2 strains into the SIDARTHE-V model suggests that maintaining non-pharmaceutical interventions during the COVID-19 vaccination campaign in Italy is essential for minimizing mortality in Italy into 2022.">
    <meta name="prism.issn" content="1546-170X">
    <meta name="prism.publicationName" content="Nature Medicine">
    <meta name="prism.publicationDate" content="2021-04-16">
    <meta name="prism.volume" content="27">
    <meta name="prism.number" content="6">
    <meta name="prism.section" content="OriginalPaper">
    <meta name="prism.startingPage" content="993">
    <meta name="prism.endingPage" content="998">
    <meta name="prism.copyright" content="2021 The Author(s)">
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="prism.url" content="https://www.nature.com/articles/s41591-021-01334-5">
    <meta name="prism.doi" content="doi:10.1038/s41591-021-01334-5">
    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41591-021-01334-5.pdf">
    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41591-021-01334-5">
    <meta name="citation_journal_title" content="Nature Medicine">
    <meta name="citation_journal_abbrev" content="Nat Med">
    <meta name="citation_publisher" content="Nature Publishing Group">
    <meta name="citation_issn" content="1546-170X">
    <meta name="citation_title" content="Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy">
    <meta name="citation_volume" content="27">
    <meta name="citation_issue" content="6">
    <meta name="citation_publication_date" content="2021/06">
    <meta name="citation_online_date" content="2021/04/16">
    <meta name="citation_firstpage" content="993">
    <meta name="citation_lastpage" content="998">
    <meta name="citation_article_type" content="Letter">
    <meta name="citation_fulltext_world_readable" content="">
    <meta name="citation_language" content="en">
    <meta name="dc.identifier" content="doi:10.1038/s41591-021-01334-5">
    <meta name="DOI" content="10.1038/s41591-021-01334-5">
    <meta name="size" content="389673">
    <meta name="citation_doi" content="10.1038/s41591-021-01334-5">
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41591-021-01334-5&amp;api_key=">
    <meta name="description" content="Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)1, population-wide interventions are still crucial to manage the pandemic, which has been aggravated by the emergence of new, highly transmissible variants. In this study, we combined the SIDARTHE model2, which predicts the spread of SARS-CoV-2 infections, with a new data-based model that projects new cases onto casualties and healthcare system costs. Based on the Italian case study, we outline several scenarios: mass vaccination campaigns with different paces, different transmission rates due to new variants and different enforced countermeasures, including the alternation of opening and closure phases. Our results demonstrate that non-pharmaceutical interventions (NPIs) have a higher effect on the epidemic evolution than vaccination alone, advocating for the need to keep NPIs in place during the first phase of the vaccination campaign. Our model predicts that, from April 2021 to January 2022, in a scenario with no vaccine rollout and weak NPIs ( $${\cal{R}}_0$$ = 1.27), as many as 298,000 deaths associated with COVID-19 could occur. However, fast vaccination rollouts could reduce mortality to as few as 51,000 deaths. Implementation of restrictive NPIs ( $${\cal{R}}_0$$ = 0.9) could reduce COVID-19 deaths to 30,000 without vaccinating the population and to 18,000 with a fast rollout of vaccines. We also show that, if intermittent open–close strategies are adopted, implementing a closing phase first could reduce deaths (from 47,000 to 27,000 with slow vaccine rollout) and healthcare system costs, without substantive aggravation of socioeconomic losses. Integration of variables to account for different speeds of vaccination rollouts and transmission dynamics of new SARS-CoV-2 strains into the SIDARTHE-V model suggests that maintaining non-pharmaceutical interventions during the COVID-19 vaccination campaign in Italy is essential for minimizing mortality in Italy into 2022.">
    <meta name="dc.creator" content="Giordano, Giulia">
    <meta name="dc.creator" content="Colaneri, Marta">
    <meta name="dc.creator" content="Di Filippo, Alessandro">
    <meta name="dc.creator" content="Blanchini, Franco">
    <meta name="dc.creator" content="Bolzern, Paolo">
    <meta name="dc.creator" content="De Nicolao, Giuseppe">
    <meta name="dc.creator" content="Sacchi, Paolo">
    <meta name="dc.creator" content="Colaneri, Patrizio">
    <meta name="dc.creator" content="Bruno, Raffaele">
    <meta name="dc.subject" content="Epidemiology">
    <meta name="citation_reference" content="citation_journal_title=Eur. J. Pharmacol.; citation_title=Treatment for COVID-19: an overview; citation_author=C Stasi, S Fallani, F Voller, C Silvestri; citation_volume=889; citation_publication_date=2020; citation_pages=173644; citation_doi=10.1016/j.ejphar.2020.173644; citation_id=CR1">
    <meta name="citation_reference" content="citation_journal_title=Nat. Med.; citation_title=Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy; citation_author=G Giordano; citation_volume=26; citation_publication_date=2020; citation_pages=855-860; citation_doi=10.1038/s41591-020-0883-7; citation_id=CR2">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A new coronavirus associated with human respiratory disease in China; citation_author=F Wu; citation_volume=579; citation_publication_date=2020; citation_pages=265-269; citation_doi=10.1038/s41586-020-2008-3; citation_id=CR3">
    <meta name="citation_reference" content="citation_journal_title=AAPS PharmSciTech.; citation_title=The COVID-19 vaccine race: challenges and opportunities in vaccine formulation; citation_author=J Wang, Y Peng, H Xu, Z Cui, RO Williams; citation_volume=21; citation_publication_date=2020; citation_pages=225; citation_doi=10.1208/s12249-020-01744-7; citation_id=CR4">
    <meta name="citation_reference" content="citation_journal_title=Eur. J. Pharmacol.; citation_title=COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies; citation_author=K Rawat, P Kumari, L Saha; citation_volume=892; citation_publication_date=2021; citation_pages=173751; citation_doi=10.1016/j.ejphar.2020.173751; citation_id=CR5">
    <meta name="citation_reference" content="citation_journal_title=BMJ; citation_title=Behavioural fatigue: a flawed idea central to a flawed pandemic response; citation_author=K Abbasi; citation_volume=370; citation_publication_date=2020; citation_pages=m3093; citation_doi=10.1136/bmj.m3093; citation_id=CR6">
    <meta name="citation_reference" content="citation_journal_title=Int. J. Environ. Res. Public Health; citation_title=Intervention fatigue is the primary cause of strong secondary waves in the COVID-19 pandemic; citation_author=K Rypdal, FM Bianchi, M Rypdal; citation_volume=17; citation_publication_date=2020; citation_pages=9592; citation_doi=10.3390/ijerph17249592; citation_id=CR7">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine; citation_author=FP Polack; citation_volume=383; citation_publication_date=2020; citation_pages=2603-2615; citation_doi=10.1056/NEJMoa2034577; citation_id=CR8">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine; citation_author=LR Baden; citation_volume=384; citation_publication_date=2021; citation_pages=403-416; citation_doi=10.1056/NEJMoa2035389; citation_id=CR9">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials; citation_author=M Voysey; citation_volume=397; citation_publication_date=2021; citation_pages=881-891; citation_doi=10.1016/S0140-6736(21)00432-3; citation_id=CR10">
    <meta name="citation_reference" content="US Food and Drug Administration. FDA Briefing Document. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting, February 26, 2021. 
                  https://www.fda.gov/media/146217/download
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=MMWR Morb. Mortal. Wkly Rep.; citation_title=First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021; citation_author=J Gee; citation_volume=70; citation_publication_date=2021; citation_pages=283-288; citation_doi=10.15585/mmwr.mm7008e3; citation_id=CR12">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK; citation_author=M Voysey; citation_volume=397; citation_publication_date=2021; citation_pages=99-111; citation_doi=10.1016/S0140-6736(20)32661-1; citation_id=CR13">
    <meta name="citation_reference" content="European Medicines Agency. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. 
                  https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots
                  
                 (2021).">
    <meta name="citation_reference" content="ANSA. Pfizer vaccine arrives in Italy. 
                  https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html
                  
                 (2020).">
    <meta name="citation_reference" content="ANSA. First Moderna vaccine doses arrive in Italy. 
                  https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html
                  
                 (2021).">
    <meta name="citation_reference" content="Reuters. Italy kicks off vaccinations against COVID-19 in Rome. 
                  https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O
                  
                 (2020).">
    <meta name="citation_reference" content="Ministero della salute (Italian Ministry of Health). Vaccinazione anti-SARS-CoV-2/COVID-19: PIANO STRATEGICO: Elementi di preparazione e di implementazione della strategia vaccinale. 
                  https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf
                  
                 (2020).">
    <meta name="citation_reference" content="Presidenza del Consiglio dei Ministri. Ministero della Salute. Commissario Straordinario Covid-19. Report Vaccini Anti COVID-19. 
                  https://www.governo.it/it/cscovid19/report-vaccini/
                  
                 (2021).">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections; citation_author=V Priesemann; citation_volume=397; citation_publication_date=2021; citation_pages=92-93; citation_doi=10.1016/S0140-6736(20)32625-8; citation_id=CR20">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=An action plan for pan-European defence against new SARS-CoV-2 variants; citation_author=V Priesemann; citation_volume=397; citation_publication_date=2021; citation_pages=469-470; citation_doi=10.1016/S0140-6736(21)00150-1; citation_id=CR21">
    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England; citation_author=NG Davies; citation_volume=372; citation_publication_date=2021; citation_pages=eabg3055; citation_doi=10.1126/science.abg3055; citation_id=CR22">
    <meta name="citation_reference" content="Abbott, S., Funk, S. &amp; CMMID COVID-19 Working Group. Local area reproduction numbers and S-gene target failure. 
                  https://cmmid.github.io/topics/covid19/local-r-sgtf.html
                  
                 (2021).">
    <meta name="citation_reference" content="Horby, P. et al. NERVTAG note on B.1.1.7 severity. 
                  https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117
                  
                 (2021).">
    <meta name="citation_reference" content="Bubar, K. M. et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science 371, 916–921 (2021).">
    <meta name="citation_reference" content="Ramos A. M., Vela-Pérez, M., Ferrández, M. R., Kubik, A. B. &amp; Ivorra, B. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19. Preprint at ResearchGate 
                  https://doi.org/10.13140/RG.2.2.32580.24967/2
                  
                 (2021).">
    <meta name="citation_reference" content="Grundel, S. et al. How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks. Preprint at medRxiv 
                  https://doi.org/10.1101/2020.12.22.20248707
                  
                 (2020).">
    <meta name="citation_reference" content="Ministero della Salute. Vaccinazione anti-SARS-CoV-2/COVID-19, Piano Strategico, elementi di preparazione e di implementazione della strategia vaccinale. 
                  http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf
                  
                 (2020).">
    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period; citation_author=SM Kissler; citation_volume=368; citation_publication_date=2020; citation_pages=860-868; citation_doi=10.1126/science.abb5793; citation_id=CR29">
    <meta name="citation_reference" content="citation_journal_title=PLoS Comput. Biol.; citation_title=Post-lockdown abatement of COVID-19 by fast periodic switching; citation_author=M Bin; citation_volume=17; citation_publication_date=2021; citation_pages=e1008604; citation_doi=10.1371/journal.pcbi.1008604; citation_id=CR30">
    <meta name="citation_reference" content="Tetteh, J. N. A., Nguyen, V. K. &amp; Hernandez-Vargas, E. A. COVID-19 network model to evaluate vaccine strategies towards herd immunity. Preprint at medRxiv 
                  https://doi.org/10.1101/2020.12.22.20248693
                  
                 (2020).">
    <meta name="citation_reference" content="Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850–854 (2021).">
    <meta name="citation_reference" content="Fontanet, A. et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet 397, 952–954 (2021).">
    <meta name="citation_reference" content="Callaway, E. Could new COVID variants undermine vaccines? Labs scramble to find out. Nature 589, 177–178 (2021).">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Understanding variants of SARS-CoV-2; citation_author=T Burki; citation_volume=397; citation_publication_date=2021; citation_pages=462; citation_doi=10.1016/S0140-6736(21)00298-1; citation_id=CR35">
    <meta name="citation_reference" content="citation_journal_title=JAMA; citation_title=Genetic variants of SARS-CoV-2—what do they mean?; citation_author=AS Lauring, EB Hodcroft; citation_volume=325; citation_publication_date=2021; citation_pages=529-531; citation_doi=10.1001/jama.2020.27124; citation_id=CR36">
    <meta name="citation_reference" content="Madhi, S. A. et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N. Engl. J. Med. 
                  https://doi.org/10.1056/NEJMoa2102214
                  
                 (2021).">
    <meta name="citation_reference" content="Lopez Bernal, J. et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.03.01.21252652
                  
                 (2021).">
    <meta name="citation_reference" content="GOV.UK. Coronavirus (COVID‑19). 
                  https://www.gov.uk/coronavirus
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Durability of responses after SARS-CoV-2 mRNA-1273 vaccination; citation_author=AT Widge; citation_volume=384; citation_publication_date=2021; citation_pages=80-82; citation_doi=10.1056/NEJMc2032195; citation_id=CR40">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Convergent antibody responses to SARS-CoV-2 in convalescent individuals; citation_author=DF Robbiani; citation_volume=584; citation_publication_date=2020; citation_pages=437-442; citation_doi=10.1038/s41586-020-2456-9; citation_id=CR41">
    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection; citation_author=JM Dan; citation_volume=371; citation_publication_date=2021; citation_pages=eabf4063; citation_doi=10.1126/science.abf4063; citation_id=CR42">
    <meta name="citation_reference" content="citation_journal_title=Biosaf. Health; citation_title=Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy; citation_author=M D’Arienzo, A Coniglio; citation_volume=2; citation_publication_date=2020; citation_pages=57-59; citation_doi=10.1016/j.bsheal.2020.03.004; citation_id=CR43">
    <meta name="citation_reference" content="MATLAB System Identification Toolbox, 9.13 (R2020b). 
                  https://www.mathworks.com/products/sysid.html
                  
                ">
    <meta name="citation_reference" content="Italian Ministry of Health. Vaccinazione anti-SARS-CoV-2/COVID-19 PIANO STRATEGICO. 
                  https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null
                  
                ">
    <meta name="citation_reference" content="Task Force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica. Istituto Superiore di Sanità. Epidemia COVID-19: Aggiornamento nazionale. 
                  https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf
                  
                 (2021).">
    <meta name="citation_reference" content="ISTAT-Istituto Nazionale di Statistica. 
                  http://dati.istat.it/Index.aspx
                  
                ">
    <meta name="citation_reference" content="GitHub. Covid-19 Opendata Vaccines. 
                  https://github.com/italia/covid19-opendata-vaccini
                  
                ">
    <meta name="citation_reference" content="Voltz, E. et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. Preprint at medRxiv 
                  https://doi.org/10.1101/2020.12.30.20249034
                  
                 (2021).">
    <meta name="citation_reference" content="Moore, J. P. Approaches for optimal use of different COVID-19 vaccines. Issues of viral variants and vaccine efficacy. JAMA 
                  https://doi.org/10.1001/jama.2021.3465
                  
                 (2021).">
    <meta name="citation_reference" content="Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 
                  https://doi.org/10.1126/science.abg3055
                  
                 (2021).">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=New Zealand eliminates COVID-19; citation_author=S Cousins; citation_volume=395; citation_publication_date=2020; citation_pages=1474; citation_doi=10.1016/S0140-6736(20)31097-7; citation_id=CR52">
    <meta name="citation_reference" content="citation_journal_title=Health Policy Technol.; citation_title=The COVID-19 pandemic in Greece, Iceland, New Zealand, and Singapore: health policies and lessons learned; citation_author=A Fouda, N Mahmoudi, N Moy, F Paolucci; citation_volume=9; citation_publication_date=2020; citation_pages=510-524; citation_doi=10.1016/j.hlpt.2020.08.015; citation_id=CR53">
    <meta name="citation_author" content="Giordano, Giulia">
    <meta name="citation_author_institution" content="Department of Industrial Engineering, University of Trento, Trento, Italy">
    <meta name="citation_author" content="Colaneri, Marta">
    <meta name="citation_author_institution" content="Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy">
    <meta name="citation_author" content="Di Filippo, Alessandro">
    <meta name="citation_author_institution" content="Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy">
    <meta name="citation_author" content="Blanchini, Franco">
    <meta name="citation_author_institution" content="Dipartimento di Scienze Matematiche, Informatiche e Fisiche, University of Udine, Udine, Italy">
    <meta name="citation_author" content="Bolzern, Paolo">
    <meta name="citation_author_institution" content="Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy">
    <meta name="citation_author" content="De Nicolao, Giuseppe">
    <meta name="citation_author_institution" content="Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy">
    <meta name="citation_author" content="Sacchi, Paolo">
    <meta name="citation_author_institution" content="Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy">
    <meta name="citation_author" content="Colaneri, Patrizio">
    <meta name="citation_author_institution" content="Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy">
    <meta name="citation_author_institution" content="IEIIT-CNR, Milan, Italy">
    <meta name="citation_author" content="Bruno, Raffaele">
    <meta name="citation_author_institution" content="Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy">
    <meta name="citation_author_institution" content="Department of Clinical, Surgical, Diagnostic, and Paediatric Sciences, University of Pavia, Pavia, Italy">
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">
    <meta name="twitter:site" content="@naturemedicine">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:image:alt" content="Content cover image">
    <meta name="twitter:title" content="Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy">
    <meta name="twitter:description" content="Nature Medicine - Integration of variables to account for different speeds of vaccination rollouts and transmission dynamics of new SARS-CoV-2 strains into the SIDARTHE-V model suggests that...">
    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png">
    

    
    
    <meta property="og:url" content="https://www.nature.com/articles/s41591-021-01334-5">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Nature">
    <meta property="og:title" content="Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy - Nature Medicine">
    <meta property="og:description" content="Integration of variables to account for different speeds of vaccination rollouts and transmission dynamics of new SARS-CoV-2 strains into the SIDARTHE-V model suggests that maintaining non-pharmaceutical interventions during the COVID-19 vaccination campaign in Italy is essential for minimizing mortality in Italy into 2022.">
    <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png">
    

    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
<style type="text/css">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}@media (min-width:680px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:16px!important;margin-right:0!important}}@media (min-width:980px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:24px!important;margin-right:0!important}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:"";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:"";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1}.cc-switch__label{cursor:pointer;display:inline-block;font-size:14px;font-weight:700;margin:0;-webkit-user-select:none;user-select:none}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;background-color:#fff!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='rgba(0, 0, 0, 0.25)'/%3E%3C/svg%3E")!important;background-position:0!important;background-repeat:no-repeat!important;border:1px solid #777!important;border-radius:16px!important;height:18px!important;margin:0 8px 0 0!important;transition:background-position .2s ease-in-out!important;width:32px!important}.cc-switch__input[type=checkbox]:focus{background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%2380b3cc'/%3E%3C/svg%3E")!important}.cc-switch__input[type=checkbox]:checked{background-color:#025e8d!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%23fff'/%3E%3C/svg%3E")!important;background-position:100%!important}.cc-switch__input[type=checkbox]:checked~.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)~.cc-switch__label>.cc-switch__text-on{display:none}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #fc0}.cc-switch__input[type=checkbox]:checked:before{background-color:none!important;color:#0000!important}html[dir=rtl] .cc-switch__input[type=checkbox]{margin-left:8px!important;margin-right:0!important}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:"";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{background-color:#eff6fb!important;border-radius:10px;font-size:14px;margin:12px 0 0;padding:12px}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{font-size:1em;font-style:normal;font-weight:400;margin:0}.cc-preferences__cookie-description{font-size:1em;margin:0 0 8px}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:4px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:"";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url("data:image/svg+xml;base64,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");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><script async="" type="text/javascript" src="https://injections.readcube.com/nature/inject.fa744f3f.js"></script><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 2px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: 1em}
.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}
.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: Highlight; color: HighlightText}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover, .MJXp-munder {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > *, .MJXp-munder > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}
</style></head>
<body class="article-page"><div id="MathJax_Message" style="display: none;"></div><dialog class="cc-banner" data-cc-banner="" data-nosnippet="" aria-labelledby="cc-banner-label" open="">
		<div class="cc-banner__content" autofocus="" tabindex="-1">
			<div class="cc-banner__container">
				<div class="cc-banner__header">
					<h2 class="cc-banner__title" id="cc-banner-label">Your privacy, your choice</h2>
				</div>
				<div class="cc-banner__body">
					<div class="cc-banner__policy">
						<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href="https://www.nature.com/info/privacy" data-cc-action="privacy">privacy policy</a> for more information on the use of your personal data.</p><p><button type="button" data-cc-action="preferences" class="cc-button cc-button--link cc-button--text">Manage preferences</button> for further information and to change your choices.</p>
					</div>
					
				</div>
				<div class="cc-banner__footer">
					
			<button data-cc-action="accept" class="cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept">Accept all cookies</button>
			
		
				</div>
			</div>
		</div>
	</dialog>

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    

    
    
        <div class="u-hide u-show-following-ad"></div>

    <aside class="c-ad c-ad--728x90" style="display: none !important;">
        <div class="c-ad__inner" data-container-type="banner-advert">
            <p class="c-ad__label">Advertisement</p>
            
        
            
    <div id="div-gpt-ad-top-1" class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type="top" data-test="top-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="728x90" data-gpt-targeting="type=article;pos=top;artid=s41591-021-01334-5;doi=10.1038/s41591-021-01334-5;subjmeta=174,308,478,692,700;kwrd=Epidemiology">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=-364794197&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-021-01334-5%26doi%3D10.1038/s41591-021-01334-5%26subjmeta%3D174,308,478,692,700%26kwrd%3DEpidemiology">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=-364794197&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-021-01334-5%26doi%3D10.1038/s41591-021-01334-5%26subjmeta%3D174,308,478,692,700%26kwrd%3DEpidemiology"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

        
    
        </div>
    </aside>


    <header class="c-header" id="header" data-header="" data-track-component="nature-150-split-header" style="border-color:#e40428">
        <div class="c-header__row">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/nm" data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" media="(min-width: 875px)">
                                <img src="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" height="32" alt="Nature Medicine">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--padding c-header__item--hide-md-max">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link" data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--pipe">
                            <a class="c-header__link c-header__link--search" href="javascript:;" data-header-expander="" data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                <svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg><span>Search</span>
                            </a><div id="search-menu" class="c-header__dropdown c-header__dropdown--full-width has-tethered u-js-hide" data-track-component="nature-150-split-header" hidden="">
    <div class="c-header__container">
        <h2 class="c-header__visually-hidden">Search</h2>
        <form class="c-header__search-form" action="/search" method="get" role="search" autocomplete="off" data-test="inline-search">
            <label class="c-header__heading" for="keywords">Search articles by subject, keyword or author</label>
            <div class="c-header__search-layout c-header__search-layout--max-width">
                <div>
                    <input type="text" required="" class="c-header__input" id="keywords" name="q" value="">
                </div>
                <div class="c-header__search-layout">
                    <div>
                        <label for="results-from" class="c-header__visually-hidden">Show results from</label>
                        <select id="results-from" name="journal" class="c-header__select">
                            
                                
                                    <option value="" selected="">All journals</option>
                                    <option value="nm">This journal</option>
                                
                            
                        </select>
                    </div>
                    <div>
                        <button type="submit" class="c-header__search-button">Search</button>
                    </div>
                </div>

            </div>
        </form>

        <div class="c-header__flush">
            <a class="c-header__link" href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">
                Advanced search
            </a>
        </div>

        <h3 class="c-header__heading c-header__heading--keyline">Quick links</h3>
        <ul class="c-header__list">
            <li><a class="c-header__link" href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li><a class="c-header__link" href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li><a class="c-header__link" href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li><a class="c-header__link" href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--snid-account-widget c-header__item--pipe">
                            
                                <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href="https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-021-01334-5"><span class="eds-c-header__widget-fragment-title">Log in</span></a>
                            
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <ul class="c-header__menu c-header__menu--journal">
                            
                                <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--explore" data-track="click" data-track-action="open explore expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header" hidden="">
            <div class="c-header__container">
                <h2 id="Explore-content" class="c-header__heading c-header__heading--js-hide">Explore content</h2>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-articles" data-track="click" data-track-action="research articles" data-track-label="link" data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-and-analysis" data-track="click" data-track-action="reviews &amp; analysis" data-track-label="link" data-test="explore-nav-item">
                                    Reviews &amp; Analysis
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/news-and-comment" data-track="click" data-track-action="news &amp; comment" data-track-label="link" data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/podcast" data-track="click" data-track-action="podcasts" data-track-label="link" data-test="explore-nav-item">
                                    Podcasts
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/current-issue" data-track="click" data-track-action="current issue" data-track-label="link" data-test="explore-nav-item">
                                    Current issue
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/collections" data-track="click" data-track-action="collections" data-track-label="link" data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                    
                </ul>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://www.facebook.com/Nature-Medicine-193691346949/" data-track="click" data-track-action="facebook" data-track-label="link">Follow us on Facebook
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://twitter.com/naturemedicine" data-track="click" data-track-action="twitter" data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=5" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-external="" data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"></path></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--about-the-journal" data-track="click" data-track-action="open about the journal expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="About-the-journal" id="about-the-journal" data-test="about-the-journal" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="About-the-journal" class="c-header__heading c-header__heading--js-hide">About the journal</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/aims" data-track="click" data-track-action="aims &amp; scope" data-track-label="link">
                                    Aims &amp; Scope
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-information" data-track="click" data-track-action="journal information" data-track-label="link">
                                    Journal Information
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-impact" data-track="click" data-track-action="journal metrics" data-track-label="link">
                                    Journal Metrics
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editors" data-track="click" data-track-action="about the editors" data-track-label="link">
                                    About the Editors
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-cross-journal-editorial-team" data-track="click" data-track-action="research cross-journal editorial team" data-track-label="link">
                                    Research Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-cross-journal-editorial-team" data-track="click" data-track-action="reviews cross-journal editorial team" data-track-label="link">
                                    Reviews Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/statistics-advisory-panel" data-track="click" data-track-action="statistical advisory panel" data-track-label="link">
                                    Statistical Advisory Panel
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/our-publishing-models" data-track="click" data-track-action="our publishing models" data-track-label="link">
                                    Our publishing models
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-values-statement" data-track="click" data-track-action="editorial values statement" data-track-label="link">
                                    Editorial Values Statement
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-policies" data-track="click" data-track-action="editorial policies" data-track-label="link">
                                    Editorial Policies
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/content" data-track="click" data-track-action="content types" data-track-label="link">
                                    Content Types
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/web-feeds" data-track="click" data-track-action="web feeds" data-track-label="link">
                                    Web Feeds
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/contact" data-track="click" data-track-action="contact" data-track-label="link">
                                    Contact
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="publish-with-us-button">
                                        <a href="javascript:;" class="c-header__link c-header__link--dropdown-menu" data-header-expander="" data-test="menu-button--publish" data-track="click" data-track-action="open publish with us expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                        </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-test="publish-with-us" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="Publish-with-us-label" class="c-header__heading c-header__heading--js-hide">Publish with us</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/submission-guidelines" data-track="click" data-track-action="submission guidelines" data-track-label="link">
                                    Submission Guidelines
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/for-reviewers" data-track="click" data-track-action="for reviewers" data-track-label="link">
                                    For Reviewers
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" data-test="nature-author-services" data-track="nav_language_services" data-track-context="header publish with us dropdown menu" data-track-action="manuscript author services" data-track-label="link manuscript author services" href="https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&amp;utm_medium=Website_Nature&amp;utm_campaign=Platform+Experimentation+2022&amp;utm_id=PE2022">
                                    Language editing services
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/open-access-funding" data-test="funding-eligibility-link" data-track="click_explore_funding" data-track-context="header publish with us" data-track-action="funding eligibility">Open access funding</a>
                            </li>
                        
                        
                            <li class="c-header__item c-header__item--keyline">
                                <a class="c-header__link" href="https://mts-nmed.nature.com/cgi-bin/main.plex" data-track="click_submit_manuscript" data-track-context="submit link in Nature header dropdown menu" data-track-action="submit manuscript" data-track-label="link (publish with us dropdown menu)" data-track-external="" data-gtm-criteo="submit-manuscript">Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"></path></svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                    </li>
                                
                            
                            
                        </ul>
                        <ul class="c-header__menu c-header__menu--hide-lg-max">
                            
                                <li class="c-header__item" data-test="alert-link">
                                    <a class="c-header__link" href="https://journal-alerts.springernature.com/subscribe?journal_id=41591" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external="">
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"></path></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                            <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope="" itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature medicine"><span itemprop="name">nature medicine</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm/articles?type=letter" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:letters"><span itemprop="name">letters</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container" data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            
                <div class="c-context-bar u-hide" id="js-enable-context-bar" data-test="context-bar" data-context-bar="" aria-hidden="true">
                    <div class="c-context-bar__container u-container" data-track-context="sticky banner">
                        <div class="c-context-bar__title">
                            Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
                        </div>
                        
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-021-01334-5.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                    </div>
                </div>
            
        
        <article lang="en">
            
                <div class="c-pdf-button__container u-mb-16 u-hide-at-lg js-context-bar-sticky-point-mobile">
                    <div class="c-pdf-container" data-track-context="article body">
                        
                            
                                
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-021-01334-5.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                            
                        
                    </div>
                </div>
            
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Letter</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">Published: <time datetime="2021-04-16">16 April 2021</time></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy</h1>
                    <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Giulia-Giordano-Aff1" data-author-popup="auth-Giulia-Giordano-Aff1" data-author-search="Giordano, Giulia" data-corresp-id="c1" data-track-context="researcher popup with no profile" data-track-index="1_9">Giulia Giordano<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0002-8600-1738"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-8600-1738</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Marta-Colaneri-Aff2" data-author-popup="auth-Marta-Colaneri-Aff2" data-author-search="Colaneri, Marta" data-track-context="researcher popup with no profile" data-track-index="2_9">Marta Colaneri</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Alessandro-Filippo-Aff2" data-author-popup="auth-Alessandro-Filippo-Aff2" data-author-search="Di Filippo, Alessandro" data-track-context="researcher popup with no profile" data-track-index="3_9">Alessandro Di Filippo</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Franco-Blanchini-Aff3" data-author-popup="auth-Franco-Blanchini-Aff3" data-author-search="Blanchini, Franco" data-track-context="researcher popup with no profile" data-track-index="4_9">Franco Blanchini</a><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Paolo-Bolzern-Aff4" data-author-popup="auth-Paolo-Bolzern-Aff4" data-author-search="Bolzern, Paolo" data-track-context="researcher popup with no profile" data-track-index="5_9">Paolo Bolzern</a><sup class="u-js-hide"><a href="#Aff4" tabindex="-1">4</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Giuseppe-Nicolao-Aff5" data-author-popup="auth-Giuseppe-Nicolao-Aff5" data-author-search="De Nicolao, Giuseppe" data-track-context="researcher popup with no profile" data-track-index="6_9">Giuseppe De Nicolao</a><sup class="u-js-hide"><a href="#Aff5" tabindex="-1">5</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Paolo-Sacchi-Aff2" data-author-popup="auth-Paolo-Sacchi-Aff2" data-author-search="Sacchi, Paolo" data-track-context="researcher popup with no profile" data-track-index="7_9">Paolo Sacchi</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Patrizio-Colaneri-Aff4-Aff6" data-author-popup="auth-Patrizio-Colaneri-Aff4-Aff6" data-author-search="Colaneri, Patrizio" data-track-context="researcher popup with no profile" data-track-index="8_9">Patrizio Colaneri</a><sup class="u-js-hide"><a href="#Aff4" tabindex="-1">4</a>,<a href="#Aff6" tabindex="-1">6</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup> &amp; </li><li class="c-article-author-list__show-more" aria-label="Show all 9 authors for this article" title="Show all 9 authors for this article">…</li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Raffaele-Bruno-Aff2-Aff7" data-author-popup="auth-Raffaele-Bruno-Aff2-Aff7" data-author-search="Bruno, Raffaele" data-track-context="researcher popup with no profile" data-track-index="9_9">Raffaele Bruno</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a>,<a href="#Aff7" tabindex="-1">7</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup>&nbsp;</li></ul><button aria-expanded="false" class="c-article-author-list__button"><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-down-medium"></use></svg><span>Show authors</span></button>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/nm" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"><i data-test="journal-title">Nature Medicine</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>&nbsp;27</b>,&nbsp;<span class="u-visually-hidden">pages </span>993–998 (<span data-test="article-publication-year">2021</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-reset">
                
                    <li class=" c-article-metrics-bar__item" data-test="access-count">
                        <p class="c-article-metrics-bar__count">27k <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                    <li class="c-article-metrics-bar__item" data-test="citation-count">
                        <p class="c-article-metrics-bar__count">147 <span class="c-article-metrics-bar__label">Citations</span></p>
                    </li>
                
                
                    
                        <li class="c-article-metrics-bar__item" data-test="altmetric-score">
                            <p class="c-article-metrics-bar__count">90 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__details"><a href="/articles/s41591-021-01334-5/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                </li>
            </ul>
        </div>
    
                    
                </header>

                
    

                
    
    

    
    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Stasi, C., Fallani, S., Voller, F. &amp; Silvestri, C. Treatment for COVID-19: an overview. Eur. J. Pharmacol. 889, 173644 (2020)." href="/articles/s41591-021-01334-5#ref-CR1" id="ref-link-section-d66285444e545">1</a></sup>, population-wide interventions are still crucial to manage the pandemic, which has been aggravated by the emergence of new, highly transmissible variants. In this study, we combined the SIDARTHE model<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat. Med. 26, 855–860 (2020)." href="/articles/s41591-021-01334-5#ref-CR2" id="ref-link-section-d66285444e549">2</a></sup>, which predicts the spread of SARS-CoV-2 infections, with a new data-based model that projects new cases onto casualties and healthcare system costs. Based on the Italian case study, we outline several scenarios: mass vaccination campaigns with different paces, different transmission rates due to new variants and different enforced countermeasures, including the alternation of opening and closure phases. Our results demonstrate that non-pharmaceutical interventions (NPIs) have a higher effect on the epidemic evolution than vaccination alone, advocating for the need to keep NPIs in place during the first phase of the vaccination campaign. Our model predicts that, from April 2021 to January 2022, in a scenario with no vaccine rollout and weak NPIs (<span class="mathjax-tex">\({\cal{R}}_0\)</span> = 1.27), as many as 298,000 deaths associated with COVID-19 could occur. However, fast vaccination rollouts could reduce mortality to as few as 51,000 deaths. Implementation of restrictive NPIs (<span class="mathjax-tex">\({\cal{R}}_0\)</span> = 0.9) could reduce COVID-19 deaths to 30,000 without vaccinating the population and to 18,000 with a fast rollout of vaccines. We also show that, if intermittent open–close strategies are adopted, implementing a closing phase first could reduce deaths (from 47,000 to 27,000 with slow vaccine rollout) and healthcare system costs, without substantive aggravation of socioeconomic losses.</p></div></div></section>

            
                
            

            
                
                    
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-022-06159-x/MediaObjects/41598_2022_6159_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41598-022-06159-x?fromPaywallRec=false" data-track="select_recommendations_1" data-track-context="inline recommendations" data-track-action="click recommendations inline - 1" data-track-label="10.1038/s41598-022-06159-x">Understanding the dynamics of SARS-CoV-2 variants of concern in Ontario, Canada: a modeling study
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">08 February 2022</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-022-30897-1/MediaObjects/41467_2022_30897_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41467-022-30897-1?fromPaywallRec=false" data-track="select_recommendations_2" data-track-context="inline recommendations" data-track-action="click recommendations inline - 2" data-track-label="10.1038/s41467-022-30897-1">Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">03 June 2022</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-023-39661-5/MediaObjects/41467_2023_39661_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41467-023-39661-5?fromPaywallRec=false" data-track="select_recommendations_3" data-track-context="inline recommendations" data-track-action="click recommendations inline - 3" data-track-label="10.1038/s41467-023-39661-5">Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">17 July 2023</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1749518349,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                
                
                <div class="main-content">
                    
                        <section data-title="Main"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Main</h2><div class="c-article-section__content" id="Sec1-content"><p>Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome was sequenced<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020)." href="/articles/s41591-021-01334-5#ref-CR3" id="ref-link-section-d66285444e633">3</a></sup>, researchers have rushed to develop vaccines to curb the spread of COVID-19 (refs. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Wang, J., Peng, Y., Xu, H., Cui, Z. &amp; Williams, R. O. The COVID-19 vaccine race: challenges and opportunities in vaccine formulation. AAPS PharmSciTech. 21, 225 (2020)." href="/articles/s41591-021-01334-5#ref-CR4" id="ref-link-section-d66285444e637">4</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Rawat, K., Kumari, P. &amp; Saha, L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. Eur. J. Pharmacol. 892, 173751 (2021)." href="/articles/s41591-021-01334-5#ref-CR5" id="ref-link-section-d66285444e640">5</a></sup>). Given the infeasibility of long-term lockdowns<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Abbasi, K. Behavioural fatigue: a flawed idea central to a flawed pandemic response. BMJ 370, m3093 (2020)." href="/articles/s41591-021-01334-5#ref-CR6" id="ref-link-section-d66285444e644">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Rypdal, K., Bianchi, F. M. &amp; Rypdal, M. Intervention fatigue is the primary cause of strong secondary waves in the COVID-19 pandemic. Int. J. Environ. Res. Public Health 17, 9592 (2020)." href="/articles/s41591-021-01334-5#ref-CR7" id="ref-link-section-d66285444e647">7</a></sup> and of effective contact tracing at high case numbers, as well as the availability of several approved COVID-19 vaccines, many countries have invested in mass vaccination rollouts. As of 13 March 2021, four vaccines—Pfizer/BioNTech, Moderna, Oxford–AstraZeneca AZD1222 and J&amp;J Ad26.COV2.S—have been approved by the European Medicines Agency and the Italian Medicines Agency. The reported efficacy rates are 94% and 95%, respectively, for the Moderna and Pfizer/BioNTech vaccines<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020)." href="/articles/s41591-021-01334-5#ref-CR8" id="ref-link-section-d66285444e651">8</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403–416 (2021)." href="/articles/s41591-021-01334-5#ref-CR9" id="ref-link-section-d66285444e654">9</a></sup>, up to 81.3% for AZD1222 after the second dose with a longer prime–boost interval<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Voysey, M. et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet 397, 881–891 (2021)." href="/articles/s41591-021-01334-5#ref-CR10" id="ref-link-section-d66285444e658">10</a></sup> and up to 85% in preventing severe disease for J&amp;J Ad26.COV2.S 28 d after vaccination<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="US Food and Drug Administration. FDA Briefing Document. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting, February 26, 2021. 
                  https://www.fda.gov/media/146217/download
                  
                " href="/articles/s41591-021-01334-5#ref-CR11" id="ref-link-section-d66285444e663">11</a></sup>. All vaccines have been reported to have favorable safety profiles<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020)." href="/articles/s41591-021-01334-5#ref-CR8" id="ref-link-section-d66285444e667">8</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403–416 (2021)." href="/articles/s41591-021-01334-5#ref-CR9" id="ref-link-section-d66285444e670">9</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="US Food and Drug Administration. FDA Briefing Document. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting, February 26, 2021. 
                  https://www.fda.gov/media/146217/download
                  
                " href="#ref-CR11" id="ref-link-section-d66285444e673">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Gee, J. et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morb. Mortal. Wkly Rep. 70, 283–288 (2021)." href="#ref-CR12" id="ref-link-section-d66285444e673_1">12</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99–111 (2021)." href="#ref-CR13" id="ref-link-section-d66285444e673_2">13</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="European Medicines Agency. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. 
                  https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR14" id="ref-link-section-d66285444e676">14</a></sup>. Italy’s vaccination program started in late December 2020<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="ANSA. Pfizer vaccine arrives in Italy. 
                  https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html
                  
                 (2020)." href="/articles/s41591-021-01334-5#ref-CR15" id="ref-link-section-d66285444e680">15</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="ANSA. First Moderna vaccine doses arrive in Italy. 
                  https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR16" id="ref-link-section-d66285444e683">16</a></sup> and prioritized healthcare workers, nursing home residents and people over 80 years of age<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Reuters. Italy kicks off vaccinations against COVID-19 in Rome. 
                  https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O
                  
                 (2020)." href="/articles/s41591-021-01334-5#ref-CR17" id="ref-link-section-d66285444e687">17</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Ministero della salute (Italian Ministry of Health). Vaccinazione anti-SARS-CoV-2/COVID-19: PIANO STRATEGICO: Elementi di preparazione e di implementazione della strategia vaccinale. 
                  https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf
                  
                 (2020)." href="/articles/s41591-021-01334-5#ref-CR18" id="ref-link-section-d66285444e690">18</a></sup>. As of 26 March 2021, 2,787,749 people have been vaccinated in Italy with both doses (8,765,085 doses have been administered in total)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Presidenza del Consiglio dei Ministri. Ministero della Salute. Commissario Straordinario Covid-19. Report Vaccini Anti COVID-19. 
                  https://www.governo.it/it/cscovid19/report-vaccini/
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR19" id="ref-link-section-d66285444e694">19</a></sup>.</p><p>Multi-pronged countermeasures, including distancing, testing and tracing, are necessary to achieve a sustained reduction in infection cases<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Priesemann, V. et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. Lancet 397, 92–93 (2021)." href="/articles/s41591-021-01334-5#ref-CR20" id="ref-link-section-d66285444e701">20</a></sup>, even more so in light of the recent emergence of new SARS-CoV-2 variants<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Priesemann, V. et al. An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet 397, 469–470 (2021)." href="/articles/s41591-021-01334-5#ref-CR21" id="ref-link-section-d66285444e705">21</a></sup>, such as B.1.1.7 and B.1.351, which are reported to have increased transmissibility<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 372, eabg3055 (2021)." href="/articles/s41591-021-01334-5#ref-CR22" id="ref-link-section-d66285444e709">22</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Abbott, S., Funk, S. &amp; CMMID COVID-19 Working Group. Local area reproduction numbers and S-gene target failure. 
                  https://cmmid.github.io/topics/covid19/local-r-sgtf.html
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR23" id="ref-link-section-d66285444e712">23</a></sup> and possibly cause more severe disease<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Horby, P. et al. NERVTAG note on B.1.1.7 severity. 
                  https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR24" id="ref-link-section-d66285444e716">24</a></sup> compared to the original strain. Vaccination alone is not expected to be able to control the spread of the infection, and a carefully planned vaccination campaign<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Bubar, K. M. et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science 371, 916–921 (2021)." href="/articles/s41591-021-01334-5#ref-CR25" id="ref-link-section-d66285444e720">25</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Ramos A. M., Vela-Pérez, M., Ferrández, M. R., Kubik, A. B. &amp; Ivorra, B. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19. Preprint at ResearchGate 
                  https://doi.org/10.13140/RG.2.2.32580.24967/2
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR26" id="ref-link-section-d66285444e723">26</a></sup> needs to be coordinated with continued implementation of NPIs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Grundel, S. et al. How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks. Preprint at medRxiv 
                  https://doi.org/10.1101/2020.12.22.20248707
                  
                 (2020)." href="/articles/s41591-021-01334-5#ref-CR27" id="ref-link-section-d66285444e728">27</a></sup> until sufficient coverage is reached to make the case fatality rate (CFR) similar to that of seasonal influenza. Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-021-01334-5#Tab1">1</a> outlines the main findings and implications for policy of our study.</p><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Table 1 Policy summary</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-021-01334-5/tables/1" aria-label="Full size table 1"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>With vaccines and variants as potential game-changers, new models to forecast epidemic scenarios and assess the associated healthcare costs are essential. Our proposed integrated model (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1a</a>) uses the compartmental model SIDARTHE<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat. Med. 26, 855–860 (2020)." href="/articles/s41591-021-01334-5#ref-CR2" id="ref-link-section-d66285444e810">2</a></sup> (which we have extended here to include the effects of vaccination and now termed SIDARTHE-V) to provide the predicted evolution of new positive cases; based on new positive cases, a new data-based dynamic model derived from Italian field data computes the time profile of the resulting healthcare system costs, including hospital and intensive care unit (ICU) occupancy and deaths. Although age classes are not explicitly included in our compartmental model, they are accounted for by the data-driven model. To capture the progressive vaccination in reverse age order, the model takes into account age-dependent aggravation and death probability (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig8">5</a>). Details are provided in the <a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-021-01334-5#Sec2">Methods</a>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Model scheme and summary of our findings."><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1: Model scheme and summary of our findings.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-021-01334-5/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="301"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p><b>a</b>, Graphical scheme of our model (adapted from Giordano et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat. Med. 26, 855–860 (2020)." href="/articles/s41591-021-01334-5#ref-CR2" id="ref-link-section-d66285444e834">2</a></sup>). The compartmental SIDARTHE-V epidemiological model provides daily new cases as an input to a novel data-based model of casualties and healthcare system costs. The SIDARTHE-V model captures the dynamic interactions among nine mutually exclusive infection stages in the population: S, Susceptible (uninfected); I, Infected (asymptomatic infected, undetected); D, Diagnosed (asymptomatic infected, detected); A, Ailing (symptomatic infected, undetected); R, Recognized (symptomatic infected, detected); T, Threatened (infected with life-threatening symptoms, detected); H, Healed (recovered); E, Extinct (dead); and V, Vaccinated (successfully immunized). The SIDARTHE-V model provides the time evolution of daily new infection cases, based on which the data-driven model computes the evolution of deaths and ICU and hospital occupancy. <b>b</b>, Death versus vaccination speed curves. For a given <span class="mathjax-tex">\({\cal{R}}_0\)</span> profile, the curve gives the death toll in the period from April 2021 to January 2022 as a function of the average vaccination speed, measured as the fraction of vaccinated population at the end of the period. The death versus vaccination speed curves corresponding to a constant reproduction number are reported in purple (<span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>), orange (<span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span>) and blue (<span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>), whereas those corresponding to intermittent strategies are reported in red (Open–Close) and green (Close–Open).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-021-01334-5/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>We compare different scenarios to assess the effect of mass vaccination campaigns with different paces, in the presence of varying profiles of the reproduction number <span class="mathjax-tex">\({\cal{R}}_0\)</span> over time, due to specific SARS-CoV-2 variants and/or restrictions. We consider four effective vaccination schedules (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig7">4</a>), obtained by modulating linearly the speed of the four phases, T1–T4, of Italy’s vaccination plan<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Ministero della Salute. Vaccinazione anti-SARS-CoV-2/COVID-19, Piano Strategico, elementi di preparazione e di implementazione della strategia vaccinale. 
                  http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf
                  
                 (2020)." href="/articles/s41591-021-01334-5#ref-CR28" id="ref-link-section-d66285444e1022">28</a></sup> and yielding a different fraction of immunized people within January 2022: absent (0%), slow (47%), medium (64%) and fast (90%). We also consider five different time profiles of <span class="mathjax-tex">\({\cal{R}}_0\)</span>: constant <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> (high transmission); Open–Close periodic <span class="mathjax-tex">\({\cal{R}}_0\)</span> with average value of 1.1, in which 1-month Openings (<span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>: leaving schools and shops open, wearing face masks and keeping physical distance) alternate with 1-month Closures (<span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>: closing schools, shops, restaurants and entertainment places), starting with an Opening phase; constant <span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span>; Close–Open periodic <span class="mathjax-tex">\({\cal{R}}_0\)</span> with average value of 1.1, in which 1-month Closures alternate with 1-month Openings, starting with a Closure phase; constant <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span> (eradication).</p><p>Our main findings are summarized by the deaths versus speed curves in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1b</a>, which show mortality as a function of the vaccination rollout speed for each <span class="mathjax-tex">\({\cal{R}}_0\)</span> profile. Vaccination is assumed to reduce viral transmission as well as disease severity and risk of death. The different vaccination schedules could also be interpreted as different proportions of infections, diseases and deaths that the vaccine successfully stops, thus constituting a sensitivity analysis. The combination of the four vaccination schedules with the five <span class="mathjax-tex">\({\cal{R}}_0\)</span> profiles leads to 20 distinct scenarios (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1b</a>). Eradication is associated with an almost constant curve; however, with <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>, the proportion of deaths with slow, medium and fast vaccination schedules could be as small as 30%, 24% and 17% of the 298,000 deaths with no vaccination, respectively. The deaths versus speed curves are flatter when <span class="mathjax-tex">\({\cal{R}}_0\)</span> is kept smaller; implementation of stringent NPIs drastically reduces sensitivity to vaccination delays. Restrictive containment strategies (<span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>) lead to a number of deaths that could be as small as 10% of deaths with weak restrictions (<span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>): depending on the <span class="mathjax-tex">\({\cal{R}}_0\)</span> profile, deaths in the period from April 2021 to January 2022 vary in the range of 30,000–298,000 (no vaccination rollout), 20,000–91,000 (slow vaccination rollout), 19,000–72,000 (medium vaccination rollout) and 18,000–51,000 (fast vaccination rollout). Therefore, NPIs appear to have a stronger effect on mortality than vaccination speed. When planning mid-term interventions, pre-emption reduces mortality and healthcare system costs at no additional socioeconomic cost by comparison with delayed implementation. Both intermittent restrictions with the same average <span class="mathjax-tex">\({\cal{R}}_0\)</span> involve similar socioeconomic costs, but starting with a Closing phase improves on constant containment, which is better than starting with an Opening phase. For all vaccination schedules, the Close–Open strategy saves more than 14,000 lives compared to Open–Close. Hospital and ICU occupancy as a function of the vaccination speed follow a similar pattern (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig11">8</a>).</p><p>Considering a medium vaccination speed, Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig2">2a–f</a> shows the epidemic evolution for different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span> (the scenarios in the absence of vaccination are in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig5">2</a>). Despite vaccination and implementation of current containment measures, a higher transmissibility due to the spread of new variants would cause a dramatic surge in infection cases, leading, within 2 months, to a peak of almost 4,000 ICU beds needed and more than 700 daily deaths. To prevent this from happening and to reduce hospital occupancy and mortality, <span class="mathjax-tex">\({\cal{R}}_0\)</span> can be reduced through increased stringency of NPIs, particularly in the presence of highly transmissible variants.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="The effect of different constant values of 
                      
                        
                      
                      $${\mathbf{{\cal{R}}}}_0$$
                      
                        
                          
                            R
                          
                          
                            0
                          
                        
                      
                     and intermittent strategies."><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2: The effect of different constant values of <span class="mathjax-tex">\({\mathbf{{\cal{R}}}}_0\)</span> and intermittent strategies.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-021-01334-5/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig2_HTML.png?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="791"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>Time evolution of the epidemic, in the presence of medium-speed vaccination (64% of the population vaccinated within January 2022), when: <b>a</b>–<b>f</b>, different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>, namely <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> (purple), <span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span> (orange) and <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span> (blue), are assumed, resulting from different variants and/or containment strategies, and when: <b>g</b>–<b>l</b>, two alternative intermittent strategies are enforced, with an average value of <span class="mathjax-tex">\({\cal{R}}_0\)</span> equal to 1.1. The Open–Close strategy (red) switches every month between <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> and <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span> starting with <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>. The Close–Open strategy (green) switches every month between <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span> and <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> starting with <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>. <b>a</b>,<b>g</b>, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. <b>b</b>,<b>h</b>, Daily new cases. <b>c</b>,<b>i</b>, Active cases. <b>d</b>,<b>j</b>, Hospital occupancy. <b>e</b>,<b>k</b>, ICU occupancy. <b>f</b>,<b>l</b>, Daily deaths.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-021-01334-5/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>The need to implement new restrictions is likely to trigger intermittent containment measures, with the alternation of higher-<span class="mathjax-tex">\({\cal{R}}_0\)</span> and lower-<span class="mathjax-tex">\({\cal{R}}_0\)</span> phases<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Kissler, S. M. et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 368, 860–868 (2020)." href="/articles/s41591-021-01334-5#ref-CR29" id="ref-link-section-d66285444e2173">29</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Bin, M. et al. Post-lockdown abatement of COVID-19 by fast periodic switching. PLoS Comput. Biol. 17, e1008604 (2021)." href="/articles/s41591-021-01334-5#ref-CR30" id="ref-link-section-d66285444e2176">30</a></sup>. In Open–Close strategies, closures are delayed and applied only in anticipation of the pressure on the healthcare system becoming unbearable. Each intermittent Open–Close strategy can be associated with a Close–Open strategy that alternates opening and closing phases of the same duration, with the only difference of starting with a closure. Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig2">2g–l</a> compares the two different intermittent strategies, with average <span class="mathjax-tex">\({\cal{R}}_0\)</span> equal to 1.1, under medium-speed vaccination (the scenarios in the absence of vaccination are in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig6">3</a>). Opening first (Open–Close) or closing first (Close–Open) strongly affects healthcare system costs (which depend on case numbers), whereas socioeconomic costs (which depend on the duration and stringency of restrictions) are substantially unchanged. Without aggravation of social and economic losses with respect to an Open–Close strategy, a pre-emptive Close–Open strategy drastically reduces forthcoming infection numbers (decreasing the peak of daily new cases from 38,000 to 14,000), hospital and ICU occupancy and deaths (decreasing the peak of daily deaths from 600 to 400). Even though the average <span class="mathjax-tex">\({\cal{R}}_0\)</span> is above 1, the effective reproduction number <span class="mathjax-tex">\({\cal{R}}_t = {\cal{R}}_0S(t)\)</span> goes below 1 due to the decreasing susceptible fraction <i>S</i>(<i>t</i>); hence, the epidemic is eventually suppressed (<a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-021-01334-5#Sec2">Methods</a>).</p><p>Finally, we comparatively assess the effect of mass vaccination with different paces (which could be also interpreted as the effect of different vaccine efficacy). We assume that the number of reinfections occurring within the considered horizon is negligible. Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig3">3</a> compares the effect of slow versus fast vaccination under the intermittent Open–Close strategy. Although vaccination leads to a net reduction in deaths and hospital and ICU occupancy compared to the corresponding scenario without vaccination, the difference in effect between slow and fast vaccination is modest. The speed of vaccination becomes more important with a higher <span class="mathjax-tex">\({\cal{R}}_0\)</span>, at the price of many more deaths. In Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig9">6</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig10">7</a>, we also consider an adaptive vaccination scenario, where an increase in the number of current infection cases leads to a reduction of the vaccination rate, due to the augmented strain on the healthcare system. Both mortality and healthcare system costs increase, reinforcing conclusions about the greater importance of containment measures over vaccination rates.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="The effect of different vaccination paces."><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3: The effect of different vaccination paces.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-021-01334-5/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig3_HTML.png?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="397"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>Time evolution of the epidemic, with an intermittent Open–Close strategy enforced, in the presence of slow vaccination (47% of the population vaccinated within January 2022, red) or fast vaccination (90% of the population vaccinated within January 2022, blue). <b>a</b>, Time evolution of the fractions of susceptible, vaccinated, infected and recovered, and dead. <b>b</b>, Daily new cases. <b>c</b>, Active cases. <b>d</b>, Hospital occupancy. <b>e</b>, ICU occupancy. <b>f</b>, Daily deaths.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-021-01334-5/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>There are limitations to our study. The SIDARTHE-V model is a mean-field compartmental model, which relies on the assumption of a large population with homogeneous mixing and provides predictions that are averaged over the whole population; hence, geographical heterogeneity is not taken into account. More complex and detailed models, which account for spatial effects, social networks and the specificity of individual behaviors, can be developed and used to evaluate vaccination strategies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Tetteh, J. N. A., Nguyen, V. K. &amp; Hernandez-Vargas, E. A. COVID-19 network model to evaluate vaccine strategies towards herd immunity. Preprint at medRxiv 
                  https://doi.org/10.1101/2020.12.22.20248693
                  
                 (2020)." href="/articles/s41591-021-01334-5#ref-CR31" id="ref-link-section-d66285444e2399">31</a></sup>. Also, we assumed that vaccination is effective against SARS-CoV-2 variants. However, several concerns are raised regarding variants and their potential for vaccine-induced immunity escape<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850–854 (2021)." href="/articles/s41591-021-01334-5#ref-CR32" id="ref-link-section-d66285444e2403">32</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Fontanet, A. et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet 397, 952–954 (2021)." href="/articles/s41591-021-01334-5#ref-CR33" id="ref-link-section-d66285444e2406">33</a></sup>; preliminary reports suggest that some COVID-19 vaccines might retain efficacy against variants<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Callaway, E. Could new COVID variants undermine vaccines? Labs scramble to find out. Nature 589, 177–178 (2021)." href="/articles/s41591-021-01334-5#ref-CR34" id="ref-link-section-d66285444e2410">34</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Burki, T. Understanding variants of SARS-CoV-2. Lancet 397, 462 (2021)." href="/articles/s41591-021-01334-5#ref-CR35" id="ref-link-section-d66285444e2413">35</a></sup>, although it might be attenuated<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Lauring, A. S. &amp; Hodcroft, E. B. Genetic variants of SARS-CoV-2—what do they mean? JAMA 325, 529–531 (2021)." href="/articles/s41591-021-01334-5#ref-CR36" id="ref-link-section-d66285444e2417">36</a></sup>, whereas data suggest that Oxford–AstraZeneca AZD1222 might be less effective against B.1.351 (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Madhi, S. A. et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N. Engl. J. Med. 
                  https://doi.org/10.1056/NEJMoa2102214
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR37" id="ref-link-section-d66285444e2421">37</a></sup>). In our scenarios, we also optimistically assumed that successfully vaccinated individuals gain protection against death and hospitalization starting 3 weeks after the first vaccine dose rather than after the second dose.</p><p>Vaccination started with slow rates, and priority was given to healthcare personnel, thus delaying the CFR decrease: even under the fast rollout, the CFR would not be halved before June (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig7">4c</a>). Because the decrease rate of the CFR cannot be made arbitrarily fast, due to availability and administration rate of vaccines, our findings confirm that, in the first phase of the mass vaccination campaign, NPIs are crucial, regardless of the (realistic) vaccination speed. Given the circulation of highly transmissible SARS-CoV-2 variants and the risk of potential emergence of vaccine-resistant mutations, <span class="mathjax-tex">\({\cal{R}}_0\)</span> must be kept low until a sufficient level of population immunity is achieved and a large enough portion of the vulnerable population has been immunized. Only then can NPIs be safely and gradually released; the time at which this happens will depend on the speed of vaccine rollout.</p><p>To outrun the faster spread of the virus variants, the United Kingdom (UK) launched an extensive COVID-19 vaccination campaign, accelerated by extending the interval between doses: more than 29 million people have received at least one vaccine dose as of 25 March, which has reduced deaths and hospital admissions<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Lopez Bernal, J. et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.03.01.21252652
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR38" id="ref-link-section-d66285444e2464">38</a></sup>. Our model confirms that implementation of strong NPIs could bring the epidemic under control without vaccines or before reaching population immunity, as happened in the UK during January 2021: the highly transmissible B.1.1.7 variant, which first emerged in Kent, UK, and spread throughout the UK, was brought under control by lockdown restrictions kept in place during the first crucial phases of the vaccine rollout campaign. In the meantime, vaccine rollout in the UK has enabled planning subsequent gradual release of NPIs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Lopez Bernal, J. et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.03.01.21252652
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR38" id="ref-link-section-d66285444e2468">38</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="GOV.UK. Coronavirus (COVID‑19). 
                  https://www.gov.uk/coronavirus
                  
                " href="/articles/s41591-021-01334-5#ref-CR39" id="ref-link-section-d66285444e2471">39</a></sup>. Although the UK is heading into the second phase of the vaccination campaign, Italy is at an early phase, close to the UK’s first. To contain the new Italian outbreak of SARS-CoV-2, driven by the new variants of concern, it is important to maintain NPIs to prevent an uncontrolled surge in the number of infections, hospitalizations and deaths, because vaccination alone will be insufficient to control the epidemic. In parallel, accelerating the vaccination campaign, as was done in the UK (perhaps also by increasing the interval between doses), would be worth considering.</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Methods</h2><div class="c-article-section__content" id="Sec2-content"><p>Our overall model (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1a</a>) combines the flexibility and insight of compartmental models with the intrinsic robustness of a black-box healthcare system cost model based on observed data. The SIDARTHE-V model, including the compartment of vaccinated individuals (first block in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1a</a>), generates the predicted evolution of new positive cases, which is used by the data-based model (second block in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1a</a>) that captures hospitalization flows and quantifies healthcare system costs in terms of deaths and of hospital and ICU occupancy.</p><p>The data used to inform the model are taken from publicly available repositories and reports: <a href="https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale">https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale</a> for epidemiological data on the evolution of the COVID-19 epidemic in Italy until 12 March 2021; <a href="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf">https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf</a> for age-dependent CFRs; and <a href="http://dati.istat.it/Index.aspx">http://dati.istat.it/Index.aspx</a> for demographic information on the Italian population (needed to take age classes into account). Indeed, although age classes are not explicitly included in our compartmental SIDARTHE-V model, they are taken into account by the data-based model for healthcare system costs, which quantifies hospitalizations, ICU occupancy and deaths. The CFRs (and hospitalization rates) are computed by taking population age classes into account, as shown in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig8">5</a>, using demographic information from <a href="http://dati.istat.it/Index.aspx">http://dati.istat.it/Index.aspx</a>.</p><h3 class="c-article__sub-heading" id="Sec3">SIDARTHE-V compartmental model</h3><p>The SIDARTHE-V compartmental model shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig1">1a</a> extends the SIDARTHE model, introduced by Giordano et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat. Med. 26, 855–860 (2020)." href="/articles/s41591-021-01334-5#ref-CR2" id="ref-link-section-d66285444e2536">2</a></sup>, by including the effect of vaccination. This leads to nine possible stages of infection: susceptible individuals (S) are uninfected and not immunized; infected individuals (I) are asymptomatic and undetected; diagnosed individuals (D) are asymptomatic but detected; ailing individuals (A) are symptomatic but undetected; recognized individuals (R) are symptomatic and detected; threatened individuals (T) have acute life-threatening symptoms and are detected; healed individuals (H) have had the infection and recovered; extinct individuals (E) died because of the infection; and vaccinated individuals (V) have successfully obtained immunity without having been infected.</p><p>The dynamic interaction among these nine clusters of the population is described by the following nine ordinary differential equations, describing how the fraction of the population in each cluster evolves over time:</p><div id="Equ1" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot S\left( t \right) = - S\left( t \right)\left( {\alpha I\left( t \right) + \beta D\left( t \right) + \gamma A\left( t \right) + \delta R\left( t \right)} \right) - \varphi (S(t))$$</span></div><div class="c-article-equation__number">
                    (1)
                </div></div><div id="Equ2" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot I\left( t \right) = S\left( t \right)\left( {\alpha I\left( t \right) + \beta D\left( t \right) + \gamma A\left( t \right) + \delta R\left( t \right)} \right) - \left( {\varepsilon + \zeta + \lambda } \right)I\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (2)
                </div></div><div id="Equ3" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot D\left( t \right) = \varepsilon I\left( t \right) - \left( {\eta + \rho } \right)D\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (3)
                </div></div><div id="Equ4" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot A\left( t \right) = \zeta I\left( t \right) - \left( {\theta + \mu + \kappa } \right)A\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (4)
                </div></div><div id="Equ5" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot R\left( t \right) = \eta D\left( t \right) + \theta A\left( t \right) - \left( {\nu + \xi + \tau _1} \right)R\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (5)
                </div></div><div id="Equ6" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot T\left( t \right) = \mu A\left( t \right) + \nu R\left( t \right) - \left( {\sigma + \tau _2} \right)T\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (6)
                </div></div><div id="Equ7" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot H\left( t \right) = \lambda I\left( t \right) + \rho D\left( t \right) + \kappa A\left( t \right) + \xi R\left( t \right) + \sigma T\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (7)
                </div></div><div id="Equ8" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot E\left( t \right) = \tau _1R(t) + \tau _2T\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (8)
                </div></div><div id="Equ9" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot V\left( t \right) = \varphi (S(t))$$</span></div><div class="c-article-equation__number">
                    (9)
                </div></div><p>The uppercase Latin letters (state variables) represent the fraction of population in each stage, whereas all the considered parameters, denoted by Greek letters, are positive numbers and have the following meaning:</p><ul class="u-list-style-bullet">
                  <li>
                    <p>The contagion parameters <i>α</i>, <i>β</i>, <i>γ</i> and <i>δ</i>, respectively, denote the transmission rate (defined as the probability of disease transmission in a single contact multiplied by the average number of contacts per person) due to contacts between a Susceptible individual and an Infected, a Diagnosed, an Ailing or a Recognized individual. These parameters can be modified by social distancing policies (for example, closing schools, remote working and lockdown) as well as physical distancing, adoption of proper hygiene behaviors and use of personal protective equipment. The risk of contagion due to Threatened individuals, treated in proper ICUs, is assumed to be negligible.</p>
                  </li>
                  <li>
                    <p>The diagnosis parameters <i>ε</i> and <i>θ</i>, respectively, denote the probability rate of detection, relative to asymptomatic and symptomatic cases. These parameters, also modifiable, reflect the level of attention on the disease and the number of tests performed over the population: they can be increased by enforcing a massive contact tracing and testing campaign.</p>
                  </li>
                  <li>
                    <p>The symptom onset parameters <i>ζ</i> and <i>η</i> represent the probability rate at which an infected individual, respectively, undetected and detected, develops clinically relevant symptoms. Although disease dependent, they might be partially reduced by improved therapies and acquisition of immunity against the virus.</p>
                  </li>
                  <li>
                    <p>The critical/aggravation parameters <i>μ</i> and <i>v</i>, respectively, denote the rate at which undetected and detected infected symptomatic individuals develop life-threatening symptoms. The parameters can be reduced by means of improved therapies and acquisition of immunity against the virus.</p>
                  </li>
                  <li>
                    <p>The mortality parameters <i>τ</i><sub>1</sub> and <i>τ</i><sub>2</sub>, respectively, denote the mortality rate for infected individuals with symptoms (presumably in hospital wards) and with acute symptoms (presumably in ICUs) and can be reduced by means of improved therapies.</p>
                  </li>
                  <li>
                    <p>The healing parameters <i>λ</i>, <i>κ</i>, <i>ξ</i>, <i>ρ</i> and <i>σ</i> denote the rate of recovery for the five classes of infected individuals and can be increased thanks to improved treatments and acquisition of immunity against the virus.</p>
                  </li>
                  <li>
                    <p>The vaccination function <i>φ</i>(<i>S</i>(<i>t</i>)) represents the rate at which susceptible individuals successfully achieve immunity through vaccination (the rate depends on both the actual vaccination rate and the vaccine efficacy); possible choices are the state-dependent <i>φ</i>(<i>S</i>(<i>t</i>)) = <i>φS</i>(<i>t</i>), leading to an exponential decay of the number of susceptible individuals, and <i>φ</i>(<i>S</i>(<i>t</i>)) = <i>φS</i>(<i>t</i>) &gt; 0 as long as <i>S</i>(<i>t</i>) &gt; 0 (<i>φ</i>(<i>S</i>(<i>t</i>) = 0 otherwise), leading to a linear decay. In the latter case, <i>φ</i>(<i>t</i>) can be piecewise constant, as in the vaccination profiles in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig7">4</a>. It is worth stressing that any vaccine (Pfizer/BioNTech, Moderna, Oxford–AstraZeneca, J&amp;J and any other) can be considered within the model as the inducer of immunity, without altering the model validity.</p>
                  </li>
                </ul><p>Concerning the duration of immunity, correlates of protection against SARS-CoV-2 infection in humans are not yet established, but the results of a clinical trial with the mRNA-1273 vaccine show that, despite a slight expected decline in titers of binding and neutralizing antibodies, mRNA-1273 has the potential to provide durable humoral immunity: as the natural infection, which produces variable antibody longevity and might induce robust memory B cell responses, also mRNA-1273 vaccine elicited primary CD4 type 1 helper T responses 43 d after the first vaccination, and protection persists after 119 d<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Widge, A. T. et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. N. Engl. J. Med. 384, 80–82 (2021)." href="/articles/s41591-021-01334-5#ref-CR40" id="ref-link-section-d66285444e3653">40</a></sup>. Although it is unclear how long protective effects last beyond the first few months after vaccination, some studies suggest that the elicited neutralizing activity is maintained for up to 8 months after the natural infection with SARS-CoV-2 (refs. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437–442 (2020)." href="/articles/s41591-021-01334-5#ref-CR41" id="ref-link-section-d66285444e3657">41</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021)." href="/articles/s41591-021-01334-5#ref-CR42" id="ref-link-section-d66285444e3660">42</a></sup>). Reasonably, considering that a similar pattern of responses lasting over time will also emerge after vaccinations, it would be at least unlikely that any potential reinfection would occur over the horizon considered by our scenarios. This is why reinfections have not been explicitly considered in the model, given that we are focused on short-term horizons.</p><p>Also, it is worth stressing that we are considering the rate of successful immunization, not of vaccine dose administration (this is why immunity is built up with a slower pace with respect to the expected vaccine roll-out logistics); people who get vaccinated, but for whom the vaccine is not effective, remain susceptible and are, therefore, equally at risk of serious disease and death.</p><p>The system is compartmental and has the mass conservation property: as it can be immediately checked, <span class="mathjax-tex">\(\dot S\left( t \right) + \dot I\left( t \right) + \dot D\left( t \right) + \dot A\left( t \right) + \dot R\left( t \right) + \dot T\left( t \right) + \dot H\left( t \right) + \dot E\left( {\mathrm{t}} \right) + \dot V({\mathrm{t}}) = 0\)</span>, hence the sum of the states (total population) is constant. Because the variables denote population fractions, we have:</p><div id="Equa" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$S(t) + I(t) + D(t) + A(t) + R(t) + T(t) + H(t) + E(t) + V(t) = 1,$$</span></div></div><p>where 1 denotes the total population, including deceased. Note that <i>H</i>(<i>t</i>), <i>E</i>(<i>t</i>) and <i>V</i>(<i>t</i>) are cumulative variables that depend only on the other ones and on their own initial conditions.</p><p>Given an initial condition <i>S</i>(0), <i>I</i>(0), <i>D</i>(0), <i>A</i>(0), <i>R</i>(0), <i>T</i>(0), <i>H</i>(0), <i>E</i>(0) and <i>V</i>(0) summing up to 1, if the vaccination function <i>φ</i>(<i>S</i>(<i>t</i>)) &gt; 0 as long as <i>S</i>(<i>t</i>) &gt; 0, the variables converge to</p><div id="Equb" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\bar S = 0,\bar I = 0,\bar D = 0,\bar A = 0,\bar R = 0,\bar T = 0,\bar H \ge 0,\bar E \ge 0,\bar V \ge 0,$$</span></div></div><p>with <span class="mathjax-tex">\(\bar H + \bar E + \bar V = 1\)</span>. So only the vaccinated/immunized, the healed and the deceased populations are eventually present, meaning that the epidemic phenomenon is over. All the possible equilibria are given by <span class="mathjax-tex">\(\left( {0,0,0,0,0,0,\bar H,\bar E,\bar V} \right)\)</span>, with <span class="mathjax-tex">\(\bar H + \bar E + \bar V = 1\)</span>.</p><p>To better understand the system behavior, we partition it into three subsystems: the first includes just variable <i>S</i> (corresponding to susceptible individuals); the second, which we denote as the <i>IDART</i> subsystem, includes <i>I</i>, <i>D</i>, <i>A</i>, <i>R</i> and <i>T</i> (the infected individuals); and the third includes variables <i>H</i>, <i>E</i> and <i>V</i> (representing healed, defunct and vaccinated/immunized).</p><p>The overall system can be seen as a positive linear system subject to a feedback signal <i>u</i>. Defining <i>x</i> = [<i>I D A R T</i>]<sup>T</sup>, we can rewrite the <i>IDART</i> subsystem as</p><div id="Equ10" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot x\left( t \right) = Fx\left( t \right) + bu\left( t \right) = \left[ {\begin{array}{*{20}{l}} { - r_1} \hfill &amp; 0 \hfill &amp; 0 \hfill &amp; 0 \hfill &amp; 0 \hfill \\ \varepsilon \hfill &amp; { - r_2} \hfill &amp; 0 \hfill &amp; 0 \hfill &amp; 0 \hfill \\ \zeta \hfill &amp; 0 \hfill &amp; { - r_3} \hfill &amp; 0 \hfill &amp; 0 \hfill \\ 0 \hfill &amp; \eta \hfill &amp; \theta \hfill &amp; { - r_4} \hfill &amp; 0 \hfill \\ 0 \hfill &amp; 0 \hfill &amp; \mu \hfill &amp; \nu \hfill &amp; { - r_5} \hfill \end{array}} \right]x(t) + \left[ {\begin{array}{*{20}{l}} 1 \hfill \\ 0 \hfill \\ 0 \hfill \\ 0 \hfill \\ 0 \hfill \end{array}} \right]u(t)$$</span></div><div class="c-article-equation__number">
                    (10)
                </div></div><div id="Equ11" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$y_S\left( t \right) = c^ \top x\left( t \right) = \left[ {\begin{array}{*{20}{c}} \alpha &amp; \beta &amp; \gamma &amp; \delta &amp; 0 \end{array}} \right]x(t)$$</span></div><div class="c-article-equation__number">
                    (11)
                </div></div><div id="Equ12" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$y_H\left( t \right) = f^ \top x\left( t \right) = \left[ {\begin{array}{*{20}{c}} \lambda &amp; \rho &amp; \kappa &amp; \xi &amp; \sigma \end{array}} \right]x(t)$$</span></div><div class="c-article-equation__number">
                    (12)
                </div></div><div id="Equ13" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$y_E\left( t \right) = d^ \top x\left( t \right) = \left[ {\begin{array}{*{20}{c}} 0 &amp; 0 &amp; 0 &amp; {\tau _1} &amp; {\tau _2} \end{array}} \right]x(t)$$</span></div><div class="c-article-equation__number">
                    (13)
                </div></div><div id="Equ14" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$u\left( t \right) = S(t)y_S\left( t \right)$$</span></div><div class="c-article-equation__number">
                    (14)
                </div></div><p>where <span class="mathjax-tex">\(r_1 = \varepsilon + \zeta + \lambda\)</span>, <span class="mathjax-tex">\(r_2 = {\upeta} + \rho\)</span>, <span class="mathjax-tex">\(r_3 = {\uptheta} + {\upmu} + \kappa\)</span>, <span class="mathjax-tex">\(r_4 = {\upnu} + \xi + \tau _1\)</span> and <span class="mathjax-tex">\(r_5 = {\upsigma} + \tau _2\)</span>. The remaining variables satisfy the differential equations</p><div id="Equ15" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot S\left( t \right) = - S\left( t \right)y_S\left( t \right) - \varphi \left( {S\left( t \right)} \right)$$</span></div><div class="c-article-equation__number">
                    (15)
                </div></div><div id="Equ16" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot H(t) = y_H(t)$$</span></div><div class="c-article-equation__number">
                    (16)
                </div></div><div id="Equ17" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot E(t) = y_E(t)$$</span></div><div class="c-article-equation__number">
                    (17)
                </div></div><div id="Equ18" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot V(t) = \varphi \left( {S\left( t \right)} \right)$$</span></div><div class="c-article-equation__number">
                    (18)
                </div></div><p>We can also distinguish between diagnosed healed <i>H</i><sub><i>D</i></sub>(<i>t</i>), evolving as</p><div id="Equc" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot H_D\left( t \right) = \rho D\left( t \right) + \xi R\left( t \right) + \sigma T\left( t \right),$$</span></div></div><p>and undiagnosed healed <i>H</i><sub><i>U</i></sub>(<i>t</i>), evolving as</p><div id="Equd" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot H_U\left( t \right) = \lambda I\left( t \right) + \kappa A\left( t \right).$$</span></div></div><p>Then, the overall system is described by the infection stage dynamics</p><div id="Eque" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\dot x\left( t \right) = (F + bS\left( t \right)c^ \top )x\left( t \right)$$</span></div></div><p>along with the equations for <i>S</i>(<i>t</i>), <i>E</i>(<i>t</i>) and <i>H</i>(<i>t</i>) (or, equivalently, <i>H</i><sub><i>D</i></sub>(<i>t</i>) and <i>H</i><sub><i>U</i></sub>(<i>t</i>)).</p><p>The parametric reproduction number <span class="mathjax-tex">\({\cal{R}}_0\)</span> is the <i>H</i><sub><i>∞</i></sub> norm of the positive system from <i>u</i> to <i>y</i><sub><i>s</i></sub> with parameters tuned at the beginning of the epidemic—that is, when the fraction of susceptible individuals is 1. A simple computation leads to</p><div id="Equf" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\cal{R}}_0 = \frac{{\alpha + \frac{{\beta \varepsilon }}{{r_2}} + \frac{{\gamma \zeta }}{{r_3}} + \delta (\frac{{\eta \varepsilon }}{{r_2r_4}} + \frac{{\zeta \theta }}{{r_3r_4}})}}{{r_1}}$$</span></div></div><p>All the parameters but <i>φ</i> are represented in <span class="mathjax-tex">\({\cal{R}}_0\)</span>. Because these parameters depend on the adopted containment measures, on the effectiveness of therapies and of the efficacy of testing and contact tracing, <span class="mathjax-tex">\({\cal{R}}_0\)</span> is time varying in principle. Conversely, the basic reproduction number is the value of the parametric reproduction number at the first onset of the epidemic outbreak, and its value was estimated to range between 2.43 and 3.1 for SARS-CoV-2 in Italy<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="D’Arienzo, M. &amp; Coniglio, A. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. Biosaf. Health 2, 57–59 (2020)." href="/articles/s41591-021-01334-5#ref-CR43" id="ref-link-section-d66285444e6517">43</a></sup>. The current reproduction number <span class="mathjax-tex">\({\cal{R}}_t\)</span> is the product between <span class="mathjax-tex">\({\cal{R}}_0\)</span> and the susceptible fraction: <span class="mathjax-tex">\({\cal{R}}_t = {\cal{R}}_0S(t)\)</span>. Notice that <span class="mathjax-tex">\({\cal{R}}_0\)</span> depends linearly on the contagion parameters. A thorough parameter sensitivity analysis has been worked out for the SIDARTHE model<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat. Med. 26, 855–860 (2020)." href="/articles/s41591-021-01334-5#ref-CR2" id="ref-link-section-d66285444e6671">2</a></sup>.</p><p>Fundamental mathematical results on the stability and convergence of the model in the absence of vaccination (that is, <i>φ</i>(<i>S</i>(<i>t</i>)) = 0) are summarized next.</p><p>The system (10), (14) with constant parameters and constant susceptible population <span class="mathjax-tex">\(S\left( {\bar t} \right)\)</span> is asymptotically stable if and only if <span class="mathjax-tex">\({\cal{R}}_{\bar t} &lt; 1\)</span>. The equilibrium point <span class="mathjax-tex">\(\bar x,\bar S\)</span> of system (10), (14) with constant parameters after <span class="mathjax-tex">\(\bar t\)</span> is given by <span class="mathjax-tex">\(\bar x = 0\)</span> and <span class="mathjax-tex">\(\bar S\)</span> satisfying</p><div id="Equg" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{ln}}\left( {\frac{{S(\bar t)}}{{\bar S}}} \right) + {\cal{R}}_0\left( {\bar S - S\left( {\bar t} \right)} \right) = - c^ \top F^{ - 1}x(\bar t)$$</span></div></div><p>The condition <span class="mathjax-tex">\({\cal{R}}_t = {\cal{R}}_0S\left( t \right) &lt; 1\)</span> is always verified after a certain time instant, so that <span class="mathjax-tex">\(x\left( t \right) \to 0\)</span> and <span class="mathjax-tex">\(S\left( t \right) \to \bar S\)</span> with <span class="mathjax-tex">\({\cal{R}}_0\bar S &lt; 1\)</span>.</p><p>As a consequence, epidemic suppression is achieved when the inequality <span class="mathjax-tex">\({\cal{R}}_t = {\cal{R}}_0S\left( t \right) &lt; 1\)</span> is always verified from a certain moment onward.</p><h3 class="c-article__sub-heading" id="Sec4">Fit of the SIDARTHE-V model for the COVID-19 epidemic in Italy</h3><p>We infer the parameters for models (1)–(9) based on the official data (source: Protezione Civile and Ministero della Salute) about the evolution of the epidemic in Italy from 24 February 2020 through 26 March 2021. We turn the data into fractions over the whole Italian population (~60 million) and adopt a best-fit approach to find the parameters that locally minimize the sum of the squares of the errors.</p><p>With parameters estimated based on data until 26 March 2021, the SIDARTHE-V model reproduces the second wave of infection and feeds the health cost model that quantifies the healthcare system costs in different scenarios, encompassing Close–Open strategies during the mass vaccination campaign.</p><p>The validation in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig4">1</a> shows how the SIDARTHE model (initially without vaccination) can faithfully reproduce the epidemic evolution observed so far. In the figures, the evolution over time of the number of active cases, hospitalizations and ICU occupancy, as well as daily deaths, is reported in logarithmic scale, comparing data (dots) with the model prediction (solid line). After 8 March 2020, a strict lockdown brought the Italian effective reproduction number below 1, successfully reversing the COVID-19 epidemic trend. Commercial and recreational activities gradually reopened, until the lockdown was fully lifted on 3 June. The lockdown relaxation coincided with a decreased risk perception and increased social gatherings when, after the first wave, restrictions were eased during the summer. Hence, as expected, a new upward trend in SARS-CoV-2 infections began in mid-August. The increase in daily cases, slow and steady at first, eventually led to a failure in the contact tracing system and the occurrence of a second wave. School reopening in the third week of September led to a steady increase in the number of new cases and hospital and ICU occupancy. This prompted the Italian government, on 4 November, to introduce a three-tier system enforcing diversely strict containment measures on a regional basis, depending on different risk scenarios. The slow decrease of the reproduction and hospitalization numbers led to stricter rules for the period of 24 December to 6 January. The initial onset of the second wave can be promptly identified at the beginning of August 2020, when the infection variables reached a minimum value. The descent phase of the second wave was much slower than that of the first, revealing that the enforced containment measures were milder. In particular, progressive countermeasures were enforced on 24 October (partial limitations), 4 November (regional lockdowns) and December (country-wide lockdown). Mild easing of restrictions and school reopening started on 7 January 2021, whereas other regional measures were implemented on 15 January, subsequently eased and then reinforced.</p><p>To reproduce the epidemic evolution over time, the system parameters are piecewise constant and are possibly updated at the following days:</p><p>[1 4 12 22 28 36 38 40 47 60 75 119 151 163 182 213 221 253 258 275 276 293 308 320 325 328 342 346 351 368 373 386]</p><p>The chosen parameter values are</p><p><i>α</i> = [0.6588 0.4874 0.4886 0.3467 0.2311 0.2543 0.2543 0.3174 0.3467 0.3351 0.3236 0.3236 0.3467 0.4391 0.4045 0.3699 0.4869 0.4166 0.3567 0.3567 0.3267 0.3567 0.3932 0.3533 0.3533 0.4032 0.3034 0.3433 0.4471 0.4471 0.4471 0.3872]</p><p><i>β</i> = [0.012 0.006 0.006 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053 0.0053]</p><p><i>γ</i> = [0.4514 0.2821 0.2821 0.1980 0.1089 0.1089 0.1089 0.1089 0.1089 0.1188 0.1188 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485 0.1485]</p><p><i>δ</i> = [0.0113 0.0056 0.0056 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005]</p><p><i>ε</i> = [0.1703 0.1703 0.1419 0.1419 0.1419 0.1419 0.1992 0.2988 0.2988 0.2988 0.2988 0.6972 0.2490 0.2988 0.2590 0.2294 0.3137 0.2868 0.2868 0.2988 0.2988 0.2988 0.2988 0.3988 0.3988 0.1988 0.2968 0.3088 0.2988 0.2988 0.2988 0.2988]</p><p><i>θ</i> = [0.3705 0.3705 0.3705 0.3705 0.3705 0.3705 0.3705 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.3 0.6 0.37 0.370 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37]</p><p><i>ζ</i> = [0.1254 0.1254 0.1254 0.0340 0.0340 0.0341 0.0250 0.0250 0.0015 0 0.0001 0.0001 0.0005 0.0020 0.0030 0.0020 0.0046 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025 0.0025]</p><p><i>η</i> = [0.1054 0.1054 0.1054 0.0286 0.0286 0.0286 0.0286 0.021 0.0015 0 0 0 0.0005 0.002 0.0031 0.0026 0.003 0.0013 0.0013 0.001 0.0015 0.0018 0.0018 0.0018 0.0018 0.0018 0.0018 0.0018 0.0018 0.0018 0.0018 0.0018]</p><p><i>μ</i> = [0.0205 0.0205 0.0205 0.0096 0.0084 0.0036 0.0036 0.0036 0 0 0 0.0036 0.0036 0 0.0024 0.0036 0.06 0.12 0.12 0. 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12]</p><p><i>ν</i> = [0.03 0.03 0.01 0.01 0.01 0.008 0.007 0.006 0.005 0.004 0.025 0.025 0.0026 0.0026 0.0026 0.002 0.002 0.002 0.002 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02]</p><p><i>τ</i><sub>2</sub> = [0 0 0 0 0 0 0.035 0.045 0.045 0.045 0.4500 0.45 0.02 0 0 0 0 0.0005 0.0005 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17]</p><p><i>τ</i><sub>1</sub> = [0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.05 0.01 0.01 0 0 0 0 0 0 0.018 0.018 0.001 0.001 0.005 0.001 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005]</p><p><i>λ</i> = [0.0482 0.0482 0.0482 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128 0.1128]</p><p><i>ρ</i> = [0.0342 0.0342 0.0342 0.017 0.017 0.017 0.02 0.022 0.022 0.045 0.045 0.045 0.02 0.018 0.018 0.018 0.018 0.018 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032 0.032]</p><p><i>κ</i> = [0.0171 0.0171 0.0171 0.0171 0.0171 0.0171 0.02 0.022 0.022 0.035 0.035 0.035 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02]</p><p><i>χ</i> = [0.00025 0.00025 0.00025 0.00025 0.00025 0.00025 0.00025 0.0083 0.0083 0.0207 0.012 0.012 0.0037 0.0019 0.0019 0.00067 0.00067 0.00067 0.00015 0.022 0.022 0.032 0.022 0.0220 0.022 0.022 0.0120 0.022 0.012 0.012 0.012 0.012]</p><p><i>σ</i> = [0.0513 0.0513 0.0513 0.0513 0.0513 0.0513 0.03 0.03 0.06 0.075 0.003 0 0 0 0.024 0.024 0.024 0.024 0.0024 0.024 0.024 0.024 0.024 0.024 0.024 0.024 0.024 0.024 0.024 0.024 0.024 0.024]</p><p>and lead to the following piecewise constant parametric reproduction number:</p><p><span class="mathjax-tex">\({\cal{R}}_0\)</span> = [2.5200 1.7692 1.9725 1.3859 0.9593 1.0448 0.9162 0.8533 1.0138 0.8997 0.8715 0.5008 1.1494 1.3398 1.3776 1.4154 1.3439 1.2464 1.0104 0.9827 0.9097 0.9812 1.0685 0.9726 0.8150 0.9113 1.0709 0.9516 1.1747 1.2004 1.2651 1.0579]</p><p>Starting with day 405 (5 April 2021), the parameters are differentiated depending on the different scenarios associated with the presence of new virus variants and/or of the adoption of different restrictions:</p><ul class="u-list-style-bullet">
                  <li>
                    <p>High transmission: <i>α</i> = 0.477, leading to a constant <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span></p>
                  </li>
                  <li>
                    <p>Open–Close: <i>α</i> switches every month between the high value 0.477 and the low value 0.3198; hence, every month <span class="mathjax-tex">\({\cal{R}}_0\)</span> switches between the values 1.27 and 0.9, with an average value of about 1.1.</p>
                  </li>
                  <li>
                    <p>Constant <i>α</i> = 0.4092, leading to <span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span></p>
                  </li>
                  <li>
                    <p>Close–Open: <i>α</i> switches every month between the low value 0.3198 and the high value 0.477; hence, every month <span class="mathjax-tex">\({\cal{R}}_0\)</span> switches between the values 0.9 and 1.27, with an average value of about 1.1. The Close–Open strategy features the same pattern as the Open–Close strategy, the only difference being that it starts with a closure phase.</p>
                  </li>
                  <li>
                    <p>Eradication: <i>α</i> = 0.3198, leading to a constant <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>.</p>
                  </li>
                </ul><p>Different parameter choices for the SIDARTHE-V model might yield the same <span class="mathjax-tex">\({\cal{R}}_0\)</span>. However, we have fitted our model based on a long history of data (since February 2020) and on a priori information about the epidemic and its management; to show the effect of a different <span class="mathjax-tex">\({\cal{R}}_0\)</span>, we are only modifying the infection parameters—that is, the high-sensitivity parameters (according to the thorough sensitivity analysis performed in our previous work<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat. Med. 26, 855–860 (2020)." href="/articles/s41591-021-01334-5#ref-CR2" id="ref-link-section-d66285444e7744">2</a></sup>) that are affected by the spread of more transmissible variants and by NPIs. If two different combinations of parameters could fit equally well all the past data history and yield the same <span class="mathjax-tex">\({\cal{R}}_0\)</span>, the resulting long-term future evolution would also be similar. Any parameter choice that successfully reproduces the observed total number of cases is suitable for our goal: through the SIDARTHE-V model, we are computing only the predicted total number of detected infection cases, which is then projected onto healthcare system costs (including deaths and hospitalizations) by the data-based model.</p><p>The vaccination function is chosen according to the three different profiles shown in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig7">4</a>, where <span class="mathjax-tex">\(\varphi \left( {S\left( t \right)} \right) = \varphi \left( t \right)\)</span> is piecewise constant (of course, <span class="mathjax-tex">\(\varphi \left( {S\left( t \right)} \right) = 0\)</span> when <i>S</i>(<i>t</i>) = 0).</p><p>In the adaptive vaccination scenarios in Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig9">6</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig10">7</a>, conversely, the vaccination function is chosen as <span class="mathjax-tex">\({\mathrm{max}}\{ \left[ {1 - r\left( {D\left( t \right) + R\left( t \right) + T\left( t \right)} \right)} \right]\varphi \left( t \right);0\}\)</span>, where <i>φ</i>(<i>t</i>) is the same piecewise constant vaccination profile as above, whereas the parameter <i>r</i> is chosen as <i>r</i> = 10<sup>−6</sup>.</p><p>Note that our model accounts for the effective immunization rate, regardless of the adopted vaccine. Any vaccine can be included in the model without altering its validity: the resulting immunization curves can be derived with the same procedure, regardless of the specific vaccine that has been used to achieve immunity.</p><p>Adaptive vaccination under a medium vaccination schedule (Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig9">6</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig10">7</a>) leads to increased healthcare system costs with respect to piecewise constant vaccination functions (Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig2">2</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig3">3</a>) for all <span class="mathjax-tex">\({\cal{R}}_0\)</span> profiles. These costs can be compared with the even worse outcomes that are expected without vaccination, displayed in Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig5">2</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig3">3</a>. When <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>, thousand deaths in the period from April 2021 to January 2022 increase from 90 to 229 (slow speed), from 72 to 220 (medium speed) and from 51 to 204 (fast speed), whereas they would be 298 without vaccination. Under the Open–Close strategy with average <span class="mathjax-tex">\({\cal{R}}_0\)</span> equal to 1.1, thousand deaths in the period from April 2021 to January 2022 increase from 47 to 76 (slow speed), from 42 to 70 (medium speed) and from 35 to 62 (fast speed), whereas they would be 126 without vaccination. When <span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span>, thousand deaths in the period from April 2021 to January 2022 increase from 34 to 48 (slow speed), from 30 to 44 (medium speed) and from 25 to 38 (fast speed), whereas they would be 96 without vaccination. Under the Close–Open strategy with average <span class="mathjax-tex">\({\cal{R}}_0\)</span> equal to 1.1, thousand deaths in the period from April 2021 to January 2022 increase from 27 to 37 (slow speed), from 24 to 33 (medium speed) and from 21 to 28 (fast speed), whereas they would be 84 without vaccination.</p><h3 class="c-article__sub-heading" id="Sec5">Data-driven model of healthcare system costs</h3><p>To predict the evolution of deaths from the time series of reported cases, a field estimate of the apparent CFR is needed. This parameter is affected by the testing protocol, the healthcare system reaction and the age distribution of vaccinated people. For these reasons, a specific model should be derived for each country resorting to a data-based approach. We considered the Italian case, but the methodology has general validity and could be promptly applied to other countries. The input–output model predicting deaths from the new cases was derived in two steps. First, a data-based dynamic model for the unvaccinated population was estimated from data collected during the second wave. The static gain of this dynamic model coincides with the CFR for the unvaccinated population. In the second step, this gain was multiplied by a time-varying function that accounts for the lethality decrease consequent to progressive vaccination of older people.</p><p>The input of the dynamic model is the time series of new cases <i>n</i>(<i>t</i>), and the output is the time series of daily deaths <i>d</i>(<i>t</i>). Given the variations of testing protocols and the large number of unreported cases during the first wave, the model was estimated using second-wave data collected within a 110-d window ending on 7 February 2021. More recent data were not used because the base CFR model should not be affected by vaccinations, whose effect is suitably incorporated in a second step as detailed below. The model assumes that the deaths at day <i>t</i> depend on the past new cases according to the equation</p><div id="Equh" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$d(t) = \mathop {\sum }\limits_{i = 0}^\infty w(i)n(t - i)$$</span></div></div><p>where the weight <i>w</i>(<i>i</i>) denotes the fraction of individuals who became infected at day <i>t</i>-<i>i</i> who eventually die at day <i>t</i>. The CFR for the unvaccinated population is then given by</p><div id="Equi" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$CFR_0 = \mathop {\sum }\limits_{i = 0}^\infty w(i)$$</span></div></div><p>To estimate the weights, an exponential model with delay was assumed:</p><div id="Equj" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$w(i) = \left\{ {\begin{array}{*{20}{c}} {0,} &amp; {i &lt; k} \\ {bf^{i - k},} &amp; {i \ge k} \end{array}} \right.$$</span></div></div><p>where <i>k</i> is the delay and <i>f</i> and <i>b</i> are unknown parameters. Because both the new cases and the daily deaths exhibit an apparent weekly seasonality, the original series were replaced by their 7-d moving average. Parameters were estimated via least squares using the function oe.m of the MATLAB System Identification Toolbox<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="MATLAB System Identification Toolbox, 9.13 (R2020b). 
                  https://www.mathworks.com/products/sysid.html
                  
                " href="/articles/s41591-021-01334-5#ref-CR44" id="ref-link-section-d66285444e8500">44</a></sup>. The estimation of <i>f</i> and <i>b</i> was repeated for all delays <i>k</i> ranging from 0 to 15, and the delay <i>k</i> = 3, associated with the best sum of squares, was eventually selected. The estimated parameters and their percent coefficients of variation were:</p><div id="Equk" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$f = 0.948,CV\left( \% \right) = 0.311$$</span></div></div><div id="Equl" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$b = 0.00141,CV(\% ) = 5.36$$</span></div></div><p>Then, recalling the formula for the sum of the harmonic series, the second-wave CFR for the unvaccinated population is given by</p><div id="Equm" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$CFR_0 = \mathop {\sum }\limits_{i = 0}^\infty w(i) = \frac{b}{{1 - f}} = 0.027$$</span></div></div><p>In the second step, the effect of vaccination on lethality was modeled by estimating a time-varying <i>CFR</i>(<i>t</i>) that depends on the vaccination schedule, described by the fraction <i>V</i>(<i>t</i>) of vaccine-immunized individuals at time <i>t</i>. Order of vaccination follows the reverse of the age. Slower or faster vaccination speeds correspond to different curves <i>V</i>(<i>t</i>), whose rate of increase might be less or more rapid. Three schedules were considered: fast, medium and slow. The fast schedule assumes that each the four phases, T1–T4, of the Italian vaccination plan<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Italian Ministry of Health. Vaccinazione anti-SARS-CoV-2/COVID-19 PIANO STRATEGICO. 
                  https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null
                  
                " href="/articles/s41591-021-01334-5#ref-CR45" id="ref-link-section-d66285444e8730">45</a></sup> is completed in one trimester. In the medium and slow schedule, the time was linearly extended by a factor 1.2 and 1.4, respectively. The three schedules are graphically displayed in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig7">4</a>. To account for vaccines that were already administered, the scheduled vaccination rate from 27 December 2020 to 12 March 2021 was replaced by the actual average rate of second-dose vaccinations from 27 December to 19 February, considering that immunization develops with some weeks of delay after the administration.</p><p>The COVID-19 lethality <i>CFR</i><sub><i>a</i></sub> for an individual of age <i>a</i> was obtained by rescaling values published the Italian National Institute of Health<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Task Force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica. Istituto Superiore di Sanità. Epidemia COVID-19: Aggiornamento nazionale. 
                  https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR46" id="ref-link-section-d66285444e8749">46</a></sup>. Rescaling was necessary because the published values were inflated by the inclusion of patients who died during the first wave, when new cases were massively underreported. Rescaling was performed in such a way that the overall lethality coincides with <i>CFR</i><sub>0</sub> = 0.027. The profile <i>CFR</i><sub><i>a</i></sub> is displayed in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig8">5c</a>.</p><p>If we assume that the number of deaths does not significantly affect the overall age distribution, the probability <i>P</i>(<i>Age</i> = <i>a</i>) can be directly inferred by ISTAT statistical tables<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="ISTAT-Istituto Nazionale di Statistica. 
                  http://dati.istat.it/Index.aspx
                  
                " href="/articles/s41591-021-01334-5#ref-CR47" id="ref-link-section-d66285444e8779">47</a></sup>. The distribution was corrected by subtracting individuals who were already vaccinated on 19 February 2021, whose ages are made available on the vaccine open data repository<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="GitHub. Covid-19 Opendata Vaccines. 
                  https://github.com/italia/covid19-opendata-vaccini
                  
                " href="/articles/s41591-021-01334-5#ref-CR48" id="ref-link-section-d66285444e8783">48</a></sup>. The distribution of population by age is displayed in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig8">5c</a>.</p><p>Recalling that <i>V</i>(<i>t</i>) is the fraction of vaccine-immunized individuals, and vaccination order follows the reverse of the age, the probability of death for an individual of age <i>a</i> who becomes infected at time <i>t</i> is</p><div id="Equn" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$P(Death|Age = a,Infected,t) = \left\{ {\begin{array}{*{20}{c}} {0,} &amp; {V(t) &gt; P(Age &gt; a)} \\ {CFR(a),} &amp; {V(t) \le P(Age &gt; a)} \end{array}} \right.$$</span></div></div><p>Then, the time-varying CFR is obtained by the total probability theorem:</p><div id="Equo" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$CFR(t) = \mathop {\sum }\limits_{a = 0}^{100} P(Death|Age = a,Infected,t)P(Age = a|Infected,t)$$</span></div></div><p>where <span class="mathjax-tex">\(P(Age = a|Infected,t)\)</span> denotes the probability that the age of an individual is <i>a</i>, knowing that the individual became infected at time <i>t</i>. During the second wave, the age distribution of the infected individuals<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Task Force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica. Istituto Superiore di Sanità. Epidemia COVID-19: Aggiornamento nazionale. 
                  https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR46" id="ref-link-section-d66285444e9250">46</a></sup> was similar to the age distribution of the Italian population. For instance, 56% of the population is in the age range 0–50 years, 28% is in the range 51–70 years and 16% is older than 70 years. In comparison, 55.6% of diagnosed cases between 18 December 2020 and 10 January 2021 were in age range 0–50 years, 28% in the range 51–70 years and 16.4% over 70 years. Therefore, <span class="mathjax-tex">\(P(Age = a|Infected,t) = P(Age = a)\)</span>, so that the CFR of an individual infected at time <i>t</i> can be computed as</p><div id="Equp" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$CFR(t) = \mathop {\sum }\limits_{a = 0}^{100} P(Death|Age = a,Infected,t)P(Age = a)$$</span></div></div><p>The steps of the procedure for the computation of <i>CFR</i>(<i>t</i>) are summarized in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig8">5</a>. The time-varying profiles <i>CFR</i>(<i>t</i>) for the three vaccination schedules are plotted in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig7">4</a>. Because protection against hospitalization and death has been observed already after the first dose, the calculation of the time-varying CFR was based on first dose administration, assumed twice as fast as second dose administration.</p><p>Finally, the input–output model that accounts for the effect of vaccination is given by</p><div id="Equq" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$d(t) = \mathop {\sum }\limits_{i = 0}^\infty w(i)C(t - i)n(t - i),C(t) = \frac{{CFR(t)}}{{CFR_0}}$$</span></div></div><p>Due to the time-varying coefficient <i>C</i>(<i>t</i>), the same number of new cases will yield fewer and fewer deaths as vaccination comes to protect older segments of the population.</p><p>Dynamic models for hospital and ICU occupancies were developed in a similar way. The estimated parameters and their percent coefficients of variation for hospital occupancy (estimated delay <i>k</i> = 0) were:</p><div id="Equr" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$a = 0.9522,CV\left( \% \right) = 0.226$$</span></div></div><div id="Equs" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$f = 0.0694,CV(\% ) = 4.26$$</span></div></div><p>Those for ICU occupancy (estimated delay <i>k</i> = 0) were:</p><div id="Equt" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$a = 0.953,CV\left( \% \right) = 0.328$$</span></div></div><div id="Equu" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$f = 0.00677,CV(\% ) = 6.297$$</span></div></div><p>Assuming that gravity reduction parallels the lethality one, the effect of vaccination on hospital and ICU occupancies was described by modulating the input through the time-varying coefficient <i>C</i>(<i>t</i>).</p><p>As seen in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig12">9</a>, the three data-based dynamic models provide a very good fitting of deaths and hospital and ICU occupancies.</p><h3 class="c-article__sub-heading" id="Sec6">Our scenarios: different values of <span class="mathjax-tex">\({\mathbf{{\cal{R}}}}_0\)</span>
                        </h3><p>The chosen values of <span class="mathjax-tex">\({\cal{R}}_0\)</span> are based on plausible scenarios, in view of what has been observed throughout the past year in Italy, with a suitable combination of (1) presence of SARS-CoV-2 variants with increased transmissibility and (2) enforced restrictions. In particular, the mild restrictions that kept <span class="mathjax-tex">\({\cal{R}}_0\)</span> around 0.9 with the original virus strain would keep it around 1.3 (at least) if the new variants increase transmissibility of at least 40–50%, as reported in the literature<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Voltz, E. et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. Preprint at medRxiv 
                  https://doi.org/10.1101/2020.12.30.20249034
                  
                 (2021)." href="#ref-CR49" id="ref-link-section-d66285444e9990">49</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Moore, J. P. Approaches for optimal use of different COVID-19 vaccines. Issues of viral variants and vaccine efficacy. JAMA 
                  https://doi.org/10.1001/jama.2021.3465
                  
                 (2021)." href="#ref-CR50" id="ref-link-section-d66285444e9990_1">50</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 
                  https://doi.org/10.1126/science.abg3055
                  
                 (2021)." href="/articles/s41591-021-01334-5#ref-CR51" id="ref-link-section-d66285444e9993">51</a></sup>. In fact, values around <span class="mathjax-tex">\({\cal{R}}_0\)</span> = 1.3 were observed in mid-March 2021 in areas of Italy where the UK variant is becoming dominant. We have not considered even worse scenarios, because a higher <span class="mathjax-tex">\({\cal{R}}_0\)</span> is unlikely to be sustainable: even stricter restrictions would then be enforced to prevent it from increasing. On the other hand, we deem it unlikely that restrictions so stringent to bring <span class="mathjax-tex">\({\cal{R}}_0\)</span> below 0.9 would be enforced; hence, we have chosen this value as the other extreme scenario.</p><h3 class="c-article__sub-heading" id="Sec7">Our scenarios: intermittent strategies, Open–Close and Close–Open</h3><p>In some of our scenarios, we consider intermittent strategies that rely on the alternation of Open phases (associated with a larger <span class="mathjax-tex">\({\cal{R}}_0\)</span>) and Close phases (associated with a smaller <span class="mathjax-tex">\({\cal{R}}_0\)</span>) with a fixed proportion.</p><p>One of our main results is that, when planning over a fixed time period and having to set the order of two phases (Open and Close) with fixed length, starting with the Close phase is always an advantage. This happens because the associated healthcare system costs depend on the total number of infection cases in the considered time period, which is much larger if the Open phase comes first; hence, starting with a Close phase drastically reduces health costs and losses. On the other hand, socioeconomic costs are proportional to the duration and stringency of the restrictions, regardless of when they are enforced; hence, intermittent closures yield similar socioeconomic costs. Given a finite horizon and Close/Open phases of fixed length, closing before opening does not bring any additional socioeconomic cost, with respect to opening before closing, because the closing (and opening) phases have the same duration in both scenarios.</p><p>This principle holds true irrespective of the initial size of the epidemic. For instance, with very low case numbers, starting with a Close phase could approach or even achieve eradication, after which reopening would be completely safe (such an eradication approach has been successfully adopted, for example, by New Zealand<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Cousins, S. New Zealand eliminates COVID-19. Lancet 395, 1474 (2020)." href="/articles/s41591-021-01334-5#ref-CR52" id="ref-link-section-d66285444e10157">52</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Fouda, A., Mahmoudi, N., Moy, N. &amp; Paolucci, F. The COVID-19 pandemic in Greece, Iceland, New Zealand, and Singapore: health policies and lessons learned. Health Policy Technol. 9, 510–524 (2020)." href="/articles/s41591-021-01334-5#ref-CR53" id="ref-link-section-d66285444e10160">53</a></sup>), whereas, if starting with an Open phase, the number of infection cases would grow exponentially, and the following Close phase could only mitigate the epidemic expansion. Of course, the higher the initial case number, the more visible the difference between the two strategies.</p><p>Also, the principle (if Open and Close phases with a fixed proportion need to be alternated in a periodic fashion, then starting with a Close phase is always preferable) remains valid regardless of the phase duration. In our scenarios, we have chosen 1-month-long phases, because this is a frequently observed choice in many countries (for example, in accordance with implemented policies in Italy but also in Israel) and is a sufficiently long time for the effect of interventions to be well visible.</p><h3 class="c-article__sub-heading" id="Sec8">Reporting Summary</h3><p>Further information on research design is available in the <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-021-01334-5#MOESM1">Nature Research Reporting Summary</a> linked to this article.</p></div></div></section>
                    
                </div>
            

            <div class="u-mt-32">
                <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>We gathered all epidemiological and demographic data from publicly available sources: <a href="https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale">https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale</a>, <a href="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf">https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf</a> and <a href="http://dati.istat.it/Index.aspx">http://dati.istat.it/Index.aspx</a>. Data are also included in Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig4">1</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-021-01334-5#Fig12">9</a> and in the code folder: <a href="https://giuliagiordano.dii.unitn.it/docs/papers/VaccineVariantsCode.zip">https://giuliagiordano.dii.unitn.it/docs/papers/VaccineVariantsCode.zip</a>.</p>
            </div></div></section><section data-title="Code availability"><div class="c-article-section" id="code-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="code-availability">Code availability</h2><div class="c-article-section__content" id="code-availability-content">
              
              <p>The codes are available at <a href="https://giuliagiordano.dii.unitn.it/docs/papers/VaccineVariantsCode.zip">https://giuliagiordano.dii.unitn.it/docs/papers/VaccineVariantsCode.zip</a>.</p>
            </div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Stasi, C., Fallani, S., Voller, F. &amp; Silvestri, C. Treatment for COVID-19: an overview. <i>Eur. J. Pharmacol.</i> <b>889</b>, 173644 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ejphar.2020.173644" data-track-item_id="10.1016/j.ejphar.2020.173644" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ejphar.2020.173644" aria-label="Article reference 1" data-doi="10.1016/j.ejphar.2020.173644">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitV2ls7jI" aria-label="CAS reference 1">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Treatment%20for%20COVID-19%3A%20an%20overview&amp;journal=Eur.%20J.%20Pharmacol.&amp;doi=10.1016%2Fj.ejphar.2020.173644&amp;volume=889&amp;publication_year=2020&amp;author=Stasi%2CC&amp;author=Fallani%2CS&amp;author=Voller%2CF&amp;author=Silvestri%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. <i>Nat. Med.</i> <b>26</b>, 855–860 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41591-020-0883-7" data-track-item_id="10.1038/s41591-020-0883-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41591-020-0883-7" aria-label="Article reference 2" data-doi="10.1038/s41591-020-0883-7">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVCitr4%3D" aria-label="CAS reference 2">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Modelling%20the%20COVID-19%20epidemic%20and%20implementation%20of%20population-wide%20interventions%20in%20Italy&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fs41591-020-0883-7&amp;volume=26&amp;pages=855-860&amp;publication_year=2020&amp;author=Giordano%2CG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Wu, F. et al. A new coronavirus associated with human respiratory disease in China. <i>Nature</i> <b>579</b>, 265–269 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-020-2008-3" data-track-item_id="10.1038/s41586-020-2008-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-020-2008-3" aria-label="Article reference 3" data-doi="10.1038/s41586-020-2008-3">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXksFKlsLc%3D" aria-label="CAS reference 3">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20new%20coronavirus%20associated%20with%20human%20respiratory%20disease%20in%20China&amp;journal=Nature&amp;doi=10.1038%2Fs41586-020-2008-3&amp;volume=579&amp;pages=265-269&amp;publication_year=2020&amp;author=Wu%2CF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Wang, J., Peng, Y., Xu, H., Cui, Z. &amp; Williams, R. O. The COVID-19 vaccine race: challenges and opportunities in vaccine formulation. <i>AAPS PharmSciTech.</i> <b>21</b>, 225 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1208/s12249-020-01744-7" data-track-item_id="10.1208/s12249-020-01744-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1208%2Fs12249-020-01744-7" aria-label="Article reference 4" data-doi="10.1208/s12249-020-01744-7">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20COVID-19%20vaccine%20race%3A%20challenges%20and%20opportunities%20in%20vaccine%20formulation&amp;journal=AAPS%20PharmSciTech.&amp;doi=10.1208%2Fs12249-020-01744-7&amp;volume=21&amp;publication_year=2020&amp;author=Wang%2CJ&amp;author=Peng%2CY&amp;author=Xu%2CH&amp;author=Cui%2CZ&amp;author=Williams%2CRO">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Rawat, K., Kumari, P. &amp; Saha, L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. <i>Eur. J. Pharmacol.</i> <b>892</b>, 173751 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ejphar.2020.173751" data-track-item_id="10.1016/j.ejphar.2020.173751" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ejphar.2020.173751" aria-label="Article reference 5" data-doi="10.1016/j.ejphar.2020.173751">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXksVSktg%3D%3D" aria-label="CAS reference 5">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20vaccine%3A%20a%20recent%20update%20in%20pipeline%20vaccines%2C%20their%20design%20and%20development%20strategies&amp;journal=Eur.%20J.%20Pharmacol.&amp;doi=10.1016%2Fj.ejphar.2020.173751&amp;volume=892&amp;publication_year=2021&amp;author=Rawat%2CK&amp;author=Kumari%2CP&amp;author=Saha%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Abbasi, K. Behavioural fatigue: a flawed idea central to a flawed pandemic response. <i>BMJ</i> <b>370</b>, m3093 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/bmj.m3093" data-track-item_id="10.1136/bmj.m3093" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fbmj.m3093" aria-label="Article reference 6" data-doi="10.1136/bmj.m3093">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Behavioural%20fatigue%3A%20a%20flawed%20idea%20central%20to%20a%20flawed%20pandemic%20response&amp;journal=BMJ&amp;doi=10.1136%2Fbmj.m3093&amp;volume=370&amp;publication_year=2020&amp;author=Abbasi%2CK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Rypdal, K., Bianchi, F. M. &amp; Rypdal, M. Intervention fatigue is the primary cause of strong secondary waves in the COVID-19 pandemic. <i>Int. J. Environ. Res. Public Health</i> <b>17</b>, 9592 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/ijerph17249592" data-track-item_id="10.3390/ijerph17249592" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fijerph17249592" aria-label="Article reference 7" data-doi="10.3390/ijerph17249592">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Intervention%20fatigue%20is%20the%20primary%20cause%20of%20strong%20secondary%20waves%20in%20the%20COVID-19%20pandemic&amp;journal=Int.%20J.%20Environ.%20Res.%20Public%20Health&amp;doi=10.3390%2Fijerph17249592&amp;volume=17&amp;publication_year=2020&amp;author=Rypdal%2CK&amp;author=Bianchi%2CFM&amp;author=Rypdal%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <i>N. Engl. J. Med.</i> <b>383</b>, 2603–2615 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa2034577" data-track-item_id="10.1056/NEJMoa2034577" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa2034577" aria-label="Article reference 8" data-doi="10.1056/NEJMoa2034577">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXotFSjuw%3D%3D" aria-label="CAS reference 8">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20efficacy%20of%20the%20BNT162b2%20mRNA%20Covid-19%20vaccine&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2034577&amp;volume=383&amp;pages=2603-2615&amp;publication_year=2020&amp;author=Polack%2CFP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. <i>N. Engl. J. Med.</i> <b>384</b>, 403–416 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa2035389" data-track-item_id="10.1056/NEJMoa2035389" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa2035389" aria-label="Article reference 9" data-doi="10.1056/NEJMoa2035389">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjvFSmsrc%3D" aria-label="CAS reference 9">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Efficacy%20and%20safety%20of%20the%20mRNA-1273%20SARS-CoV-2%20Vaccine&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2035389&amp;volume=384&amp;pages=403-416&amp;publication_year=2021&amp;author=Baden%2CLR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Voysey, M. et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. <i>Lancet</i> <b>397</b>, 881–891 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(21)00432-3" data-track-item_id="10.1016/S0140-6736(21)00432-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2821%2900432-3" aria-label="Article reference 10" data-doi="10.1016/S0140-6736(21)00432-3">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXltFSnu7Y%3D" aria-label="CAS reference 10">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Single-dose%20administration%20and%20the%20influence%20of%20the%20timing%20of%20the%20booster%20dose%20on%20immunogenicity%20and%20efficacy%20of%20ChAdOx1%20nCoV-19%20%28AZD1222%29%20vaccine%3A%20a%20pooled%20analysis%20of%20four%20randomised%20trials&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900432-3&amp;volume=397&amp;pages=881-891&amp;publication_year=2021&amp;author=Voysey%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">US Food and Drug Administration. FDA Briefing Document. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting, February 26, 2021. <a href="https://www.fda.gov/media/146217/download" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.fda.gov/media/146217/download">https://www.fda.gov/media/146217/download</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Gee, J. et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>70</b>, 283–288 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.15585/mmwr.mm7008e3" data-track-item_id="10.15585/mmwr.mm7008e3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15585%2Fmmwr.mm7008e3" aria-label="Article reference 12" data-doi="10.15585/mmwr.mm7008e3">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXnt1Wrur0%3D" aria-label="CAS reference 12">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=First%20month%20of%20COVID-19%20vaccine%20safety%20monitoring%E2%80%94United%20States%2C%20December%2014%2C%202020%E2%80%93January%2013%2C%202021&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7008e3&amp;volume=70&amp;pages=283-288&amp;publication_year=2021&amp;author=Gee%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <i>Lancet</i> <b>397</b>, 99–111 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(20)32661-1" data-track-item_id="10.1016/S0140-6736(20)32661-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2820%2932661-1" aria-label="Article reference 13" data-doi="10.1016/S0140-6736(20)32661-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFCgt77I" aria-label="CAS reference 13">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20efficacy%20of%20the%20ChAdOx1%20nCoV-19%20vaccine%20%28AZD1222%29%20against%20SARS-CoV-2%3A%20an%20interim%20analysis%20of%20four%20randomised%20controlled%20trials%20in%20Brazil%2C%20South%20Africa%2C%20and%20the%20UK&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2932661-1&amp;volume=397&amp;pages=99-111&amp;publication_year=2021&amp;author=Voysey%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">European Medicines Agency. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. <a href="https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots">https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">ANSA. Pfizer vaccine arrives in Italy. <a href="https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html">https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html</a> (2020).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">ANSA. First Moderna vaccine doses arrive in Italy. <a href="https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html">https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Reuters. Italy kicks off vaccinations against COVID-19 in Rome. <a href="https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O">https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O</a> (2020).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Ministero della salute (Italian Ministry of Health). Vaccinazione anti-SARS-CoV-2/COVID-19: PIANO STRATEGICO: Elementi di preparazione e di implementazione della strategia vaccinale. <a href="https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf">https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf</a> (2020).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Presidenza del Consiglio dei Ministri. Ministero della Salute. Commissario Straordinario Covid-19. Report Vaccini Anti COVID-19. <a href="https://www.governo.it/it/cscovid19/report-vaccini/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.governo.it/it/cscovid19/report-vaccini/">https://www.governo.it/it/cscovid19/report-vaccini/</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Priesemann, V. et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. <i>Lancet</i> <b>397</b>, 92–93 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(20)32625-8" data-track-item_id="10.1016/S0140-6736(20)32625-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2820%2932625-8" aria-label="Article reference 20" data-doi="10.1016/S0140-6736(20)32625-8">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXks1Wluw%3D%3D" aria-label="CAS reference 20">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Calling%20for%20pan-European%20commitment%20for%20rapid%20and%20sustained%20reduction%20in%20SARS-CoV-2%20infections&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2932625-8&amp;volume=397&amp;pages=92-93&amp;publication_year=2021&amp;author=Priesemann%2CV">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Priesemann, V. et al. An action plan for pan-European defence against new SARS-CoV-2 variants. <i>Lancet</i> <b>397</b>, 469–470 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(21)00150-1" data-track-item_id="10.1016/S0140-6736(21)00150-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2821%2900150-1" aria-label="Article reference 21" data-doi="10.1016/S0140-6736(21)00150-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFegs78%3D" aria-label="CAS reference 21">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20action%20plan%20for%20pan-European%20defence%20against%20new%20SARS-CoV-2%20variants&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900150-1&amp;volume=397&amp;pages=469-470&amp;publication_year=2021&amp;author=Priesemann%2CV">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. <i>Science</i> <b>372</b>, eabg3055 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abg3055" data-track-item_id="10.1126/science.abg3055" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abg3055" aria-label="Article reference 22" data-doi="10.1126/science.abg3055">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXosFelurY%3D" aria-label="CAS reference 22">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Estimated%20transmissibility%20and%20impact%20of%20SARS-CoV-2%20lineage%20B.1.1.7%20in%20England&amp;journal=Science&amp;doi=10.1126%2Fscience.abg3055&amp;volume=372&amp;publication_year=2021&amp;author=Davies%2CNG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Abbott, S., Funk, S. &amp; CMMID COVID-19 Working Group. Local area reproduction numbers and S-gene target failure. <a href="https://cmmid.github.io/topics/covid19/local-r-sgtf.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://cmmid.github.io/topics/covid19/local-r-sgtf.html">https://cmmid.github.io/topics/covid19/local-r-sgtf.html</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Horby, P. et al. NERVTAG note on B.1.1.7 severity. <a href="https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117">https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Bubar, K. M. et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. <i>Science</i> <b>371</b>, 916–921 (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Ramos A. M., Vela-Pérez, M., Ferrández, M. R., Kubik, A. B. &amp; Ivorra, B. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19. Preprint at ResearchGate <a href="https://doi.org/10.13140/RG.2.2.32580.24967/2" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.13140/RG.2.2.32580.24967/2">https://doi.org/10.13140/RG.2.2.32580.24967/2</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Grundel, S. et al. How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2020.12.22.20248707" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2020.12.22.20248707">https://doi.org/10.1101/2020.12.22.20248707</a> (2020).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Ministero della Salute. Vaccinazione anti-SARS-CoV-2/COVID-19, Piano Strategico, elementi di preparazione e di implementazione della strategia vaccinale. <a href="http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf">http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf</a> (2020).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Kissler, S. M. et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. <i>Science</i> <b>368</b>, 860–868 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abb5793" data-track-item_id="10.1126/science.abb5793" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abb5793" aria-label="Article reference 29" data-doi="10.1126/science.abb5793">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtVWnur%2FI" aria-label="CAS reference 29">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Projecting%20the%20transmission%20dynamics%20of%20SARS-CoV-2%20through%20the%20postpandemic%20period&amp;journal=Science&amp;doi=10.1126%2Fscience.abb5793&amp;volume=368&amp;pages=860-868&amp;publication_year=2020&amp;author=Kissler%2CSM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Bin, M. et al. Post-lockdown abatement of COVID-19 by fast periodic switching. <i>PLoS Comput. Biol.</i> <b>17</b>, e1008604 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1371/journal.pcbi.1008604" data-track-item_id="10.1371/journal.pcbi.1008604" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pcbi.1008604" aria-label="Article reference 30" data-doi="10.1371/journal.pcbi.1008604">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjs1ars7g%3D" aria-label="CAS reference 30">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Post-lockdown%20abatement%20of%20COVID-19%20by%20fast%20periodic%20switching&amp;journal=PLoS%20Comput.%20Biol.&amp;doi=10.1371%2Fjournal.pcbi.1008604&amp;volume=17&amp;publication_year=2021&amp;author=Bin%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">Tetteh, J. N. A., Nguyen, V. K. &amp; Hernandez-Vargas, E. A. COVID-19 network model to evaluate vaccine strategies towards herd immunity. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2020.12.22.20248693" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2020.12.22.20248693">https://doi.org/10.1101/2020.12.22.20248693</a> (2020).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. <i>Science</i> <b>371</b>, 850–854 (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Fontanet, A. et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. <i>Lancet</i> <b>397</b>, 952–954 (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Callaway, E. Could new COVID variants undermine vaccines? Labs scramble to find out. <i>Nature</i> <b>589</b>, 177–178 (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Burki, T. Understanding variants of SARS-CoV-2. <i>Lancet</i> <b>397</b>, 462 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(21)00298-1" data-track-item_id="10.1016/S0140-6736(21)00298-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2821%2900298-1" aria-label="Article reference 35" data-doi="10.1016/S0140-6736(21)00298-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjslWltrw%3D" aria-label="CAS reference 35">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Understanding%20variants%20of%20SARS-CoV-2&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900298-1&amp;volume=397&amp;publication_year=2021&amp;author=Burki%2CT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Lauring, A. S. &amp; Hodcroft, E. B. Genetic variants of SARS-CoV-2—what do they mean? <i>JAMA</i> <b>325</b>, 529–531 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.2020.27124" data-track-item_id="10.1001/jama.2020.27124" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.2020.27124" aria-label="Article reference 36" data-doi="10.1001/jama.2020.27124">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjvV2rs7w%3D" aria-label="CAS reference 36">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Genetic%20variants%20of%20SARS-CoV-2%E2%80%94what%20do%20they%20mean%3F&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2020.27124&amp;volume=325&amp;pages=529-531&amp;publication_year=2021&amp;author=Lauring%2CAS&amp;author=Hodcroft%2CEB">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Madhi, S. A. et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. <i>N. Engl. J. Med</i>. <a href="https://doi.org/10.1056/NEJMoa2102214" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1056/NEJMoa2102214">https://doi.org/10.1056/NEJMoa2102214</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">Lopez Bernal, J. et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2021.03.01.21252652" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.03.01.21252652">https://doi.org/10.1101/2021.03.01.21252652</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">GOV.UK. Coronavirus (COVID‑19). <a href="https://www.gov.uk/coronavirus" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.gov.uk/coronavirus">https://www.gov.uk/coronavirus</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Widge, A. T. et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. <i>N. Engl. J. Med.</i> <b>384</b>, 80–82 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMc2032195" data-track-item_id="10.1056/NEJMc2032195" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMc2032195" aria-label="Article reference 40" data-doi="10.1056/NEJMc2032195">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXotV2ktQ%3D%3D" aria-label="CAS reference 40">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Durability%20of%20responses%20after%20SARS-CoV-2%20mRNA-1273%20vaccination&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMc2032195&amp;volume=384&amp;pages=80-82&amp;publication_year=2021&amp;author=Widge%2CAT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. <i>Nature</i> <b>584</b>, 437–442 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-020-2456-9" data-track-item_id="10.1038/s41586-020-2456-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-020-2456-9" aria-label="Article reference 41" data-doi="10.1038/s41586-020-2456-9">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsFegtb3P" aria-label="CAS reference 41">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals&amp;journal=Nature&amp;doi=10.1038%2Fs41586-020-2456-9&amp;volume=584&amp;pages=437-442&amp;publication_year=2020&amp;author=Robbiani%2CDF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. <i>Science</i> <b>371</b>, eabf4063 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abf4063" data-track-item_id="10.1126/science.abf4063" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abf4063" aria-label="Article reference 42" data-doi="10.1126/science.abf4063">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjsFCrsL8%3D" aria-label="CAS reference 42">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunological%20memory%20to%20SARS-CoV-2%20assessed%20for%20up%20to%208%20months%20after%20infection&amp;journal=Science&amp;doi=10.1126%2Fscience.abf4063&amp;volume=371&amp;publication_year=2021&amp;author=Dan%2CJM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">D’Arienzo, M. &amp; Coniglio, A. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. <i>Biosaf. Health</i> <b>2</b>, 57–59 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bsheal.2020.03.004" data-track-item_id="10.1016/j.bsheal.2020.03.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bsheal.2020.03.004" aria-label="Article reference 43" data-doi="10.1016/j.bsheal.2020.03.004">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20the%20SARS-CoV-2%20basic%20reproduction%20number%2C%20R0%2C%20based%20on%20the%20early%20phase%20of%20COVID-19%20outbreak%20in%20Italy&amp;journal=Biosaf.%20Health&amp;doi=10.1016%2Fj.bsheal.2020.03.004&amp;volume=2&amp;pages=57-59&amp;publication_year=2020&amp;author=D%E2%80%99Arienzo%2CM&amp;author=Coniglio%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">MATLAB System Identification Toolbox, 9.13 (R2020b). <a href="https://www.mathworks.com/products/sysid.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.mathworks.com/products/sysid.html">https://www.mathworks.com/products/sysid.html</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Italian Ministry of Health. Vaccinazione anti-SARS-CoV-2/COVID-19 PIANO STRATEGICO. <a href="https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null">https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46">Task Force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica. Istituto Superiore di Sanità. Epidemia COVID-19: Aggiornamento nazionale. <a href="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf">https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47">ISTAT-Istituto Nazionale di Statistica. <a href="http://dati.istat.it/Index.aspx" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://dati.istat.it/Index.aspx">http://dati.istat.it/Index.aspx</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48">GitHub. Covid-19 Opendata Vaccines. <a href="https://github.com/italia/covid19-opendata-vaccini" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://github.com/italia/covid19-opendata-vaccini">https://github.com/italia/covid19-opendata-vaccini</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49">Voltz, E. et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2020.12.30.20249034" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2020.12.30.20249034">https://doi.org/10.1101/2020.12.30.20249034</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50">Moore, J. P. Approaches for optimal use of different COVID-19 vaccines. Issues of viral variants and vaccine efficacy. <i>JAMA</i> <a href="https://doi.org/10.1001/jama.2021.3465" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1001/jama.2021.3465">https://doi.org/10.1001/jama.2021.3465</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."><p class="c-article-references__text" id="ref-CR51">Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. <i>Science</i> <a href="https://doi.org/10.1126/science.abg3055" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1126/science.abg3055">https://doi.org/10.1126/science.abg3055</a> (2021)<i>.</i></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."><p class="c-article-references__text" id="ref-CR52">Cousins, S. New Zealand eliminates COVID-19. <i>Lancet</i> <b>395</b>, 1474 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(20)31097-7" data-track-item_id="10.1016/S0140-6736(20)31097-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2820%2931097-7" aria-label="Article reference 52" data-doi="10.1016/S0140-6736(20)31097-7">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXovFKltLs%3D" aria-label="CAS reference 52">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=New%20Zealand%20eliminates%20COVID-19&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2931097-7&amp;volume=395&amp;publication_year=2020&amp;author=Cousins%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."><p class="c-article-references__text" id="ref-CR53">Fouda, A., Mahmoudi, N., Moy, N. &amp; Paolucci, F. The COVID-19 pandemic in Greece, Iceland, New Zealand, and Singapore: health policies and lessons learned. <i>Health Policy Technol.</i> <b>9</b>, 510–524 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.hlpt.2020.08.015" data-track-item_id="10.1016/j.hlpt.2020.08.015" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.hlpt.2020.08.015" aria-label="Article reference 53" data-doi="10.1016/j.hlpt.2020.08.015">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20COVID-19%20pandemic%20in%20Greece%2C%20Iceland%2C%20New%20Zealand%2C%20and%20Singapore%3A%20health%20policies%20and%20lessons%20learned&amp;journal=Health%20Policy%20Technol.&amp;doi=10.1016%2Fj.hlpt.2020.08.015&amp;volume=9&amp;pages=510-524&amp;publication_year=2020&amp;author=Fouda%2CA&amp;author=Mahmoudi%2CN&amp;author=Moy%2CN&amp;author=Paolucci%2CF">
                    Google Scholar</a>&nbsp;
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-021-01334-5?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>We acknowledge financial support through the Italian grant PRIN 2017 ‘Monitoring and Control Underpinning the Energy-Aware Factory of the Future: Novel Methodologies and Industrial Validation’ (ID 2017YKXYXJ). This research has also received funding from the European Union’s Horizon 2020 Research and Innovation Program ‘PERISCOPE: Pan European Response to the ImpactS of COvid-19 and future Pandemics and Epidemics’ under grant agreement no. 101016233, H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><span class="c-article-author-information__subtitle u-visually-hidden" id="author-notes">Author notes</span><ol class="c-article-author-information__list"><li class="c-article-author-information__item" id="na1"><p>These authors contributed equally: Patrizio Colaneri, Raffaele Bruno.</p></li></ol><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Department of Industrial Engineering, University of Trento, Trento, Italy</p><p class="c-article-author-affiliation__authors-list">Giulia Giordano</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy</p><p class="c-article-author-affiliation__authors-list">Marta Colaneri,&nbsp;Alessandro Di Filippo,&nbsp;Paolo Sacchi&nbsp;&amp;&nbsp;Raffaele Bruno</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Dipartimento di Scienze Matematiche, Informatiche e Fisiche, University of Udine, Udine, Italy</p><p class="c-article-author-affiliation__authors-list">Franco Blanchini</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy</p><p class="c-article-author-affiliation__authors-list">Paolo Bolzern&nbsp;&amp;&nbsp;Patrizio Colaneri</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy</p><p class="c-article-author-affiliation__authors-list">Giuseppe De Nicolao</p></li><li id="Aff6"><p class="c-article-author-affiliation__address">IEIIT-CNR, Milan, Italy</p><p class="c-article-author-affiliation__authors-list">Patrizio Colaneri</p></li><li id="Aff7"><p class="c-article-author-affiliation__address">Department of Clinical, Surgical, Diagnostic, and Paediatric Sciences, University of Pavia, Pavia, Italy</p><p class="c-article-author-affiliation__authors-list">Raffaele Bruno</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Giulia-Giordano-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Giulia Giordano</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Giulia%20Giordano" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Giulia%20Giordano" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Giulia%20Giordano%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Marta-Colaneri-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Marta Colaneri</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Marta%20Colaneri" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marta%20Colaneri" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marta%20Colaneri%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Alessandro-Filippo-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Alessandro Di Filippo</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Alessandro%20Di%20Filippo" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Alessandro%20Di%20Filippo" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Alessandro%20Di%20Filippo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Franco-Blanchini-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Franco Blanchini</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Franco%20Blanchini" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Franco%20Blanchini" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Franco%20Blanchini%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Paolo-Bolzern-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Paolo Bolzern</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Paolo%20Bolzern" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Paolo%20Bolzern" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Paolo%20Bolzern%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Giuseppe-Nicolao-Aff5"><span class="c-article-authors-search__title u-h3 js-search-name">Giuseppe De Nicolao</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Giuseppe%20De%20Nicolao" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Giuseppe%20De%20Nicolao" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Giuseppe%20De%20Nicolao%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Paolo-Sacchi-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Paolo Sacchi</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Paolo%20Sacchi" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Paolo%20Sacchi" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Paolo%20Sacchi%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Patrizio-Colaneri-Aff4-Aff6"><span class="c-article-authors-search__title u-h3 js-search-name">Patrizio Colaneri</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Patrizio%20Colaneri" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Patrizio%20Colaneri" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Patrizio%20Colaneri%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Raffaele-Bruno-Aff2-Aff7"><span class="c-article-authors-search__title u-h3 js-search-name">Raffaele Bruno</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Raffaele%20Bruno" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Raffaele%20Bruno" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Raffaele%20Bruno%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>F.B., P.B., P.C., G.D.N. and G.G. proposed the model and performed the model fitting, simulations, analysis and interpretation of the results. R.B., M.C., A.D.F. and P.S. provided first-hand clinical insight and contextualization. All authors wrote and approved the manuscript.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:giulia.giordano@unitn.it">Giulia Giordano</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
                <h3 class="c-article__sub-heading" id="FPar3">Competing interests</h3>
                <p>The authors declare no competing interests.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><p><b>Peer review information</b> <i>Nature Medicine</i> thanks Tim Colbourn and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Jennifer Sargent was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p><p><b>Publisher’s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Extended data"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10">Extended data</h2><div class="c-article-section__content" id="Sec10-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 1 epidemic evolution in italy f" href="/articles/s41591-021-01334-5/figures/4" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig4_ESM.jpg">Extended Data Fig. 1 Epidemic evolution in Italy from late February 2020 to March 2021.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Data (stars) and estimation (solid lines), based on the SIDARTHE model, of the time evolution of the epidemic, in logarithmic scale. Active cases (current diagnosed infected, related to the SIDARTHE variables R+T+D) are shown in orange; hospital occupancy (related to the SIDARTHE variables R+T) is shown in blue; ICU occupancy (related to variable T) is shown in magenta; daily deaths (related to the derivative of variable E) are shown in black.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 2 epidemic evolution without va" href="/articles/s41591-021-01334-5/figures/5" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig5_ESM.jpg">Extended Data Fig. 2 Epidemic evolution without vaccination for different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Time evolution of the epidemic, in the absence of vaccination, when different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>, namely <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> (purple), <span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span> (orange), <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span> (blue), are assumed, resulting from different variants and/or containment strategies. <b>a</b>, Time evolution of the fractions of susceptibles, infected and recovered, and dead. <b>b,</b> Daily new cases. <b>c</b>, Active cases. <b>d</b>, Hospital occupancy. <b>e</b>, ICU occupancy. <b>f</b>, Daily deaths.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 3 epidemic evolution without va" href="/articles/s41591-021-01334-5/figures/6" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig6_ESM.jpg">Extended Data Fig. 3 Epidemic evolution without vaccination for different intermittent strategies.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Time evolution of the epidemic, in the absence of vaccination, when two alternative intermittent strategies are enforced, with an average value of <span class="mathjax-tex">\({\cal{R}}_0\)</span> equal to 1.1. The Open-Close strategy (red) switches every month between <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> and <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>, starting with <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>. The Close-Open strategy (green) does the same, but starts with <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>. <b>a</b>, Time evolution of the fractions of susceptibles, infected and recovered, and dead. <b>b</b>, Daily new cases. <b>c</b>, Active cases. <b>d</b>, Hospital occupancy. <b>e</b>, ICU occupancy. <b>f</b>, Daily deaths.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 4 effective vaccination schedul" href="/articles/s41591-021-01334-5/figures/7" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig7_ESM.jpg">Extended Data Fig. 4 Effective vaccination schedules.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Profiles of the considered three different effective vaccination schedules: slow, medium and fast. For each of the three schedules, we show: the evolution over time of the daily effective vaccination rate, namely the fraction of population successfully immunised (second dose) in one day (<b>a-d-g</b>), the cumulative fraction of immunised population as a function of time (<b>b-e-h</b>), the resulting time-varying Case Fatality Rate as a function of time, obtained taking population age classes into account and assuming a vaccination schedule that prioritises the elderly (<b>c-f-i</b>).</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 5 time-varying age-dependent ca" href="/articles/s41591-021-01334-5/figures/8" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig8_ESM.jpg">Extended Data Fig. 5 Time-varying age-dependent Case Fatality Rate as a function of the vaccination schedule.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Computation of the time-varying Case Fatality Rate as a function of the vaccination roadmap, taking population age classes into account. <b>a</b>, Considered vaccination roadmap: fraction of non-vaccinated population over time. <b>b</b>, Cumulative Italian population as a function of age. <b>c</b>, Fraction of the population (red) and Case Fatality Rate (purple) as a function of age. <b>d</b>, Evolution of the overall Case Fatality Rate over time, assuming a vaccination schedule that gives priority to the elderly.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 6 epidemic evolution with adapt" href="/articles/s41591-021-01334-5/figures/9" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig9_ESM.jpg">Extended Data Fig. 6 Epidemic evolution with adaptive vaccination for different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Time evolution of the epidemic, with adaptive vaccination, when different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>, namely <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> (purple), <span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span> (orange), <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span> (blue), are assumed, associated with different variants and/or containment strategies. The adaptive vaccination speed is inversely proportional to the size of the epidemic, that is to the number of infection cases. <b>a</b>, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. <b>b</b>, Daily new cases. <b>c</b>, Active cases. <b>d</b>, Hospital occupancy. <b>e</b>, ICU occupancy. <b>f</b>, Daily deaths.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig10"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 7 epidemic evolution with adapt" href="/articles/s41591-021-01334-5/figures/10" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig10_ESM.jpg">Extended Data Fig. 7 Epidemic evolution with adaptive vaccination for different intermittent strategies.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Time evolution of the epidemic, with adaptive vaccination, when different intermittent strategies are enforced, with an average value of <span class="mathjax-tex">\({\cal{R}}_0\)</span> equal to 1.1. The Open-Close strategy (red) switches every month between <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span> and <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>, starting with <span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>. The Close-Open strategy (green) does the same, but starts with <span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>. The adaptive vaccination speed is inversely proportional to the size of the epidemic, that is to the number of infection cases. <b>a</b>, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. <b>b</b>, Daily new cases. <b>c</b>, Active cases. <b>d</b>, Hospital occupancy. <b>e</b>, ICU occupancy. <b>f</b>, Daily deaths.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig11"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 8 health costs as a function of" href="/articles/s41591-021-01334-5/figures/11" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig11_ESM.jpg">Extended Data Fig. 8 Health costs as a function of vaccination speed.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Health-cost vs. vaccination-speed curves: for a given <span class="mathjax-tex">\({\cal{R}}_0\)</span> profile, the curve gives the total ICU occupancy (<b>a</b>) and the total hospital occupancy (<b>b</b>) in the period from April 2021 to January 2022, as a function of the average vaccination speed, measured as the fraction of two-dose vaccinated population at the end of the period. The health-cost vs. vaccination-speed curves corresponding to a constant reproduction number are reported in purple (<span class="mathjax-tex">\({\cal{R}}_0 = 1.27\)</span>), orange (<span class="mathjax-tex">\({\cal{R}}_0 = 1.1\)</span>) and blue (<span class="mathjax-tex">\({\cal{R}}_0 = 0.9\)</span>), while those corresponding to intermittent strategies are reported in red (Open-Close) and green (Close-Open).</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig12"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 9 dynamic input-output models f" href="/articles/s41591-021-01334-5/figures/12" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig12_ESM.jpg">Extended Data Fig. 9 Dynamic input-output models for health costs.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Estimation of the three dynamic input-output models linking new cases (input) to three outputs: deaths (<b>a</b>), hospital occupancy (<b>b</b>) and ICU occupancy (<b>c</b>). Each panel displays the observed outputs (grey) and the values predicted by the identified dynamic system (blue). In order to allow for weekly oscillations both input and output series were prefiltered with a 7-day moving average before performing nonlinear least squares fitting of a first-order model with delay. The FIT ratios of the three models are 83.16%, 84.67%, and 87.53%.</p></div></div></div></div></div></section><section data-title="Supplementary information"><div class="c-article-section" id="Sec11-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec11">Supplementary information</h2><div class="c-article-section__content" id="Sec11-content"><div data-test="supplementary-info"><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="reporting summary" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_MOESM1_ESM.pdf" data-supp-info-image="">Reporting Summary</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Modeling%20vaccination%20rollouts%2C%20SARS-CoV-2%20variants%20and%20the%20requirement%20for%20non-pharmaceutical%20interventions%20in%20Italy&amp;author=Giulia%20Giordano%20et%20al&amp;contentID=10.1038%2Fs41591-021-01334-5&amp;copyright=The%20Author%28s%29&amp;publication=1078-8956&amp;publicationDate=2021-04-16&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1038/s41591-021-01334-5" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41591-021-01334-5" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Giordano, G., Colaneri, M., Di Filippo, A. <i>et al.</i> Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.
                    <i>Nat Med</i> <b>27</b>, 993–998 (2021). https://doi.org/10.1038/s41591-021-01334-5</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-021-01334-5?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-02-15">15 February 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-03-31">31 March 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-04-16">16 April 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-06">June 2021</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41591-021-01334-5</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-block"><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><div data-component="article-info-list">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/epidemiology" data-track="click" data-track-action="view subject" data-track-label="link">Epidemiology</a></li>
        </ul>
    </div></div></div></div></div></section>
            </div>

            
        <section>
            <div class="c-article-section js-article-section" id="further-reading-section" data-test="further-reading-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">This article is cited by</h2>
                <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
                    <ul class="c-article-further-reading__list" id="further-reading-list">
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Validity of Markovian modeling for transient memory-dependent epidemic dynamics" href="https://doi.org/10.1038/s42005-024-01578-w">
                                        Validity of Markovian modeling for transient memory-dependent epidemic dynamics
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Mi Feng</li><li>Liang Tian</li><li>Changsong Zhou</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Communications Physics</i> (2024)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States" href="https://doi.org/10.1038/s41467-024-45549-9">
                                        Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Hailey J. Park</li><li>Gregg S. Gonsalves</li><li>Nathan C. Lo</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Nature Communications</i> (2024)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:A hybrid compartmental model with a case study of COVID-19 in Great Britain and Israel" href="https://doi.org/10.1186/s13362-022-00130-1">
                                        A hybrid compartmental model with a case study of COVID-19 in Great Britain and Israel
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Greta Malaspina</li><li>Stevo Racković</li><li>Filipa Valdeira</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Journal of Mathematics in Industry</i> (2023)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:A comparative analysis of the effects of containment policies on the epidemiological manifestation of the COVID-19 pandemic across nine European countries" href="https://doi.org/10.1038/s41598-023-37751-4">
                                        A comparative analysis of the effects of containment policies on the epidemiological manifestation of the COVID-19 pandemic across nine European countries
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Chiara Podrecca</li><li>Enea Parimbelli</li><li>Riccardo Bellazzi</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Scientific Reports</i> (2023)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Cost-effectiveness analysis of COVID-19 variants effects in an age-structured model" href="https://doi.org/10.1038/s41598-023-41876-x">
                                        Cost-effectiveness analysis of COVID-19 variants effects in an age-structured model
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Giphil Cho</li><li>Young Jin Kim</li><li>Hyojung Lee</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Scientific Reports</i> (2023)</p>
                            </li>
                        
                    </ul>
                </div>
            </div>
        </section>
    

        </div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion="" data-container-type="reading-companion" data-track-component="reading companion">
    <div class="js-context-bar-sticky-point-desktop" data-track-context="reading companion">
        

        
            
                
                    
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-021-01334-5.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                
            
        
    </div>

    
        
    

    
    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky" style="top: 40px;">
            <ul class="c-reading-companion__tabs" role="tablist"><li role="presentation"><button data-tab-target="sections" role="tab" id="tab-sections" aria-controls="tabpanel-sections" aria-selected="true" class="c-reading-companion__tab c-reading-companion__tab--active" data-track="click" data-track-action="sections tab" data-track-label="tab">Sections</button></li><li role="presentation"><button data-tab-target="figures" role="tab" id="tab-figures" aria-controls="tabpanel-figures" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="figures tab" data-track-label="tab">Figures</button></li><li role="presentation"><button data-tab-target="references" role="tab" id="tab-references" aria-controls="tabpanel-references" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="references tab" data-track-label="tab">References</button></li></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections" aria-labelledby="tab-sections" role="tabpanel"><div class="c-reading-companion__scroll-pane" style="max-height: 409.45px;"><ul class="c-reading-companion__sections-list"><li id="rc-sec-Abs1" class="c-reading-companion__section-item"><a href="#Abs1" data-track="click" data-track-action="section anchor" data-track-label="link:Abstract">Abstract</a></li><li id="rc-sec-Sec1" class="c-reading-companion__section-item"><a href="#Sec1" data-track="click" data-track-action="section anchor" data-track-label="link:Main">Main</a></li><li id="rc-sec-Sec2" class="c-reading-companion__section-item"><a href="#Sec2" data-track="click" data-track-action="section anchor" data-track-label="link:Methods">Methods</a></li><li id="rc-sec-data-availability" class="c-reading-companion__section-item"><a href="#data-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Data availability">Data availability</a></li><li id="rc-sec-code-availability" class="c-reading-companion__section-item"><a href="#code-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Code availability">Code availability</a></li><li id="rc-sec-Bib1" class="c-reading-companion__section-item"><a href="#Bib1" data-track="click" data-track-action="section anchor" data-track-label="link:References">References</a></li><li id="rc-sec-Ack1" class="c-reading-companion__section-item"><a href="#Ack1" data-track="click" data-track-action="section anchor" data-track-label="link:Acknowledgements">Acknowledgements</a></li><li id="rc-sec-author-information" class="c-reading-companion__section-item"><a href="#author-information" data-track="click" data-track-action="section anchor" data-track-label="link:Author information">Author information</a></li><li id="rc-sec-ethics" class="c-reading-companion__section-item"><a href="#ethics" data-track="click" data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a></li><li id="rc-sec-additional-information" class="c-reading-companion__section-item"><a href="#additional-information" data-track="click" data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a></li><li id="rc-sec-Sec10" class="c-reading-companion__section-item"><a href="#Sec10" data-track="click" data-track-action="section anchor" data-track-label="link:Extended data">Extended data</a></li><li id="rc-sec-Sec11" class="c-reading-companion__section-item"><a href="#Sec11" data-track="click" data-track-action="section anchor" data-track-label="link:Supplementary information">Supplementary information</a></li><li id="rc-sec-rightslink" class="c-reading-companion__section-item"><a href="#rightslink" data-track="click" data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a></li><li id="rc-sec-article-info" class="c-reading-companion__section-item"><a href="#article-info" data-track="click" data-track-action="section anchor" data-track-label="link:About this article">About this article</a></li><li id="rc-sec-further-reading" class="c-reading-companion__section-item"><a href="#further-reading" data-track="click" data-track-action="section anchor" data-track-label="link:This article is cited by">This article is cited by</a></li></ul></div>
                <div class="u-lazy-ad-wrapper u-mt-16 u-show" data-component-mpu="" style="display: none !important;">
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2" class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type="right" data-test="right-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="300x250" data-gpt-targeting="type=article;pos=right;artid=s41591-021-01334-5;doi=10.1038/s41591-021-01334-5;subjmeta=174,308,478,692,700;kwrd=Epidemiology">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=-1557455207&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-021-01334-5%26doi%3D10.1038/s41591-021-01334-5%26subjmeta%3D174,308,478,692,700%26kwrd%3DEpidemiology">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=-1557455207&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-021-01334-5%26doi%3D10.1038/s41591-021-01334-5%26subjmeta%3D174,308,478,692,700%26kwrd%3DEpidemiology"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures" aria-labelledby="tab-figures" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ul class="c-reading-companion__figures-list"><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig1">Fig. 1: Model scheme and summary of our findings.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png" alt="figure 1" aria-describedby="rc-Fig1"></picture><p class="c-reading-companion__figure-links"><a href="#Fig1" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/1" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig2">Fig. 2: The effect of different constant values of <span class="mathjax-tex">\({\mathbf{{\cal{R}}}}_0\)</span> and intermittent strategies.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig2_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig2_HTML.png" alt="figure 2" aria-describedby="rc-Fig2"></picture><p class="c-reading-companion__figure-links"><a href="#Fig2" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/2" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig3">Fig. 3: The effect of different vaccination paces.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig3_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig3_HTML.png" alt="figure 3" aria-describedby="rc-Fig3"></picture><p class="c-reading-companion__figure-links"><a href="#Fig3" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/3" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig4">Extended Data Fig. 1 Epidemic evolution in Italy from late February 2020 to March 2021.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig4_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig4_ESM.jpg" alt="extended data figure 4" aria-describedby="rc-Fig4"></picture><p class="c-reading-companion__figure-links"><a href="#Fig4" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/4" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig5">Extended Data Fig. 2 Epidemic evolution without vaccination for different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig5_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig5_ESM.jpg" alt="extended data figure 5" aria-describedby="rc-Fig5"></picture><p class="c-reading-companion__figure-links"><a href="#Fig5" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/5" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig6">Extended Data Fig. 3 Epidemic evolution without vaccination for different intermittent strategies.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig6_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig6_ESM.jpg" alt="extended data figure 6" aria-describedby="rc-Fig6"></picture><p class="c-reading-companion__figure-links"><a href="#Fig6" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/6" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig7">Extended Data Fig. 4 Effective vaccination schedules.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig7_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig7_ESM.jpg" alt="extended data figure 7" aria-describedby="rc-Fig7"></picture><p class="c-reading-companion__figure-links"><a href="#Fig7" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/7" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig8">Extended Data Fig. 5 Time-varying age-dependent Case Fatality Rate as a function of the vaccination schedule.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig8_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig8_ESM.jpg" alt="extended data figure 8" aria-describedby="rc-Fig8"></picture><p class="c-reading-companion__figure-links"><a href="#Fig8" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/8" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig9">Extended Data Fig. 6 Epidemic evolution with adaptive vaccination for different constant values of <span class="mathjax-tex">\({\cal{R}}_0\)</span>.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig9_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig9_ESM.jpg" alt="extended data figure 9" aria-describedby="rc-Fig9"></picture><p class="c-reading-companion__figure-links"><a href="#Fig9" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/9" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig10">Extended Data Fig. 7 Epidemic evolution with adaptive vaccination for different intermittent strategies.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig10_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig10_ESM.jpg" alt="extended data figure 10" aria-describedby="rc-Fig10"></picture><p class="c-reading-companion__figure-links"><a href="#Fig10" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/10" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig11">Extended Data Fig. 8 Health costs as a function of vaccination speed.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig11_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig11_ESM.jpg" alt="extended data figure 11" aria-describedby="rc-Fig11"></picture><p class="c-reading-companion__figure-links"><a href="#Fig11" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/11" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig12">Extended Data Fig. 9 Dynamic input-output models for health costs.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig12_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig12_ESM.jpg" alt="extended data figure 12" aria-describedby="rc-Fig12"></picture><p class="c-reading-companion__figure-links"><a href="#Fig12" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-021-01334-5/figures/12" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li></ul></div></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references" aria-labelledby="tab-references" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ol class="c-reading-companion__references-list c-reading-companion__references-list--numeric" data-track-context="article references sidebar"><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR1">Stasi, C., Fallani, S., Voller, F. &amp; Silvestri, C. Treatment for COVID-19: an overview. <i>Eur. J. Pharmacol.</i> <b>889</b>, 173644 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ejphar.2020.173644" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ejphar.2020.173644" data-track-item_id="10.1016/j.ejphar.2020.173644">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitV2ls7jI" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Treatment%20for%20COVID-19%3A%20an%20overview&amp;journal=Eur.%20J.%20Pharmacol.&amp;doi=10.1016%2Fj.ejphar.2020.173644&amp;volume=889&amp;publication_year=2020&amp;author=Stasi%2CC&amp;author=Fallani%2CS&amp;author=Voller%2CF&amp;author=Silvestri%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR2">Giordano, G. et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. <i>Nat. Med.</i> <b>26</b>, 855–860 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41591-020-0883-7" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41591-020-0883-7" data-track-item_id="10.1038/s41591-020-0883-7">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVCitr4%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Modelling%20the%20COVID-19%20epidemic%20and%20implementation%20of%20population-wide%20interventions%20in%20Italy&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fs41591-020-0883-7&amp;volume=26&amp;pages=855-860&amp;publication_year=2020&amp;author=Giordano%2CG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR3">Wu, F. et al. A new coronavirus associated with human respiratory disease in China. <i>Nature</i> <b>579</b>, 265–269 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-020-2008-3" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-020-2008-3" data-track-item_id="10.1038/s41586-020-2008-3">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXksFKlsLc%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=A%20new%20coronavirus%20associated%20with%20human%20respiratory%20disease%20in%20China&amp;journal=Nature&amp;doi=10.1038%2Fs41586-020-2008-3&amp;volume=579&amp;pages=265-269&amp;publication_year=2020&amp;author=Wu%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR4">Wang, J., Peng, Y., Xu, H., Cui, Z. &amp; Williams, R. O. The COVID-19 vaccine race: challenges and opportunities in vaccine formulation. <i>AAPS PharmSciTech.</i> <b>21</b>, 225 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1208%2Fs12249-020-01744-7" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1208/s12249-020-01744-7" data-track-item_id="10.1208/s12249-020-01744-7">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20COVID-19%20vaccine%20race%3A%20challenges%20and%20opportunities%20in%20vaccine%20formulation&amp;journal=AAPS%20PharmSciTech.&amp;doi=10.1208%2Fs12249-020-01744-7&amp;volume=21&amp;publication_year=2020&amp;author=Wang%2CJ&amp;author=Peng%2CY&amp;author=Xu%2CH&amp;author=Cui%2CZ&amp;author=Williams%2CRO" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR5">Rawat, K., Kumari, P. &amp; Saha, L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. <i>Eur. J. Pharmacol.</i> <b>892</b>, 173751 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ejphar.2020.173751" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ejphar.2020.173751" data-track-item_id="10.1016/j.ejphar.2020.173751">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXksVSktg%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20vaccine%3A%20a%20recent%20update%20in%20pipeline%20vaccines%2C%20their%20design%20and%20development%20strategies&amp;journal=Eur.%20J.%20Pharmacol.&amp;doi=10.1016%2Fj.ejphar.2020.173751&amp;volume=892&amp;publication_year=2021&amp;author=Rawat%2CK&amp;author=Kumari%2CP&amp;author=Saha%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR6">Abbasi, K. Behavioural fatigue: a flawed idea central to a flawed pandemic response. <i>BMJ</i> <b>370</b>, m3093 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fbmj.m3093" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/bmj.m3093" data-track-item_id="10.1136/bmj.m3093">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Behavioural%20fatigue%3A%20a%20flawed%20idea%20central%20to%20a%20flawed%20pandemic%20response&amp;journal=BMJ&amp;doi=10.1136%2Fbmj.m3093&amp;volume=370&amp;publication_year=2020&amp;author=Abbasi%2CK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR7">Rypdal, K., Bianchi, F. M. &amp; Rypdal, M. Intervention fatigue is the primary cause of strong secondary waves in the COVID-19 pandemic. <i>Int. J. Environ. Res. Public Health</i> <b>17</b>, 9592 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.3390%2Fijerph17249592" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.3390/ijerph17249592" data-track-item_id="10.3390/ijerph17249592">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Intervention%20fatigue%20is%20the%20primary%20cause%20of%20strong%20secondary%20waves%20in%20the%20COVID-19%20pandemic&amp;journal=Int.%20J.%20Environ.%20Res.%20Public%20Health&amp;doi=10.3390%2Fijerph17249592&amp;volume=17&amp;publication_year=2020&amp;author=Rypdal%2CK&amp;author=Bianchi%2CFM&amp;author=Rypdal%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR8">Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <i>N. Engl. J. Med.</i> <b>383</b>, 2603–2615 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa2034577" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa2034577" data-track-item_id="10.1056/NEJMoa2034577">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXotFSjuw%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20efficacy%20of%20the%20BNT162b2%20mRNA%20Covid-19%20vaccine&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2034577&amp;volume=383&amp;pages=2603-2615&amp;publication_year=2020&amp;author=Polack%2CFP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR9">Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. <i>N. Engl. J. Med.</i> <b>384</b>, 403–416 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa2035389" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa2035389" data-track-item_id="10.1056/NEJMoa2035389">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjvFSmsrc%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Efficacy%20and%20safety%20of%20the%20mRNA-1273%20SARS-CoV-2%20Vaccine&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2035389&amp;volume=384&amp;pages=403-416&amp;publication_year=2021&amp;author=Baden%2CLR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR10">Voysey, M. et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. <i>Lancet</i> <b>397</b>, 881–891 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2821%2900432-3" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(21)00432-3" data-track-item_id="10.1016/S0140-6736(21)00432-3">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXltFSnu7Y%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Single-dose%20administration%20and%20the%20influence%20of%20the%20timing%20of%20the%20booster%20dose%20on%20immunogenicity%20and%20efficacy%20of%20ChAdOx1%20nCoV-19%20%28AZD1222%29%20vaccine%3A%20a%20pooled%20analysis%20of%20four%20randomised%20trials&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900432-3&amp;volume=397&amp;pages=881-891&amp;publication_year=2021&amp;author=Voysey%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR11">US Food and Drug Administration. FDA Briefing Document. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting, February 26, 2021. <a href="https://www.fda.gov/media/146217/download" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.fda.gov/media/146217/download">https://www.fda.gov/media/146217/download</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR12">Gee, J. et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>70</b>, 283–288 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.15585%2Fmmwr.mm7008e3" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.15585/mmwr.mm7008e3" data-track-item_id="10.15585/mmwr.mm7008e3">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXnt1Wrur0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=First%20month%20of%20COVID-19%20vaccine%20safety%20monitoring%E2%80%94United%20States%2C%20December%2014%2C%202020%E2%80%93January%2013%2C%202021&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7008e3&amp;volume=70&amp;pages=283-288&amp;publication_year=2021&amp;author=Gee%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR13">Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <i>Lancet</i> <b>397</b>, 99–111 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2820%2932661-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(20)32661-1" data-track-item_id="10.1016/S0140-6736(20)32661-1">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFCgt77I" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20efficacy%20of%20the%20ChAdOx1%20nCoV-19%20vaccine%20%28AZD1222%29%20against%20SARS-CoV-2%3A%20an%20interim%20analysis%20of%20four%20randomised%20controlled%20trials%20in%20Brazil%2C%20South%20Africa%2C%20and%20the%20UK&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2932661-1&amp;volume=397&amp;pages=99-111&amp;publication_year=2021&amp;author=Voysey%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR14">European Medicines Agency. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. <a href="https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots">https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR15">ANSA. Pfizer vaccine arrives in Italy. <a href="https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html">https://www.ansa.it/english/news/2020/12/30/pfizer-vaccine-arrives-in-italy_4690fcec-88a8-4919-b821-afc01fc3955a.html</a> (2020).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR16">ANSA. First Moderna vaccine doses arrive in Italy. <a href="https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html">https://www.ansa.it/english/news/general_news/2021/01/12/first-moderna-vaccine-doses-arrive-in-italy_ce39273f-aa51-4d55-9f8b-d5c658633007.html</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR17">Reuters. Italy kicks off vaccinations against COVID-19 in Rome. <a href="https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O">https://www.reuters.com/article/health-coronavirus-italy-vaccine/italy-kicks-off-vaccinations-against-covid-19-in-rome-idUKL1N2J703O</a> (2020).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR18">Ministero della salute (Italian Ministry of Health). Vaccinazione anti-SARS-CoV-2/COVID-19: PIANO STRATEGICO: Elementi di preparazione e di implementazione della strategia vaccinale. <a href="https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf">https://www.vaccinarsinsardegna.org/assets/uploads/files/378/piano-strategico-vaccinazione-anti-covid19.pdf</a> (2020).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR19">Presidenza del Consiglio dei Ministri. Ministero della Salute. Commissario Straordinario Covid-19. Report Vaccini Anti COVID-19. <a href="https://www.governo.it/it/cscovid19/report-vaccini/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.governo.it/it/cscovid19/report-vaccini/">https://www.governo.it/it/cscovid19/report-vaccini/</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR20">Priesemann, V. et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. <i>Lancet</i> <b>397</b>, 92–93 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2820%2932625-8" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(20)32625-8" data-track-item_id="10.1016/S0140-6736(20)32625-8">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXks1Wluw%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Calling%20for%20pan-European%20commitment%20for%20rapid%20and%20sustained%20reduction%20in%20SARS-CoV-2%20infections&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2932625-8&amp;volume=397&amp;pages=92-93&amp;publication_year=2021&amp;author=Priesemann%2CV" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR21">Priesemann, V. et al. An action plan for pan-European defence against new SARS-CoV-2 variants. <i>Lancet</i> <b>397</b>, 469–470 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2821%2900150-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(21)00150-1" data-track-item_id="10.1016/S0140-6736(21)00150-1">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFegs78%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=An%20action%20plan%20for%20pan-European%20defence%20against%20new%20SARS-CoV-2%20variants&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900150-1&amp;volume=397&amp;pages=469-470&amp;publication_year=2021&amp;author=Priesemann%2CV" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR22">Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. <i>Science</i> <b>372</b>, eabg3055 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscience.abg3055" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/science.abg3055" data-track-item_id="10.1126/science.abg3055">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXosFelurY%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Estimated%20transmissibility%20and%20impact%20of%20SARS-CoV-2%20lineage%20B.1.1.7%20in%20England&amp;journal=Science&amp;doi=10.1126%2Fscience.abg3055&amp;volume=372&amp;publication_year=2021&amp;author=Davies%2CNG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR23">Abbott, S., Funk, S. &amp; CMMID COVID-19 Working Group. Local area reproduction numbers and S-gene target failure. <a href="https://cmmid.github.io/topics/covid19/local-r-sgtf.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://cmmid.github.io/topics/covid19/local-r-sgtf.html">https://cmmid.github.io/topics/covid19/local-r-sgtf.html</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR24">Horby, P. et al. NERVTAG note on B.1.1.7 severity. <a href="https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117">https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR25">Bubar, K. M. et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. <i>Science</i> <b>371</b>, 916–921 (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR26">Ramos A. M., Vela-Pérez, M., Ferrández, M. R., Kubik, A. B. &amp; Ivorra, B. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19. Preprint at ResearchGate <a href="https://doi.org/10.13140/RG.2.2.32580.24967/2" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.13140/RG.2.2.32580.24967/2">https://doi.org/10.13140/RG.2.2.32580.24967/2</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR27">Grundel, S. et al. How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2020.12.22.20248707" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2020.12.22.20248707">https://doi.org/10.1101/2020.12.22.20248707</a> (2020).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR28">Ministero della Salute. Vaccinazione anti-SARS-CoV-2/COVID-19, Piano Strategico, elementi di preparazione e di implementazione della strategia vaccinale. <a href="http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf">http://www.salute.gov.it/imgs/C_17_pubblicazioni_2986_allegato.pdf</a> (2020).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR29">Kissler, S. M. et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. <i>Science</i> <b>368</b>, 860–868 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscience.abb5793" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/science.abb5793" data-track-item_id="10.1126/science.abb5793">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtVWnur%2FI" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Projecting%20the%20transmission%20dynamics%20of%20SARS-CoV-2%20through%20the%20postpandemic%20period&amp;journal=Science&amp;doi=10.1126%2Fscience.abb5793&amp;volume=368&amp;pages=860-868&amp;publication_year=2020&amp;author=Kissler%2CSM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR30">Bin, M. et al. Post-lockdown abatement of COVID-19 by fast periodic switching. <i>PLoS Comput. Biol.</i> <b>17</b>, e1008604 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1371%2Fjournal.pcbi.1008604" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1371/journal.pcbi.1008604" data-track-item_id="10.1371/journal.pcbi.1008604">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjs1ars7g%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Post-lockdown%20abatement%20of%20COVID-19%20by%20fast%20periodic%20switching&amp;journal=PLoS%20Comput.%20Biol.&amp;doi=10.1371%2Fjournal.pcbi.1008604&amp;volume=17&amp;publication_year=2021&amp;author=Bin%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR31">Tetteh, J. N. A., Nguyen, V. K. &amp; Hernandez-Vargas, E. A. COVID-19 network model to evaluate vaccine strategies towards herd immunity. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2020.12.22.20248693" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2020.12.22.20248693">https://doi.org/10.1101/2020.12.22.20248693</a> (2020).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR32">Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. <i>Science</i> <b>371</b>, 850–854 (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR33">Fontanet, A. et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. <i>Lancet</i> <b>397</b>, 952–954 (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR34">Callaway, E. Could new COVID variants undermine vaccines? Labs scramble to find out. <i>Nature</i> <b>589</b>, 177–178 (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR35">Burki, T. Understanding variants of SARS-CoV-2. <i>Lancet</i> <b>397</b>, 462 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2821%2900298-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(21)00298-1" data-track-item_id="10.1016/S0140-6736(21)00298-1">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjslWltrw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Understanding%20variants%20of%20SARS-CoV-2&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900298-1&amp;volume=397&amp;publication_year=2021&amp;author=Burki%2CT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR36">Lauring, A. S. &amp; Hodcroft, E. B. Genetic variants of SARS-CoV-2—what do they mean? <i>JAMA</i> <b>325</b>, 529–531 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjama.2020.27124" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jama.2020.27124" data-track-item_id="10.1001/jama.2020.27124">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjvV2rs7w%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Genetic%20variants%20of%20SARS-CoV-2%E2%80%94what%20do%20they%20mean%3F&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2020.27124&amp;volume=325&amp;pages=529-531&amp;publication_year=2021&amp;author=Lauring%2CAS&amp;author=Hodcroft%2CEB" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR37">Madhi, S. A. et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. <i>N. Engl. J. Med</i>. <a href="https://doi.org/10.1056/NEJMoa2102214" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1056/NEJMoa2102214">https://doi.org/10.1056/NEJMoa2102214</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR38">Lopez Bernal, J. et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2021.03.01.21252652" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.03.01.21252652">https://doi.org/10.1101/2021.03.01.21252652</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR39">GOV.UK. Coronavirus (COVID‑19). <a href="https://www.gov.uk/coronavirus" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.gov.uk/coronavirus">https://www.gov.uk/coronavirus</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR40">Widge, A. T. et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. <i>N. Engl. J. Med.</i> <b>384</b>, 80–82 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMc2032195" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMc2032195" data-track-item_id="10.1056/NEJMc2032195">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXotV2ktQ%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Durability%20of%20responses%20after%20SARS-CoV-2%20mRNA-1273%20vaccination&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMc2032195&amp;volume=384&amp;pages=80-82&amp;publication_year=2021&amp;author=Widge%2CAT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR41">Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. <i>Nature</i> <b>584</b>, 437–442 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-020-2456-9" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-020-2456-9" data-track-item_id="10.1038/s41586-020-2456-9">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsFegtb3P" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals&amp;journal=Nature&amp;doi=10.1038%2Fs41586-020-2456-9&amp;volume=584&amp;pages=437-442&amp;publication_year=2020&amp;author=Robbiani%2CDF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR42">Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. <i>Science</i> <b>371</b>, eabf4063 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscience.abf4063" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/science.abf4063" data-track-item_id="10.1126/science.abf4063">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjsFCrsL8%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Immunological%20memory%20to%20SARS-CoV-2%20assessed%20for%20up%20to%208%20months%20after%20infection&amp;journal=Science&amp;doi=10.1126%2Fscience.abf4063&amp;volume=371&amp;publication_year=2021&amp;author=Dan%2CJM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR43">D’Arienzo, M. &amp; Coniglio, A. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. <i>Biosaf. Health</i> <b>2</b>, 57–59 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.bsheal.2020.03.004" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.bsheal.2020.03.004" data-track-item_id="10.1016/j.bsheal.2020.03.004">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20the%20SARS-CoV-2%20basic%20reproduction%20number%2C%20R0%2C%20based%20on%20the%20early%20phase%20of%20COVID-19%20outbreak%20in%20Italy&amp;journal=Biosaf.%20Health&amp;doi=10.1016%2Fj.bsheal.2020.03.004&amp;volume=2&amp;pages=57-59&amp;publication_year=2020&amp;author=D%E2%80%99Arienzo%2CM&amp;author=Coniglio%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR44">MATLAB System Identification Toolbox, 9.13 (R2020b). <a href="https://www.mathworks.com/products/sysid.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.mathworks.com/products/sysid.html">https://www.mathworks.com/products/sysid.html</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR45">Italian Ministry of Health. Vaccinazione anti-SARS-CoV-2/COVID-19 PIANO STRATEGICO. <a href="https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null">https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&amp;codLeg=78657&amp;parte=1%20&amp;serie=null</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR46">Task Force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica. Istituto Superiore di Sanità. Epidemia COVID-19: Aggiornamento nazionale. <a href="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf">https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_13-gennaio-2021.pdf</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR47">ISTAT-Istituto Nazionale di Statistica. <a href="http://dati.istat.it/Index.aspx" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://dati.istat.it/Index.aspx">http://dati.istat.it/Index.aspx</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR48">GitHub. Covid-19 Opendata Vaccines. <a href="https://github.com/italia/covid19-opendata-vaccini" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://github.com/italia/covid19-opendata-vaccini">https://github.com/italia/covid19-opendata-vaccini</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR49">Voltz, E. et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2020.12.30.20249034" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2020.12.30.20249034">https://doi.org/10.1101/2020.12.30.20249034</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR50">Moore, J. P. Approaches for optimal use of different COVID-19 vaccines. Issues of viral variants and vaccine efficacy. <i>JAMA</i> <a href="https://doi.org/10.1001/jama.2021.3465" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1001/jama.2021.3465">https://doi.org/10.1001/jama.2021.3465</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR51">Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. <i>Science</i> <a href="https://doi.org/10.1126/science.abg3055" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1126/science.abg3055">https://doi.org/10.1126/science.abg3055</a> (2021)<i>.</i></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR52">Cousins, S. New Zealand eliminates COVID-19. <i>Lancet</i> <b>395</b>, 1474 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2820%2931097-7" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(20)31097-7" data-track-item_id="10.1016/S0140-6736(20)31097-7">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXovFKltLs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=New%20Zealand%20eliminates%20COVID-19&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2931097-7&amp;volume=395&amp;publication_year=2020&amp;author=Cousins%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR53">Fouda, A., Mahmoudi, N., Moy, N. &amp; Paolucci, F. The COVID-19 pandemic in Greece, Iceland, New Zealand, and Singapore: health policies and lessons learned. <i>Health Policy Technol.</i> <b>9</b>, 510–524 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.hlpt.2020.08.015" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.hlpt.2020.08.015" data-track-item_id="10.1016/j.hlpt.2020.08.015">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20COVID-19%20pandemic%20in%20Greece%2C%20Iceland%2C%20New%20Zealand%2C%20and%20Singapore%3A%20health%20policies%20and%20lessons%20learned&amp;journal=Health%20Policy%20Technol.&amp;doi=10.1016%2Fj.hlpt.2020.08.015&amp;volume=9&amp;pages=510-524&amp;publication_year=2020&amp;author=Fouda%2CA&amp;author=Mahmoudi%2CN&amp;author=Moy%2CN&amp;author=Paolucci%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li></ol></div></div>
        </div>
    </div>
</aside>
</div>


    
        
    
    
        
            
        

        
            
        
    
    <script>
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            page: {
                content: {
                    fundingWidget: "true",
                        }
                    }
                });
    </script>




<footer class="composite-layer" itemscope="" itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        

        <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <div class="c-meta u-ma-0 u-flex-shrink">
                <p class="c-meta__item c-meta__type u-mt-0">
                    <span itemprop="name">
                        Nature Medicine
                    </span>
                    (<i itemprop="alternateName">Nat Med</i>)
                </p>
                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1546-170X</span> (online)
        </p>
    

                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1078-8956</span> (print)
        </p>
    

            </div>
        </div>
    </div>
</div>

    <div class="c-footer">
        <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__container">
        <div class="c-footer__grid c-footer__group--separator">
            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">About Nature Portfolio</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" data-track-label="link">About us</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link">Press releases</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link">Press office</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" data-track-label="link">Contact us</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Discover content</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link">Journals A-Z</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/subjects" data-track="click" data-track-action="article by subject" data-track-label="link">Articles by subject</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.protocols.io/" data-track="click" data-track-action="protocols.io" data-track-label="link">protocols.io</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link">Nature Index</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Publishing policies</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/authors/editorial_policies" data-track="click" data-track-action="Nature portfolio policies" data-track-label="link">Nature portfolio policies</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nature-research/open-access" data-track="click" data-track-action="open access" data-track-label="link">Open access</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Author &amp; Researcher services</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/reprints" data-track="click" data-track-action="reprints and permissions" data-track-label="link">Reprints &amp; permissions</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link">Research data</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/language-editing/" data-track="click" data-track-action="language editing" data-track-label="link">Language editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link">Scientific editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link">Nature Masterclasses</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://solutions.springernature.com/" data-track="click" data-track-action="research solutions" data-track-label="link">Research Solutions</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Libraries &amp; institutions</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link">Librarian service &amp; tools</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link">Librarian portal</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/openresearch/about-open-access/information-for-institutions" data-track="click" data-track-action="open research" data-track-label="link">Open research</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/recommend-to-your-library" data-track="click" data-track-action="Recommend to library" data-track-label="link">Recommend to library</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Advertising &amp; partnerships</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link">Advertising</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link">Partnerships &amp; Services</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link">Media kits</a>
                    </li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link">Branded
                        content</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Professional development</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/naturecareers/" data-track="click" data-track-action="nature careers" data-track-label="link">Nature Careers</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://conferences.nature.com" data-track="click" data-track-action="nature conferences" data-track-label="link">Nature<span class="u-visually-hidden"> </span>
                        Conferences</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Regional websites</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natafrica" data-track="click" data-track-action="nature africa" data-track-label="link">Nature Africa</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link">Nature China</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link">Nature India</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natitaly" data-track="click" data-track-action="nature Italy" data-track-label="link">Nature Italy</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureasia.com/ja-jp" data-track="click" data-track-action="nature japan" data-track-label="link">Nature Japan</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nmiddleeast" data-track="click" data-track-action="nature middle east" data-track-label="link">Nature Middle East</a></li>
                </ul>
            </div>

        </div>
    </div>
    <div class="c-footer__container">
        <ul class="c-footer__links">
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/privacy" data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy
                Policy</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/cookies" data-track="click" data-track-action="use of cookies" data-track-label="link">Use
                of cookies</a></li>
            <li class="c-footer__item">
                <button class="optanon-toggle-display c-footer__link" onclick="javascript:;" data-cc-action="preferences" data-track="click" data-track-action="manage cookies" data-track-label="link">Your privacy choices/Manage cookies
                </button>
            </li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/legal-notice" data-track="click" data-track-action="legal notice" data-track-label="link">Legal
                notice</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/accessibility-statement" data-track="click" data-track-action="accessibility statement" data-track-label="link">Accessibility
                statement</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/terms-and-conditions" data-track="click" data-track-action="terms and conditions" data-track-label="link">Terms &amp; Conditions</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/ccpa" data-track="click" data-track-action="california privacy statement" data-track-label="link">Your US state privacy rights</a></li>
            
        </ul>
    </div>
</div>


        <div class="c-footer__container">
    <a href="https://www.springernature.com/" class="c-footer__link">
        <img src="/static/images/logos/sn-logo-white-ea63208b81.svg" alt="Springer Nature" loading="lazy" width="200" height="20">
    </a>
    <p class="c-footer__legal" data-test="copyright">© 2025 Springer Nature Limited</p>
</div>

    </div>
    <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><defs><path id="a" d="M0 .74h56.72v55.24H0z"></path></defs><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"></path></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"></path></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"></path></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"></path></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"></path></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"></path></symbol><symbol id="icon-cart" viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"></path></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"></path></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"></path></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"></path></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"></path></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand"><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"></path></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"></path></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"></path></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"></path></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"></path></symbol><symbol id="icon-minus" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"></path></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"></path></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"></path></symbol><symbol id="icon-search" viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"></path></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"></path></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"></path></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"></path></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"></path></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"></path></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"><path style="fill:none" d="M0 0h56.69v56.69H0z"></path><clipPath id="b"><use xlink:href="#a" style="overflow:visible"></use></clipPath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"></path></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"></path></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"></path></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"></path></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"></path><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"></path><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"></path><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"></path></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"></path></g></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 24 24"><path d="m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z"></path></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"></path></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"></path></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"></path></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand-image" viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"></path></symbol><symbol id="icon-github" viewBox="0 0 100 100"><path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"></path></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id="icon-submit-open" viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"></path></symbol></svg>
</div>
</footer>




    

    

<div class="c-site-messages message u-hide u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif " data-component-id="nature-briefing-banner" data-component-expirydays="30" data-component-trigger-scroll-percentage="15" data-track="in-view" data-track-action="in-view" data-track-category="nature briefing" data-track-label="Briefing banner visible: Flagship">

    
    <div class="c-site-messages__banner-large">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__form-container">

            <div class="grid grid-12 last">
                <div class="grid grid-4">
                    <img alt="Nature Briefing" src="/static/images/logos/nature-briefing-logo-n150-white-d81c9da3ec.svg" width="250" height="40">
                    <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing</em> newsletter — what matters in science, free to your inbox daily.</p>
                </div>
                <div class="grid grid-8 last">
                    <form action="https://www.nature.com/briefing/briefing" method="post" data-location="banner" data-track="signup_nature_briefing_banner" data-track-action="transmit-form" data-track-category="nature briefing" data-track-label="Briefing banner submit: Flagship">
                        <input id="briefing-banner-signup-form-input-track-originReferralPoint" type="hidden" name="track_originReferralPoint" value="MainBriefingBanner">
                        <input id="briefing-banner-signup-form-input-track-formType" type="hidden" name="track_formType" value="DirectEmailBanner">

                        <input type="hidden" value="false" name="gdpr_tick" id="gdpr_tick_banner">
                        <input type="hidden" value="false" name="marketing" id="marketing_input_banner">
                        <input type="hidden" value="false" name="marketing_tick" id="marketing_tick_banner">
                        <input type="hidden" value="MainBriefingBanner" name="brieferEntryPoint" id="brieferEntryPoint_banner">

                        <label class="nature-briefing-banner__email-label" for="emailAddress">Email address</label>

                        <div class="nature-briefing-banner__email-wrapper">
                            <input class="nature-briefing-banner__email-input box-sizing text14" type="email" id="emailAddress" name="emailAddress" value="" placeholder="e.g. jo.smith@university.ac.uk" required="" data-test-element="briefing-emailbanner-email-input">
                            
                            <input type="hidden" value="true" name="N:nature_briefing_daily" id="defaultNewsletter_banner">
                            <button type="submit" class="nature-briefing-banner__submit-button box-sizing text14" data-test-element="briefing-emailbanner-signup-button">Sign up</button>
                        </div>

                        <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
                            <input class="nature-briefing-banner__checkbox-checkbox" id="gdpr-briefing-banner-checkbox" type="checkbox" name="gdpr" value="true" data-test-element="briefing-emailbanner-gdpr-checkbox" required="">
                            <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for="gdpr-briefing-banner-checkbox">I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href="https://www.nature.com/info/privacy">Privacy Policy</a>.</label>
                        </div>
                    </form>
                </div>
            </div>

        </div>

    </div>

    
    <div class="c-site-messages__banner-small">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__content text14">
            <span class="c-site-messages--nature-briefing__strapline strong">Get the most important science stories of the day, free in your inbox.</span>
            <a class="nature-briefing__link text14 sans-serif" data-track="click" data-track-category="nature briefing" data-track-label="Small-screen banner CTA to site" data-test-element="briefing-banner-link" target="_blank" rel="noreferrer noopener" href="https://www.nature.com/briefing/signup/?brieferEntryPoint=MainBriefingBanner">Sign up for Nature Briefing
            </a>
        </div>

    </div>

</div>






<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="//content.readcube.com/ping?doi=10.1038/s41591-021-01334-5&amp;format=js&amp;last_modified=2021-04-16" async=""></script>

<dii-qjozoxrhcdse></dii-qjozoxrhcdse><div data-cc-ghost="" style="height: 352px;"></div><script type="text/javascript" id="fetch-contextual-ads-campaign-data" charset="">(function(){var g=function(a){a=new CustomEvent("campaignDataLoaded",{detail:a});document.dispatchEvent(a)},b=google_tag_manager["rm"]["50443292"](18);if(b){var k=1500;b=google_tag_manager["rm"]["50443292"](19);b="link"===b?google_tag_manager["rm"]["50443292"](20):google_tag_manager["rm"]["50443292"](21);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(","):null))};d.open("GET",
"/platform/contextual?doi\x3d"+a);d.send()},n=function(a,c){a&&-1===a.indexOf("not set")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds="",g(null)})();</script>
<script type="text/javascript" id="gtm-setup-accessdetailsloaded-handler" charset="">document.addEventListener("accessdetailsloaded",function(a){a=a.detail||{};var b={event:"update-access-details"};a.institutional_business_partner_ids&&a.resolved_by||console.log("BPID data could not be retrieved from /exposed-details");a.logged_in_to_sn_profile||console.log("logged_in_to_sn_profile could not be retrieved from /exposed-details");var c=a.institutional_business_partner_ids&&a.institutional_business_partner_ids.join?a.institutional_business_partner_ids.join(";"):"",d=a.resolved_by&&a.resolved_by.join?
a.resolved_by.join(";"):"",e=a.personal_business_partner_id_found,f=a.logged_in_to_sn_profile,g=a.snid;b.user={};b.user.profile={};b.user.profile.profileInfo={resolvedBy:d||null,bpid:c||null,personal:e||null,logged_in_to_sn_profile:f,snid:g||null};b.session={};b.session.authentication={};b.session.authentication.token=a.token||null;b.session.authentication.legacy={};window.dataLayer.push(b);window.idpUserDataLoaded=!0},!1);window.dataLayer.push({event:"accessdetailsloaded-handler-added"});
window.accessDetailsLoadedHandlerAdded=!0;</script><script type="text/javascript" id="gtm-mediatrust" charset="">var s=document.getElementsByTagName("script")[0],p=document.createElement("script");p.async="async";p.src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2";s.parentNode.insertBefore(p,s);</script><script id="crossmark-script" text="" charset="" type="text/javascript" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><script type="text/javascript" id="polyfill-matches" charset="">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script><script type="text/javascript" id="fetch-idp-user-data" charset="">(function(a){if("function"===typeof window.CustomEvent)return!1;var c=function(d,b){b=b||{};var e=document.createEvent("CustomEvent");e.initCustomEvent(d,b.bubbles||!1,b.cancelable||!1,b.detail||a);return e};c.prototype=window.Event.prototype;window.CustomEvent=c})();var parse=function(a,c){try{return 200===a?JSON.parse(c):null}catch(d){return null}},dispatch=function(a){a=new CustomEvent("accessdetailsloaded",{detail:a});document.dispatchEvent(a)},site=google_tag_manager["rm"]["50443292"](59),idpUrl;
switch(site){case "nature":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?"https://staging-idp.nature.com/exposed-details":"https://idp.nature.com/exposed-details";break;case "link":idpUrl=-1<window.location.hostname.indexOf("link-qa")?"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details";break;case "springer":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?
"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details"}if(void 0!==idpUrl){var transport=new XMLHttpRequest;transport.open("GET",idpUrl,!0);transport.withCredentials=!0;transport.onreadystatechange=function(){4===transport.readyState&&dispatch(parse(transport.status,transport.responseText))};transport.send()}else dispatch(null);</script><script src="https://verify.nature.com/verify/nature.min.js"></script><script type="text/javascript" id="create-ad-slots" charset="">function createAndLoadAds(){function h(b){"nature"===a&&google_tag_manager["rm"]["50443292"](87)(b);"bmc"!==a&&"springeropen"!==a||google_tag_manager["rm"]["50443292"](99)(b);("link"===a&&"oscar"===google_tag_manager["rm"]["50443292"](100)||"springer"===a||"link"===a&&!0===google_tag_manager["rm"]["50443292"](101))&&google_tag_manager["rm"]["50443292"](126)(b);"link"===a&&"bunsen"===google_tag_manager["rm"]["50443292"](127)&&google_tag_manager["rm"]["50443292"](152)(b);"link"===a&&"Core"===google_tag_manager["rm"]["50443292"](153)&&google_tag_manager["rm"]["50443292"](165)(b)}window.googletag=window.googletag||{cmd:[]};var a=google_tag_manager["rm"]["50443292"](166),e=google_tag_manager["rm"]["50443292"](168);
if(-1===window.location.search.indexOf("hide_ads\x3dtrue"))if(window.adSlots&&0!==Object.keys(window.adSlots).length)console.log("Ads previously loaded. Will not update ad slots until next page load.");else{window.adSlots||(window.adSlots={});window.getAd=function(b,f){for(var c in window.adSlots)if(-1<c.indexOf(b)){if("object"===f)return adSlots[c];if("slot"===f)return adSlots[c].slot}};googletag.cmd.push(function(){googletag.pubads().setPrivacySettings({limitedAds:e});console.log("limitedAds is ",
e);googletag.pubads().setRequestNonPersonalizedAds(google_tag_manager["rm"]["50443292"](170));googletag.pubads().enableSingleRequest();googletag.pubads().disableInitialLoad()});for(var g=document.querySelectorAll("[data-gpt]"),d=0;g[d];++d)h(g[d]);googletag.cmd.push(function(){googletag.enableServices()})}}createAndLoadAds();</script>
</body></html>